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SUMMARY
XVI
Over the past 25 years research on the pathogenesis of cholera 
has focused on the role of enterotoxin, largely to the neglect of the 
other extracellular components such as neuraminidase, mucinase and 
proteinase. The main object of this thesis has been to study the 
effect of Vibrio cholerae neuraminidase on the histochemistry of the 
sialomucin layer, and the binding of the bacteria and of the enterotoxin 
to gut mucosa.
Both laboratory-prepared and commercial sources of neuramini­
dase were utilised. For the former, V. cholerae NCTC 10732 was grown 
in proteose peptone broth containing bovine colostrum. The culture 
supernate, which contained the enzyme, was precipitated with methanol 
and the methanolic precipitate filtered on Sephadex G 100. The peak 
of neuraminidase activity in the eluate from the gel column did not 
coincide with the main protein peak as measured by either 280 nm 
absorption or the Lowry method. The partially purified neuraminidase 
preparations contained endoglycosidase, phospholipase-C and proteinase 
activity (as expected from previous studies) but lacked aldolase 
activity.
Neuraminidase activity was determined both by the thiobarbituric 
acid assay (T.B.A.) and also by the methoxyphenyl neuraminic acid method 
(M.P.N.). Both procedures had advantages and limitations. The 
advantages of the M.P.N, method were greater sensitivity and better 
stability of the colour complex, especially at low enzyme concentrations. 
The main drawback of the method was its dependence on the synthetic
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substrate M.P.N. which is not part of the mucin of the small-gut. The 
main virtue of the T.B.A. assay was its applicability to detecting 
N-acetylneuraminic acid (NANA)-containing moieties liberated from a 
variety of natural substrates. However,, the procedure could not 
determine whether the NANA was liberated as monosaccharides (indicative 
of neuraminidase activity) or as more complex NANA-containing entities 
(indicative either of endoglycosidase activity or simple solubilisation 
of sialomucin). A further drawback of the T.B.A. method is that its 
colour complex is generated not only by NANA but by 2-oxo-3-deoxy sugar 
acids.
In order to investigate the possible effect of neuraminidase 
on rat intestinal mucosa vitro, it was first necessary to find a 
tissue fixation procedure which preserved the sialomucin layer in 
tissue segments and frozen sections against loss during exposure to 
aqueous environments. Neither formal-saline nor Bouin's fluid were 
satisfactory but the paraformaldehyde vapour method cited by Culling 
gave adequate retention of the mucin layer.
The susceptibility of the NANA moiety of mucin in para­
formaldehyde vapour-fixed frozen sections to neuraminidase activity was 
monitored by Alcian Blue-Periodic Acid Schiff (PAS) staining. In 
agreement with previous published observations, it was noted that 
treatment of the sections with V. cholerae neuraminidase caused a 
general reduction in Alcian blue staining and a corresponding increase 
in PAS staining. This was interpreted as being due to loss of NANA 
(detected by Alcian blue) coupled with retention of the general muco- 
substance (detected by PAS). Quantitation of this phenomenon was 
obtained by determining the proportion of goblet cells staining with
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Alcian blue or PAS. The proportion of PAS-staining goblet cells was 
related to enzyme activity and thus provided a histochemical assay for 
neuraminidase.
Although V, cholerae neuraminidase pretreatment of fixed rat 
ileal tissue caused significant histochemical change in the sialomucin 
layer, as revealed by the Alcian blue/PAS staining, it did not affect 
the adherence capacity of the tissue for live V. cholerae organisms. 
This result emerged from 8 experiments in which the numbers of these 
bacteria adhering to standardised tissue segments showed no significant 
difference when exposed to highly purified commercial V. cholerae 
neuraminidase compared with enzyme-free buffer. By contrast, the 
neuraminidase pretreatments of these tissue segments caused a highly 
significant increase in the binding of cholera enterotoxin (in agree­
ment with previous findings). This was demonstrated by the rabbit 
skin-blueing test of solutions of enterotoxin which had been previously 
exposed to ileal segments which in turn had been either treated with 
neuraminidase or buffer.
Initial attempts to study the neutralisation of V. cholerae 
neuraminidase by specific antibody were frustrated by the presence of 
endogenous neuraminidase in the mammalian serum. This problem was 
overcome by using the IgG fraction of the anti-serum, with a similar 
fraction from normal serum as control. Immune serum IgG had definite 
neuraminidase-neutralising activity as measured by a variety of pro­
cedures: MPN, TEA and goblet cell assays. Normal serum IgG lacked
these neutralising activities.
In regard to the pathogenesis of cholera, the observations in 
this thesis suggest that the role of neuraminidase may be to enhance 
the effect of enterotoxin through promotion of its binding to tissue.
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but without .affecting the initial adherence of the vibrios to the 
mucosa. It must be recognised, however, that neuraminidase is only 
one component of the ensemble of enzymes produced by V, cholerae and 
currently known under the collective heading of "mucinase". Therefore 
the exact role of neuraminidase in pathogenesis must necessarily be 
defined in relation to the activities of the other extracellular 
enzymes,
INTRODUCTION
HISTORICAL PERSPECTIVE
1,1 Definition of Cholera
The Shorter Oxford English Dictionary On Historical Principles 
described cholera as having been derived from the Latin word for bile 
(Onions, 1973), The ancient medical literature described bile as one 
of the "four humours" of the classical physiologists. In line with 
the notion of bile, it was stated in 1634 that cholera was a malady 
associated with bilious diarrhoea, vomiting, stomach-ache and cramps 
(Onions, 1973), Cholera is now known to be a disease that is an acute 
(frequently severe) and dehydrating diarrhoeal infection which usually 
occurs with epidemic incidence and is caused by infection with vibrios 
(Finkelstein, 1975),
1,2 Endemic Indian Infection to Pandemic 
In a classic monograph on the History of Asiatic Cholera,
Macnamara (1876) stated that the greats of the classical period of 
medicine in Western Europe and China (Hippocrates, Galen and Wang-shooho) 
had never seen cholera in its epidemic or Asiatic form. The disease, 
however, was well known to the Indian subcontinent, and ancient Indian 
Medical literature (802-849 A.D.) noted that the disease was so wide­
spread and feared, that the local people of lower Bengal actually 
prayed to a goddess of cholera in order to save themselves from this 
dreaded disease (Macnamara, 1876),
The disease did not spread throughout the rest of the world 
until 1817 (Macnamara, 1876; Pollitzer, 1959; Rosenberg, 1962;
Longmath, 1966), and from then on became world-wide. Since the first 
world-wide epidemic or pandemic in 1817, there have beep 6  other
pandemics commencing in 1829, 1852, 1863, 1881, 1899, 1961 (Pollitzer, 
1959; Kamal, 1974).
1,3 Finding the Causative Agent 
The causative agent of Asiatic cholera was first observed 
microscopically by Pacini (Pacini, 1854; Hugh, 1964) and first isolated 
by Robert Koch (Koch, 1883; Pollitzer, 1959) but the notion that it was 
due to a specific intestinal infection was shared by many of the 19th 
century cholera investigators. The Bengal Medical Board that reviewed 
the reports of the 1817-1819 India Cholera Epidemic, stated that the 
disease was due to a "pestilential virus" which acted upon stomach and 
small intestines but was not contagious. It was not until 1831 that 
Neale proposed that the disease was due to a contagium vivum. In 1838 
Boehm made the first claim to have observed the causative agent from 
the faeces of cholera patients and described these organisms as 
"spherical organic particles". While microscopic investigation as to 
the nature of the causative agent was being pursued, epidemiological 
observations on the infectious nature of the disease were being made,
A monumental epidemiological observation was made by Dr, John Snow in 
1849, Snow traced the origin of a London cholera outbreak to a water 
pump in Broad Street, He demanded that the water pump handle be
removed, and the outbreak subsided. It was concluded from this Broad 
Street water-pump cholera outbreak that the disease was a contagious 
infection which was the result of a poison that reproduced itself in 
the bodies of its victims. In addition. Snow further stated that it 
was these poisonous substances that spread the disease and were to be 
found in the excreta and vomitus of the cholera patients. The most
important observation made by Snow, however, was that the disease was 
spread to others by a contaminated water supply.
In 1854 when London was again gripped by a cholera outbreak,
Snow noted that the infection was much more frequent among Londoners who 
utilized water from the sewage-contaminated lower Thames rather than 
those who utilized water from the Thames above the city of London 
(Macnamara, 1876), The views of Snow were further supported by the 
German investigator Max von Pettenkofer (1855), who held the view that 
the development of cholera took place in the soil and thus cholera and 
typhoid were dependent on the level of the ground water of a given region. 
While the epidemiological theories of Snow were being confirmed in the 
1854-1855 London Cholera Epidemic, progress in the microscopic 
identification of the causative agent was being made, Pacini described 
comma-shaped organisms (microbio colerigentio) which he had observed 
microscopically from the infected intestinal tissues of cholera 
victims of the 1854 epidemic in Florence (Pacini, 1854), This finding 
has been cited as the earliest observation of the cholera vibrio (Hugh, 
1964), At the same time that Pacini had described comma-shaped 
organisms in infected tissues, Hassall (1855) in London, also observed 
such organisms in the microscopic preparations of ricewater discharge 
from cholera patients. These organisms were described as vibriones 
and as such marked the first time that the causative agent was so 
described (Sticker, 1912),
The ing of comma-shaped organisms in infected tissues and 
faeces were reported again by numerous other investigators after Pacini 
and Hassall (Leyden, 1866; from Sticker, 1912; Klob, 1867), It was, 
however, Robert Koch (1883) who first isolated motile comma-shaped
bacilli from tissues and faeces of cholera patients during an outbreak 
of cholera in Alexandria, Egypt, and named the organism Vibrio cholerae.
Though Koch (1883) isolated and described the causative agent, 
there still persisted some confusion as to non-cholera vibrios also 
capable of causing gastrointestinal infection. This confusion first 
appeared in 1884 when Finkler and Prior discovered a cholera nostras 
during a cholera outbreak in the city of Bonn, The first basic key to 
resolve this problem came from Koch himself, namely, that blood contain­
ing stools used to make gelatin plates showed haemolytic zones around 
V, cholerae colonies (Koch, 1884a), The actual utilization of the 
phenomenon haemolysis or the lack of it was put into proper perspective 
by Kraus in 1903, After experimenting with 12 cholera-like and 9 true 
cholera organisms, Kraus found that only the cholera-like organisms were 
capable of producing zones of ,haemolysis on blood agar. Thus it was 
recommended that haemolysis or the lack of it be utilized as a means of 
differentiating the cholera-like from the true cholera vibrios.
The whole concept of haemolytic versus non-haemolytic vibrios 
became of critical importance after 1905, with the isolation by Gotschlich 
of vibrios from the intestines of Mecca pilgrims who died at the El Tor 
quarantine station but did not show signs of cholera while alive and at 
post-mortem. These vibrios taken from the Mecca pilgrims did, however, 
show agglutination with cholera-immune serum. When these strains 
(eltor isolates) were again examined by Kraus and Pribram (1905), it 
was found that the strains produced a soluble haemotoxin and an exotoxin 
which was lethal to experimental animals. There followed a period of 
uncertainty concerning the, role of El Tor vibrios and cholera infection, 
Kraus (1922) maintained the view that the El Tor vibrios were a class of
organisms that were distinct from the non-haemolytic V, cholerae 
organism, while other investigators (Kolle and Prigge, 1928) held the 
view that cholera vibrios could show a variable reaction concerning their 
haemolytic ability, and therefore such tests were not suitable for 
characterising the organisms.
The tragedy of this whole confusing state of affairs was that 
the world health authorities responsible for dealing with cholera 
declared that V, cholerae biovar eltor was free of any choleragenic 
capacity (Kamal, 1974). The refusal to accept V. cholerae biovar eltor 
as a causative agent of cholera infection persisted despite the fact 
that outbreaks of cholera had been reported in the Celebes (Indonesia) 
in the late 1930s, the mid-1940s and late 1950s (Van Loghem, 1938; 
Tanamal, 1959) and V. cholerae biovar eltor was isolated in each case.
The World Health Organisation was finally forced by the weight 
of mounting laboratory and epidemiological evidence (Felsenfeld, 1963, 
1966; World Health Organisation, 1965) that V. cholerae eltor was 
also a causative agent of cholera infection. The agent (V, cholerae 
eltor) was declared responsible for causing the Seventh Pandemic of 
cholera which began in 1961 on the island of Sulawesi, and spread 
throughout the world (Kamal, 1974),
II TOXIN
2,1 Cholera a Toxicosis 
' With the discovery and isolation of the causative agent(s)
(V, cholerae, biovar Classical; V, cholerae biovar eltor) of cholera 
infection, the question that followed was what was the pathogenesis
of the disease? It was suggested by Koch (1884b) that the disease 
was a toxicosis, but unfortunately the leading pathologist of the time, 
Virchow (1879), believed that the primary lesion in cholera infection 
was denudation of the intestinal epithelium resulting in exudation and 
fluid loss. It would take 82 years to establish firmly that f^och was 
correct in his assumption that cholera was indeed a toxicosis,
Virchow's view was first challenged by Cohnheim (1882), who 
refuted the entire concept of desquamation as being nothing more than 
post-mortem maceration. The notion of an intact membrane was further 
supported by later investigators (Goodpasture, 1922; Dutta, Panse and 
Kulkarni, 1959; Gangarosa £t a]^ , 1960; Fresh, Versage and Reyes,
1964), The first investigation to show that a toxin was responsible 
for water and ion loss was done by De in 1959, However, it was 
Benyajata in 1966, who established the role of cholera enterotoxin in 
man by instilling a sterile preparation into the small intestine of a 
volunteer, who later manifested diarrhoea, which resembled that found in 
cholera infection. With the aid of both light microscopy and electron 
microscopy, it was observed that the jejunum and ileal tissue sections 
from dogs orally infected with live V, cholerae organisms did not differ 
from the tissue sections of control dogs (non-infected), with the 
exception of a slight inflammation of the Crypts of Lieberkühn in infected 
tissues (Elliott et al, 1970), Thus the production of rice-water 
stools found in cholera infection was due to hypersecretion in the region 
of the Crypts of Lieberkühn (Elliott et al, 1970),
2,2 Molecular Structure of Cholera Enterotoxin 
The enterotoxin of V, cholerae was first isolated and purified
by Finkelstein and Lo Spalluto in 1969, In a subsequent investigation, 
a protein that was immunologically identical to enterotoxin but 
biologically inactive was isolated (Finkelstein, Fujita and Lo 
Spalluto, 1971), This biologically inactive substance was later called 
toxoid (enterotoxoid) or choleragenoid. The intact and biologically 
active enterotoxin molecule was a protein of about 84 k. Dal, and did 
not contain any detectable lipid or carbohydrate (Lo Spalluto and 
Finkelstein, 1972), The molecular weights of the enterotoxin and 
enterotoxoid differed, in that the former had a molecular weight of 
84 k. Dal, whereas the latter had a molecular weight of 58 k. Dal,,
Both the enterotoxin and the enterotoxoid reversibly dissociated into 
15 k. Dal, sub-units when treated with Tris +  10 ^ M dithiothreitol or 
glycine (up to pH 6 ,8 ), If the enterotoxin molecule was electrophoresed 
in gel containing SDS, two bands were seen with molecular mass of 56 
k. Dal., and 28 k. Dal, (Finkelstein, La Rue and Lo Spalluto, 1972),
By contrast, when enterotoxoid was electrophoresed by the same method, 
only a single band of 56 k. Dal, was seen, Finkelstein (1973) stated 
that his pure enterotoxin did not have any of the following enzymic 
activities: neuraminidase, proteinase, lyase, lecithinase, hyaluronidase,
chondroitin sulphatase, RNAase, DNAase and mucinase,
Enterotoxin was later found to be composed two oligomeric 
sub-units which were noncovalently bound; one of about 60 k. Dal, (an 
aggregate of 8-10 k. Dal, peptides) and another major sub-unit of about 
30 k. Dal, which contained 25 k. Dal, and 5 k. Dal, components (Cuatre- 
casas, Parikh and Hollenberg, 1973). The 60 k. Dal, enterotoxin unit 
could be dissociated into 10 k. Dal, peptides (B-sub-unit) and recombined 
with the 30 k. Dal, component (A-sub-unit) to restore the biological
activity of the parent molecule. When the intact toxin molecule was 
heated in 1.0-2,0% SDS, the enterotoxin components were consistently 
36 k. Dal, and 8  k. Dal,, It was further found that after reduction 
and carboxymethylation, the 36 k. Dal, sub-unit was reduced to 27 k. Dal,, 
A smaller peptide was released by reduction and carboxymethylation^but 
this did not prove that the components were covalently coupled by 
disulphide linkage to the larger component because boiling for 50 min 
without reducing agents also brought about dissociation. It was there­
fore concluded that the two components were associated by 'extraordinarily 
tight non-covalent forces'. The 36 k. Dal,, as well as the 27 k. Dal, 
components, were not soluble in aqueous media. Antisera against the 
36 k. Dal, component gave rise to antibodies which cross-reacted with 
enterotoxin components (Table 1), This suggested that the 36 k. Dal, 
unit was composed of a unique peptide, the 27 k. Dal,, which was 
associated with a smaller sub-unit k. Dal,) similar or identical
to the B sub-unit. The 36 k. Dal, sub-unit was called the active 
sub-unit, with the 27 k. Dal, component being the unique, biologically- 
active portion,
Enterotoxoid proved to be a powerful antagonist of enterotoxin 
in intestinal loops (Pierce, 1973; Holmgren, 1973), The role of
enterotoxoid as an antagonist of the action of enterotoxin was also
<-
produced in experiments which utilized isolated rat fat cells (Cuatre- 
casas, 1973a), and with human neutrophils (Bourne et al, 1973), Entero­
toxoid bound to the identical membrane receptor with the same avidity 
as did enterotoxin and therefore was a competitive antagonist of the 
binding and action of enterotoxin,
!
Antigen
Antiserum against 
toxin components 
36 27 
k. Dal. k. Dal
36 k. Dal. ++ ++
enterotoxin ++ -
enterotoxoid + + -
27 k. Dal. + ++
Table 1: Reaction of antiserum a&ainst
enterotoxin components
Legend :
“ " no reaction
+ = weak reaction
++ = strong reaction
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It was proposed that the B sub-unit was responsible for the 
initial interaction with cell surface, while the A sub-unit represented 
the biologically-active portion of the molecule (Cuatrecasas, Parikh and 
Hollenberg, 1973; Van Heyningen, 1974; Finkelstein e_t al, 1974; 
Holmgren and Lonnroth, 1975). The molecular difference between entero­
toxin and enterotoxoid was the presence of a toxic sub-unit A in the 
former, and the A sub-unit contained two disulphide linked peptides
of unequal sizes which were called A^  ^ (28 k. Dal.) and A^ (5 k. Dal.) 
(Finkelstein et al, 1974). By contrast, the B sub-unit was common to 
both enterotoxin and enterotoxoid. The A sub-unit was linked to five 
B units (11 k. Dal, each) in a noncovalent fashion (Figures la,b).
The A sub-unit alone activated adenylate cyclase to a similar extent 
as enterotoxin but higher concentrations were required than that 
necessary for the intact molecule, and this activity was not blocked by 
the presence of gangliosides or enterotoxoid (Figure lb) (Van Heyningen
and King, 1975; Sahyoun and Cuatrecasas, 1975; Gill and King, 1975),
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Direct measurement of the interaction of I labelled A sub-unit with 
fat cell membranes provided additional evidence that this molecule did 
not react with the membrane receptors for enterotoxin or enterotoxoid 
(Sahyoun and Cuatrecasas, 1975),
2,3 Binding of Enterotoxin to Monosialoganglioside (G^ ) 
Gangliosides have been defined as being sialomucolipids which 
are soluble in water and consist of a non-polar ceramide residue linked 
to a polar residue which is composed of a polysaccharide chain with one 
or more N-acetylneuraminic acid (NANA) moieties (Figure 2) (Bizzini, 
1977), At present those gangliosides that have been described differ
11 The »ub-umi io*im&
(al plan
 7
Figure la:
(b) elevation
The ariangerneni of Ihe sub-units ol choleia toxin The five B sub-units
lorm a img stiuctuie (a) into which the A sub-unii pamally inserts (b)
(Stephen and Piecrowski, 1981b).
glucose 
amino acids 
Na^
ATP
r k i A - cAMP
Figure lb : Mechanism by which cholera toxin causes diarrhoea Binding of toxin 
to receptors on the lumen surface d ileal mucosal cells is followed by entry ol fragment 
A which interacts with the adenylate cyclase complex on the basal membrane, inhibit­
ing the GTPase-mediated turn-off the cyclase (probably by ADP-r.bosylat.on of the 
GTP-dependent regulator protein). Increased Jntracellular cyclic AMP levels cause, by 
s o m e  a s  yet unknown mechanism, efflux of Na and Cl ions, and hence also water.
(Stephen and Pietrowski, 1981b).
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from each other in the composition of the polysaccharide residue 
(Bizzini, 1977)* In nervous tissue, four types of gangliosides are
commonly found. The polysaccharide chainfof these gangliosides found
in nervous tissue contains two galactose, one N-acetylglucosamine and 
from one to three NANA groups (Bizzini, 1977),
The effect of cholera enterotoxin in intestinal loops of rabbits 
and on epididymal fat cells of rats was neutralised by purified ganglio­
sides (Van Heyningen et al, 1971), This finding suggested that 
fixation of enterotoxin to gangliosides might be involved in the binding 
of cholera enterotoxin to cell membranes, Holmgren (1973) found that 
monosialoganglioside (G^ ) in contrast to other gangliosides tested,
fixed cholera enterotoxin in vivo, and that one mole of G ganglioside
1
(16 k. Dal,) could fix as well as inactivate about one mole of entero­
toxin (84 k. Dal,), indicating specific 1:1 stoichiometric proportions. 
This finding strongly suggested that G^  ^ ganglioside could be the tissue 
receptor for cholera enterotoxin. The fixation of tetanus toxin and 
the de-activation of cholera enterotoxin, was described as being toxin 
specific by Van Heyningen and Mellanby (1973), In addition, these 
investigators further stated that the de-activation of cholera entero­
toxin was like the fixation of tetanus toxin because: (a) it was 
apparently limited to a particular enterotoxin, (b) it was specific to 
a particular ganglioside and (c) it took place at very low concentrations 
of ganglioside. De-activation of cholera enterotoxin and the inactiv­
ation of a number of other enterotoxins was distinguished on the 
grounds that de-activation wasî<^ specific with respect to both entero­
toxin and ganglioside, (b) occurred at much lower concentrations of
ganglioside than required for inactivation and (c) occurred relatively
!
quickly.
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Neuraminidase-resistant monosialoganglioside (G^ ) or GG^SIC, 
was able to prevent cholera enterotoxin from acting in rabbit skin, and 
also prevented the adenyl cyclase system from acting in the small 
intestine of guinea-pigs. In addition, it was stated that the de­
activation of cholera enterotoxin by a specific ganglioside could be 
due to its presence in the cell membrane, or to the presence of 
molecular structures in the cell membrane which closely, resembled that 
of G^ ganglioside (King and Van Heyningen, 1973), Inhibition of the
biological activity of enterotoxin with G» was confirmed by other
^ 1
investigators (Cuatrecasas, 1973b,c,d; Holmgren, Lonnroth and 
Svennerholm, 1973a,b), A variety of gangliosides blocked the binding 
of enterotoxin to cell membranes but the most potent inhibitor of 
these was the G^ ganglioside (Cuatrecasas, 1973c,d). The enterotoxin 
showed an affinity for the carbohydrate region of the Gj^  ganglioside 
(King and Van Heyningen, 1973; Holmgren, Lonnroth and Svennerholm, 
1973b), Derivatives of the G^ ganglioside which had only one hydro­
carbon chain were shown to bind enterotoxin (StSerk ^  al, 1974; 
Holmgren, Mansson and Svennerholm, 1974), whereas the oligosaccharide
fragments of the G^ ganglioside were shown to bind to enterotoxin with
 ^ 125
somewhat reduced affinity. I-labelled enterotoxin was bound to all
regions of the gastrointestinal tract of adult guinea-pigs with equal
avidity (Peterson, 1974), The conclusion drawn from this finding
was that the enterotoxin receptor was a universal component of many
125
mammalian cell membranes, I-labelled enterotoxin binding was
inhibited by preincubation of the tissue homogenates with unlabelled 
enterotoxin but not by comparable concentrations of normal rabbit serum 
(Peterson, 1974), The binding of enterotoxin to three transformed
15
mouse epithelial cell lines derived from the parent strain, the effect 
of enterotoxin on DNA synthesis and adenylate cyclase activity varied 
in parallel with the ganglioside composition of the cells (Hollenberg 
et al, 1974).
The binding of enterotoxin by brain tissue increased during 
incubation for 1 h at 37°C. However, the binding of cholera entero­
toxin to rabbit small intestinal epithelial tissue was,less affected by 
the same conditions of exposure to enterotoxin. In addition, the 
epithelial tissue in guinea-pigs was found to bind enterotoxin (Gascoyne 
and Van Heyningen, 1975), thus confirming an earlier finding made by 
Peterson (1974), Rabbit liver tissue was also capable of binding 
enterotoxin at levels comparable to that bound by the epithelial tissue 
of rabbit small intestine (Gascoyne and Van Heyningen, 1975), The 
binding capacity of the tissues tested with the exception of the brain 
was found to vary when tissues taken from guinea-pig were compared 
with those taken from rabbit, A variation in binding capacity was 
even found to exist when different individuals of the same species were 
compared, A slight difference existed between the enterotoxin binding 
capacity of various tissues and their content of enterotoxin-binding 
ganglioside, Enterotoxoid bound more slowly and less strongly than 
enterotoxin to the intestinal mucosa. It was suggested that both the 
binding and the active components of the enterotoxin molecule may be 
necessary for optimal binding of the enterotoxin to the intact cell.
In ruptured cells enterotoxoid only partially blocked the action of the 
enterotoxin (King and Van Heyningen, 1975), This suggested that while 
binding to a membrane receptor was necessary for the action of the
16
enterotoxin,on the whole cell, it was possible to activate adenyl 
cyclase in a perforated cell by a process which was apparently 
independent of membrane binding. It was noted, however, that this 
activation of adenyl cyclase could only be possible if the A  sub-unit 
dissociated from enterotoxoid, B sub-unit. It was demonstrated by 
immunofluorescence microscopy using normal human lymphocyte membranes 
and C 1210 lymphoma cells, that when enterotoxin and fluorescein- 
labelled antibodies were employed as ligands, the gangliosides on 
the lymphocytes were redistributed into aggregates and caps (Révész and 
Greaves, 1975),
G„ -deficient cells also showed by immunofluorescence microscopy 
1
a similar pattern of ligand-induced redistribution when exogenous G^ 
ganglioside was inserted. This observation was later confirmed by 
other investigators (Craig and Cuatrecasas, 1975; Bennett, O'Keefe 
and Cuatrecasas, 1975; Sedlacek ejb al, 1976) who also utilised immuno­
fluorescence microscopy. The effect of enterotoxin binding caused by
the addition of exogenous G^  ^ ganglioside upon ganglioside-deficient
 ^ 125
guinea-pig tumour (104C1) cells was further examined with I-labelled
enterotoxin or Dolichos biflorus lectin (specific for the terminal
nonreducing a-linked N-acetylgalactosamine moieties of glycoproteins and
125
glycosphingolipids) (Basu ^  al, 1976), Increased binding of I- 
labelled Dolichos biflorus lectin and enterotoxin to the cell surfaces 
of those tumour cells occurred after the exposure of the cells
to exogenous G^ ganglioside. Normal human fibroblasts were stated to
contain approximately 8 , 0  x 1 0  molecules of G^ ganglioside per cell 
(Moss, Mangiello and Fishman, 1977),
V
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It was proposed that there existed multiple sites on the entero­
toxin molecule which enabled it to bind to the oligosaccharide portion 
of the ganglioside (Fishman, Moss and Osborne, 1978). Equilibrium 
dialysis and gel permeation chromatography confirmed that each entero­
toxin molecule was able to bind between 5 and 6  molecules of oligo­
saccharide. This finding supported the earlier findings of King and 
Van Heyningen (1973) and Holmgren, LBnnroth and Svennerholm (1973b), who
also found that the enterotoxin was bound to the G» ganglioside by the
1
carbohydrate region. Studies conducted by O'Keefe and Cuatrecasas 
(1978) which utilised mouse fibroblasts (KBALB/3T3) which had been 
transf)rmed by sarcoma virus (transformation caused a marked loss in 
G^ ganglioside to that of the original parent strain of fibroblasts 
(BALB/G3T3) ), and rat fat cells supported the findings of earlier 
investigation (Basu et al, 1976), namely, that preincubation of
transformed, and rat fat cells with exogenous G^ gangliosides did
125 ^
enhance the binding of I-labelled enterotoxin. However, despite
the enhanced binding of enterotoxin to the transformed cell line, there 
did not occur any enhanced biological response (stimulation of 
adenylate cyclase). By contrast, preincubation of the rat fat cells 
with exogenous G^ gangliosides did enhance the stimulation of 
adenylate cyclase. The failure of the transformed cell to manifest an 
increase in biological response despite having bound increased amounts 
of enterotoxin, was explained by the fact that the addition of exo­
genous G^ would not be expected to alter sensitivity to enterotoxin 
1
in a cell which already contained more enterotoxin binding sites than 
normally required for maximal stimulation of adenylate cyclase (O'Keefe 
and Cuatrecasas, 1978),
18
It was found that endogenous neuraminidases were capable of 
unmasking neuraminidase-stable and neuraminidase-labile gangliosides 
in rabbit intestinal homogenates by attacking glycoproteins (Gascoyne 
and Van Heyningen, 1979), In addition, exogenous neuraminidase 
caused neuraminidase-labile gangliosides to be converted into cholera 
enterotoxin-binding_,neuraminidase—stable ganglioside. When the
cell surfaceyof human neutrophils were first pretreated with V» cholerae 
neuraminidase, there occurred an increased binding of fluorescein- 
labelled cholera enterotoxin (Ackerman, Wolken and Gelder, 1980),
This finding was attributed to conversion of the membrane gangliosides 
to enterotoxin-binding gangliosides, as had been previously stated 
(Gascoyne and Van Heyningen, 1979), However, the findings of Gascoyne 
and Van Heyningen (1979), and Ackerman, WoIker and Gelder (1980) 
conflicted with those of Holmgren (1981) who found that the treatment 
of rabbit intestinal epithelium with V, cholerae neuraminidase failed 
to create new receptors for enterotoxin, despite the fact that neura­
minidase pretreatment created new receptor sites in the epithelium 
of other tissues, Vertiev, Shaginiyan and Ezepchuk (1981) stated 
that it was difficult to prove that neuraminidase treatment increased 
the number of specific cell receptors for enterotoxin because both 
experimental and commercial preparations of V, cholerae neuraminidase 
were contaminated by proteinase and glycosidase activities.
Thus, with the binding of cholera enterotoxin to its receptor 
site on the epithelial cell membrane the initial process in cholera 
pathogenesis has been established.
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III INTESTINAL COLONISATION AND RELATED ASPECTS
With the finding in the mid-1960s (Benyajata, 1966) that cholera 
pathogensis was indeed due to a toxin, the greater part of scientific 
investigation on this subject was dominated in one way or other by 
enterotoxin. By the mid-1970s, however, researchers began to realise 
that an understanding of the manner in which the vibrios associated 
themselves with the host mucosa was equally important. This new 
focus of research endeavour was put forth as follows; If V» cholerae 
was to be a successful pathogen several conditions must be satisfied, 
(a) survival through the stomach's acid barrier, (b) colonisation of 
the ileum and (c) secretion of its enterotoxin (Nelson, Clements and 
Finkelstein, 1976),
3,1 Motility
Motile strains of V, cholerae were more virulent for suckling 
pigs, because the chance of the organism coming into contact with the 
small intestinal mucosa cells was greater (Guentzel and Berry, 1975),
! Non-motile cholera vibrios were found to be unable to attach to rabbitI
brush border membranes (Jones and Freter, 1976a,b). When thin 
I sections of rabbit ileum were exposed to vibrios, 8  h and 1 2  h post­
infection, microscopic (fluorescence) observations with fluorescein- 
labelled anti-vibrio antibody showed that only motile organisms had 
penetrated into the intervillous areas (Guentzel et al, 1977), 
Fluorescence microscopy again revealed that while nonmotile organisms 
remained in the gut, motile organisms were able to penetrate into the 
intervillous spaces and deep within the Crypts of Lieberkühn (Yancey,
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Willes and Berry, 1978), In addition to motility, Allweiss at al^
(1977) proposed that V, cholerae organisms must also possess chemotactic 
factors that enable them to interact with small intestinal mucosal 
surfaces (see section on Adhesion),
These investigations have revealed that those V, cholerae 
organisms which were highly motile and also possessed a directed chemo- 
tactic response were better able to associate with the intestinal 
mucosa,
3,2 Mucin
Perhaps one of the most formidable barriers preventing the 
association of V, cholerae organisms with the small intestinal mucosa 
is the mucin layer. As early as 1933, Florey noted that mucus was 
seen as lace-like strands under the light-microscope. He had found 
that the mucus which clung to the villi in the cat small intestine, was 
able to be cleansed of foreign particles (inert hydrokollog particles) 
by contractions of the underlying villi. Since Florey, other investigators 
have examined the mucin layer more closely with electron microscopy 
(Nelson, Clements and Finkelstein, 1976; Rozee e_t al, 1982) and have 
confirmed that the mucus existed as lace-like strands (Plate 1).
The mucus in the rabbit small intestine was described as a 
gel-like zone which separated the villi of the ileum from particulate 
intestinal contents (Schrank and Verwey, 1976), This region of ileal 
mucus extended 1 0 0  |j,m. above the villi tips, and when stained by either 
Toluidine blue or Theonine, it stained the characteristic reddish colour. 
The recent studies of the development of the blanket in ilea of 1-44 
day old mice were carried out with both scanning and transmission 
electron microscopy (Rozee et al, 1982), Electron micrographs of day
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old mice revealed that the mucus was only seen at the depressed
openings of the goblet cells. At a period of 4 days after birth the
mucus blanket coated a few areas of the epithelial surface of the 
ileum (Plate 1), Mice that were 12-14 days old possessed a much 
thicker blanket which was seen microscopically as a discontinuous 
balled and rolled up layered structure. Mice that were 24-30 days 
old possessed a mucus layer 1 0 - 2 0  pm in thickness which was described 
as being a continuous blanket which covered the villi of the ileum.
It was noted that there sometimes occurred cracks in this layer. By a 
period of 44 days after birth, the mucin was estimated to be 30-50 pm 
in thickness. From the period of 24 days after birth, it was
observed that there was present on the mucus a complete community of
bacteria and protozoa.
A variety of raucosubstances of the human alimentary tract were 
studied utilising the Alcian blue/PAS staining method at pH 2.5 (Gad, 
1969). The Alcian blue/PAS staining method enabled a distinction to 
be made between periodate unreactive and periodate reactive acid 
mucosubstances, from neutral periodate reactive mucosubstances. 
Periodate-unreactive acid mucosubstances stained blue, periodate- 
reactive mucosubstances stained blue, and neutral periodate muco­
subs tances stained magenta. At pH 1.0 the Alcian blue/PAS method 
differentiated between sulphomucins which stained blue, and neutral 
and sialomucins which stained red. The striated border of the small 
intestine gave a reaction which indicated the presence of sialomucin. 
In contrast, the colon and rectum demonstrated the presence of 
sulphomucin. Pearse (1968a) stated that the only possible way in
22
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Plate 1; Unwashed ileal epithelium from a 4 day old
mouse showing the degree of fragmentation and 
condensation of the mucus blanket.
(Bar = 50 pm).
(Rozee et al, 1982).
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which mucosubstancercan be defined histochemically was in terms of 
their response to the application of localising reagents used under 
rigorously defined conditions (Tables 2, 3). A  distinction was found 
between submucosal gland mucin and goblet cell mucin, namely, that 
the former was rich in sulphate while goblet cell mucin showed reduced 
sulphation and thé levels of sialic acid were increased at the expense 
of fucose moieties (Gallagher and Corfield, 1978). The presence of 
sialic acid in the goblet cell mucin was clearly revealed by localising 
its presence in microscopic sections using a peroxidase-labelled 
Limulus polyphemus lectin which has affinity for sialic acid moieties 
(Yamada and Shimazu, 1979). When the goblet cell mucin was analysed, 
protein accounted for 1 2 % of the dry weight, with the most abundant 
amino acids being threonine, serine and proline (Forstner, Jabbal and 
Forstner, 1973), In goblet cell mucus, the acidic amino acids were 
more numerous than the basic amino acids and sulphur-containing amino 
acids were low in concentration. The analysis of the sugar composition 
of the goblet cell mucus revealed that hexose, hexosamine, sialic acid 
and fucose were present. The composition of sugar per dry weight of 
goblet cell mucus was, total hexose 23%, hexosamine 22.4%, sialic acid 
10% and fucose 6 .6 %. The sulphur content of goblet cell mucus was 
less than 1 .0 % of the dry weight and there was an absence of lipid.
In two separate investigations (Finkelstein, 1973; Holmgren and 
Svennerholm, 1977) it was observed that the mucus layer must be 
penetrated before there could be a large established number of cholera 
vibrios in the intervillous spaces and the crypts of the small intestine 
(see section on adhesion). When live V. cholerae organisms were 
injected into cat small intestine, there appeared antibodies in the
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( I )  t ^ i M u œ s u a n A N C t s
N c u in l fly& oprolrlni 
I mmunof Inbulint 
Furo-miicoidi 
M innn-m uc/ildt
(A ll T A S -p o iiiivc ) (Perio<l»if-if»ciivc)
C*m uroiuliftanrr
( I I )  AaDMucxJSUBSiANcn 
. A Sulphiird
(1) Connrclirt T itfu r Muropofyiacchorides. (PAS-tirf»>ive) (Pcriodalc 
uiircaciivc)
(o) Stable 10 icsiicuUr hyaluronidaM
( i)  Alcianophilic in l-O M -M ^C Ij-kcraun tu lp b ile , bcpario.
S Y M B O L , S-n)ucopoIyMcx:b«ridt A ( l-O M g O ,)
(ii) Alcianophilic in O-VM-MgCti-dcrmaiiD fulphalc,
SYMBOL, S-muoopo1yMiccb«ndc A(0-7MgO,)
(6) Labile lo iciticular byaluronidite
(i) Alcobol-rcsislant «mrophilia (002 per cxni.) at or above 
pH 2‘B—chondroitin sulphalea in cartilage.
SYMBOL, S-œucopoljTJtcLiarîde B2-0T
(ii) Alcohol-resistant aiZurophilia (002 per cent.) at or above 
pH 4-B—chondroiiio sulphates in vascular walls.
SYMBOL, S-mucopolyuecharide B4-0T
(2) E pU htlia t Sulphomucins (testicular hyaluronidase-nrsistanl)
(a) PAS-negative
(i) Sulphate esters on ric-JslycoU.
SYMBOL, VGS-OJocin
(ii) Sulphate caters not on Wr-glycoU.
SYMBOL, S-mucin
(o) Akohol-resistanl azurophilia (0B2 per cent.) at or above 
pH 2-0.
SYMBOL, S-tDuda B I  O 
(6) Alcohol-rcsistaunt azurophilia (0-02 per cent.) at or above 
pH 4 3.
SYMBOL. S-DDCÎD B4 5 "
B. Noo-sulphaltd
(1) H tru ro n ic  add-rich  mucopolysaccharide]—hyaluronic add.
SYMBOL, U-*nucopolysacch*ride
(2) Sia lic  acid-rich mucosubnancoj 
(o) Conneaive Tissue Sialoirtudni
SYMBOL, C-inocopplysacchiride
(6) Epithelial Sialomucins
(i) Labile to Neuraminidase, PAS positive, mclachromatic with 
Azure A.
SYMBOL. CG mucin BN
(ii) Slowly digested by Neuraminidase 
(a) PAS-posithfc.
SYMBOL CG-mucin NJb
(fc) PAS-negiiivc.*
SYMBOL C-mocm N±
(iii) Stable to Neuraminidase.
(n) Rendered mcta chroma tic and ausoeptiblc to enzyme by 
prior saponibcation.
SYMBOL S-mucin (Sap)BN 
(h) Stable to Neuraminidase after aapontbcation.
(i) PAS-poôtivc.
SYMBOL CC-mucin
(ii) PASoegatrve.
S'L'MBOL C-mucio
Table 2 ; Classification of mucosubstances 
(Pearse, 1968b),
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Symbol Eguiralenfs o f Some Characseristic Mucosubitartcet
Symbol
Localization and Description of 
Tissue Mucosubstancc
G'tnucosubstaoce
S-mucopoIy saccha ride 
A(|-OMga,)
S-muco polysaccharide 
B2-0T 
S-mucopoIysaccharide 
B40T 
VGS-raucio
S-mudo B2-0 
S-mudn B4-5 
SO mucin B2-0
SG-mucia B4-S.
U-muco polysaccharide
C-mucopolysaccharide 
CG-mucin BN 
CG-mudn N± 
C-mucin N±
S-mucin (Sap) BN
GC-inucta
C-mucia
Gastric surface epithclia
'Thyroid Colloid (Man, Guinea pig, Rabbit)
Coagulating Gland Fluid (Rat, Mouse)
Cornea and Mast Cells
Cartilage
Ovarian Follicle Fluid
Aorta, Heart valves. Renal papilla.
Some areas of Cartilage
Sublingual glands (Hamster), Glossal mucous
glands (Rabbit), Colonic Goblets (Rabbit)
Colon (Guinea pig)
Exorbital Lacrimal Gland (Mouse)
Glossal mucous glands (R^ Mouse) 
Recto-sigmoid colonic goblets (Rat, Mouse) 
Duodenal Goblets (Rat, Mouse)
Pyloric Glands (Rat, Mouse)
Ganglion cysts of Synovia (Man), Vitreous 
(Man), Cock's comb. Oestrogen-treated cervix 
uteri (Mouse)
7 Cartilage
Sublingual glands (Mouse, Hamster, Guinea pig) 
Vaginal epithelium (Pregnant Meuse) 
Rectosigmoid mucous cells (House)
Sublingual Gland (Rat)
Sublingual Gland (Man, Monkey)
Mammary gland secretion (Mouse)
Table 3 : Symbol equivalents of some characteristic
mucosubstances
(Pearse, 1968b),
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mucins secretions (Cooper and Jackson, 1981), The intestinal route of 
injection favoured the local formation of agglutinating antibodies 
that were directly transferred to mupus secretions and were of the 
s-IgA class (see sections on Adhesion and Immunological 
factor#),
The presence of a mucus blanket and its associated flora, 
prevented colonisation of the intestinal epithelium by potential patho­
genic organisms (Rozee £t al, 1982), The presence of agglutinating 
antibodies of the s-IgA class in the mucus secretions of a host that has 
been orally immunised further facilitate the effectiveness of the mucin 
barrier to clear itself of foreign organisms (Williams and Gibbons,
1972; Freter, 1972). The removal of this mucus blanket and its 
normal associated flora by dietary changes, antibiotic treatment, or 
exposure to microbial toxins would effectively neutralise the mucin 
barrier and therefore facilitated tissue colonisation to invading 
organisms with the establishment of their associated pathology (Rozee 
al^ , 1982; see section on Non-Immunological Factors), Allen (1983) 
has stated that progress in the study and better understanding of mucus 
has been slow mainly because of numerous technical problems encountered 
in isolating it a soluble pure, native and undegraded mucus glyco­
protein that retains both the viscous and gel-forming properties of 
the native secretion,
3.3 Extracellular Enzymes
Though the intestinal sialomucin layer presents a physical barrier 
to the V, cholerae organisms associating with the intestinal epithelial 
cell surface, it has been proposed (Arbuthnott and Smyth, 1979;
Savage, 1980) that the major extracellular enzymes (muclnase, neura-
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minidase and proteinase) produced by the organisms could provide an 
effective means of hydrolysing the mucus. The final outcome of such 
extracellular enzymic activity could enable the organisms to create 
random tracks in the sialomucin which would permit penetration *bo
the columnar epithelial surface (Arbuthnott and Smyth, 1979). Thus, 
the V. cholerae organisms could then colonise a habitat on the surface 
of the small intestinal epithelium (Savage, 1980).
3.3a Mucinase
The mucinase (glycosidase) of V. cholerae was first mentioned by 
Burnet and Stone (1947a) who noted that when guinea-pig ileal segments 
were exposed to seitz-filtrates of 16 h old V. cholerae for 3 h at 37°C, 
there occurred desquamation of the ileal tissue. The filtrates of 
V. cholerae also possessed an enzyme which removed the influenza virus- 
receptor from red blood cells and designated it as Receptor Destroying 
Enzyme or R.D.E, (Burnet and Stone, 1947b), To establish whether the 
desquamation of guinea-pig epithelium was due to the R.D.E., the 
V, cholerae filtrate was heated for 30 min at 56^C- and it was found 
that the receptor destroying activity was destroyed, but the desquamating 
activity was still present. Purified V. cholerae mucinase could be 
precipitated in the cold with ammonium sulphate, and after dialysis 
with borate buffered saline pH 7,0, could be precipitated further by 
two volumes of acetone in the cold (Burnet, 1948), The mucinase 
activity was not significantly affected between pH 7,0 - 8 . 6  but was 
ill-defined below pH 6.5 . The mucinase activity was
slightly higher in the presence of C a ^  ions than in their absence.
If, however, the V. cholerae filtrate was treated with excess CaClg, at
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pH 6.0 and heated for 30 min at 55°C, R.D.E. was fully active but 
mucinase activity was destroyed (Burnet, 1949). Mucinase activity yas 
present in non-cholera vibrios as well as in cholera vibrips (Singh and 
Ahuja, 1953),
Jensen (1953) observed that immunisation of rabbits with
mucinase from culture filtrates of 24-h-old V. cholerae (93A) grown on
?
brain heart infusion agar gave rise not only to relatively high titrej 
of antimucinase antibody but to agglutinins as well. The antigenic 
properties of mucinase were found not to be impaired by lyophilisation. 
When rabbits were immunised with washed, viable cholera vibrios, 
agglutinins were produced but, in contrast, the level of antimucinase 
antibody was very low. Immunisation of rabbits with mucinase filtrates 
that were heated or treated with phenol or formalin gave agglutinins 
and little or no antimucinase activity, Antimucinase immunity was 
unable to prevent desquamation (Singh and Ahuja, 1953), It was not 
possible, however, to serologically differentiate the mucinase produced 
by non-cholera from that of cholera vibrios (Freter, 1955).
After a period of 35 years since Burnet's first paper on mucinase 
in 1947, Schneider and Parker (1982) re-examined the purification and 
characterisation of V. cholerae mucinase. The crude mucinase was 
purified on a Bio-Gel P-lOO column and two peaks were obtained. These 
peaks were re-chromatographed on the same column and the peaks were termed 
fraction 3 and 4, The G 100 Sephadex column gave weights for fractions 
3 and 4 which were respectively 38 k. Dal. and 22 k. Dal.. If, 
however, the estimation procedure was carried out on the Bio-Gel P-100 
column the weights of fractions 3 and 4 were 18 k. Dal, and 10 k. Dal, 
respectively. These findings were consistently obtained with ammonium
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sulphate-precipitated material or with highly purified material which 
was chromatographed.
These peaks (fractions 3 and 4) were assayed for proteinase, 
intestinal mucinase and ovomucinase enzyme activities. The re-chromato­
graphed fraction 3 had a protein content of 1.14 mg (mucinase active 
fraction)  ^ and a proteinase specific activity of 7,3 units (mg mucin­
ase active fraction) and an intestinal mucinase specific activity of 
0,554 units (mg mucinase active fraction) The re-chromatographed
fraction 4 had a protein content of 0,37 mg (mucinase active fraction) 
a proteinase specific activity of 5,9 units (mg mucinase active 
fraction)  ^ and an intestinal mucinase specific activity of 0,397 
units (mg mucinase active fraction) The ratio of proteinase to
mucinase in fraction 3 was 13,2 and 14,9 in fraction 4, Fraction 3 
when tested on SDS-PAGE and non-denaturing PAGE gels showed only a 
single band and in both gel systems had a molecular weight of approx­
imately 36 k. Dal,, Electrophoresis in high pH nondenaturing gels 
was performed on fractions 3 and 4, Assays of gel slices demonstrated 
that proteinase, intestinal mucinase and ovomucinase activity occurred 
at the same position of the fraction 3 protein. Activity stains on 
casein agar revealed only a single band of proteinase activity at the 
position of the fraction 3, The optimum pH for proteinase activity 
was 9,0 but the preparation showed an activity pH range of 6 ,2 -9 ,6 ,
The proteinase activity was destroyed when the enzyme preparation was 
heated to 65°C for 35 min. The enzyme was active against such 
substrates as immunoglobulins, bovine serum albumin and bovine catalase. 
When enzyme inhibitors of ovomucinase, intestinal mucinase and proteinase
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activity were investigated, only heavy metals were highly inhibitory.
Antiserum produced in New Zealand rabbits against fraction 3 
inhibited proteinase, intestinal mucinase and ovomucinase activity as 
well as fraction 4 enzyme activity. The anti-fraction 3 serum 
possessed both vibriocidal and agglutinating activity but it did not 
neutralise cholera enterotoxin in tissue studies.
When the antiserum was passed through a lipopolysaccharide- 
Sepharose column, the resulting antibody had a low titre of vibriocidal 
activity, and the agglutination activity titre was reduced from 256 to 
32, The adsorbed antibody gave a single line of identity with fraction 
3 and 4 in an Ouchferlony double diffusion assay. The protective 
capacity of the anti-sera preparations was determined by the "passive 
protection of infant mice". In this assay suckling mice which had 
not been fed for 4 h were inoculated perorally with 0,05 ml of the
antiserum to mucinase or the adsorbed antisera to mucinase, and within
7 8
30 min were challenged with 10 -10 CPU of V, cholerae strain GA401, 
and killed after 16 h. The small intestine was removed, weighed, 
and the remaining body weight determined, • A ratio of less than or equal 
to 0,060 was considered to signify a negative response while a ratio of 
greater than or equal to 0,065 indicated fluid secretion. The adsorbed 
antiserum was protective against mucinase (ratio of 0,060) even at 
dilutions where it was no longer vibriocidal. The unadsorbed antiserum 
which possessed antibody to somatic antigens and mucinase gave protection 
(ratio = 0,061) even when diluted to a low titre of vibriocidal activity* 
The protection afforded by this vaccine against fraction 3 was not 
directed against vibrio somatic antigen or cholera enterotoxin.
Culture fluids used for the purification of mucinase lacked
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neuraminidase activity. This lack of neuraminidase activity, however, 
could perhaps have been due to the fact that the buffer (pH 8,0) used 
was not at the optimum pH for V. cholerae neuraminidase activity 
(5,5-6,2; Ada, French and Lind, 1961; Schick and Zilg, 1977),
The role of mucinase, however, in V, cholerae still remains 
unclear,
3,3b Neuraminidase 
In 1956 R,D,E, was characterised as a glycosidase by Gottschalk. 
The R,D,E, was termed sialidase by Heimer and Meyer (1956), and later 
neuraminidase (Gottschalk, 1957), V, cholerae neuraminidase caused 
the removal of the terminal neuraminic acid unit from a neuramin- 
lactose substrate by hydrolytic cleavage of the glycosidic bond joining 
the keto group of N-acetylneuraminic acid to D-galactose or galactos- 
amine (Figure 4a,b). Sialic acid moieties liberated as a result of 
the enzymic activity of neuraminidase were measured by the use of 
periodate oxidation, the development of a colour complex with thio- 
barbituric acid, and extraction of the colour complex in an organic 
phase, cyclohexanone (Warren, 1959), The colour complex was read In 
a spectrophotometer at K5 3 2  The maximal
absorption for sialic acid was at E^^g and the second absorption 
at E^32 nm 2-deoxyribose, Aminoff (1961) noted that the
N-acetylneuraminic acid coloured complex of the thiobarbituric acid 
procedure was identical to the colour complex obtained with 2-oxo-3- 
deoxy sugar acids. It was emphasised therefore that there existed , 
a danger in relying solely on the thiobarbituric acid procedure to 
determine the sialic acid content of mucin.
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V» cholerae neuraminidase was successfully purified from
culture filtrates of V. cholerae strain 4 Z (Ada, French and Lind,
1961), The purification involved a five step procedure, namely,
fractionation with concentrated cold methanol, adsorption to and
elution from human red blood cells, fractionation with aqueous
saturated ammonium sulphate, chromatography on columns of hydroxyl
apatite and finally crystallisation. Enzyme activity was stimulated 
+4-
with Ca ions and was inhibited by ethylenediaminetetra-acetate.
The enzyme showed maximal activity at pH 5,6, Moving boundary electro­
phoresis carried out on the crystalline V, cholerae neuraminidase (the 
crystalline neuraminidase prepared by Ada, French and Lind, 1961) 
revealed electrophoretic patterns at pH 6,7, 8,5 and 5,1 (Pye and 
Curtain, 1961), At each pH a corresponding single band was seen 
migrating in the direction of the anode. The enzyme sedimented as a 
single symmetrical boundary at pH 6,7 and 8,5 (Pye and Curtain, 1961), 
Neuraminidase from V, cholerae. Cl, perfringens and influenza virus 
had different isoelectric points, namely, 4,8, 4,95 and 8,9 respect­
ively (Neurath, Hartzell and Rubin, 1970),
When V, cholerae strains Inaba 569B and Ogawa B 1307 were 
utilised for the production of neuraminidase (Kusama and Craig, 1970), 
strain 569B produced greater quantities of neuraminidase after 12 hr 
growth at 37°C. At 48 h and a temperature of 37°C, both strains 
produced equal quantities of neuraminidase but, after 48 h neuramini­
dase production by strain B 1307 continued to increase whereas that of 
strain 569B decreased. Affinity chromatography was successfully 
utilised to purify V, cholerae and Cl, perfringens neuraminidase 
(Cuatrecasas and Illiano, 1971), The affinity column consisted of
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agarose beads which were linked to glyc-glyc-tyr by cyanogen bromide, 
and which in turn were linked by azo linkage to an inhibitor of neura­
minidase, namely, N-(p-aminophenyl) oxamic acid* The neuraminidase 
activity present in extracts of Cl* perfringens and V* cholerae was 
completely adsorbed by this affinity column. An improved assay was 
developed which measured neuraminidase activity by the liberation of 
blue methoxyphenyl (Figure 3) from an artificial substrate (2-(3* 
methoxyphenyl-N-acetylaneuraminic acid - M.P.N.) (Palese, Ducher and 
Kilbourne, 1973), The assay was both rapid and precise and, in 
addition, the artificial substrate could be used for standardising 
the activity of neuraminidase from viral, bacterial and mammalian 
sources. Subsequent investigators (Sedmak and Grossberg, 1973) studied 
the enzyme kinetics of influenza virus and V, cholerae neuraminidase 
with the M,P,N, assay, and found the assay to be a rapid and precise 
measurement of neuraminidase activity but suggested that its use be 
limited to highly purified enzyme preparations, because contaminating 
proteins gave high background readings. Neuraminidase was also purified 
by Schick and Zilg (1978) who utilised a simplified procedure wherein 
crude neuraminidase obtained from culture fluid of V, cholerae organisms 
was passed two times through a DEAE cellulose column and eluted by an 
ionic strength gradient (0,1-0,3 M sodium acetate buffer pH 5,5), The 
specificity of neuraminidase action was related to the bacterial origin 
of the enzyme (Finné, 1978a), V, cholerae neuraminidase cleaved sialic 
acid from follicle stimulating hormone (FSH) but did not cleave sialic 
acid from luteinising hormone (LH) and therefore did not influence the 
biological activity of the hormone (Finné, 1978a), By contrast.
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Cl. perfringens neuraminidase did not possess the selective activity 
of the V. cholerae neuraminidase and therefore it destroyed the LH 
activity.
The effect that neuraminidase pretreatment had upon tissue 
sections was studied by Spicer and Warren (1960) who utilised Alcian 
blue stain followed by periodic acid schiff to histologically localise 
sialomucin. Histologically such neuraminidase pretreatment produced 
a loss of raetachromasia. N-acetylneuraminic acid containing mucins 
of bovine submaxillary and rat sublingual glands pretreated with O.lN 
H^SO^ (1 h at 80°C) or influenza neuraminidase (24 h at 37^C), showed 
a loss in Alcian blue staining in the mucus acini of the bovine 
submaxillary gland (Quintarelli £_t al, 1961). This loss of Alcian 
blue staining after pretreatment with either the acid or neuraminidase 
was attributed to the loss of sialic acid groups (Figures 4a, b).
Another investigator (Kent, 1963) noted that "since chemically active 
groups in polysaccharide antigens in sections (e.g. hydroxyl, carboxyl) 
can be readily altered, the effect of these alterations can be 
investigated". Neuraminidase treatment of pig submaxillary gland for 
24 h caused a complete removal of sialic acid as seen by a loss in the 
Alcian blue staining reaction. When the cow and pig submaxillary mucin 
were submitted to neuraminidase digestion, the loss of sialic acid was 
seen histochemically as an absence of Alcian blue staining. Neuramini­
dase digestion did not remove the whole mucin molecule, because mucinous 
areas continued to give positive PAS staining reactions (Figure 4a,b).
In addition, when the cow submaxillary mucin failed to react with 
fluorescein labelled antibody after neuraminidase digestion, this
N«ur*fniitiOd^
uHt 06 'the.
i>K/'t 0 6 llxvy
Figure 4a R' H // R" H It
O
Diagrammatic segment o f bovine submaxillary gland glycoprotein, showing ( I )  
the structure of the prosthetic group; (2) the glycosidic ester linkages joining the prosthetic' 
groups to the /3- and y-carboxyl groups, respectively, o f aspartic and glutamic acid residues; 
(3) the neuraminidase-susceptible a-ketosidic linkage within the prosthetic group.
(white, Handler and Smich, 1968),
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Figure 4b : Structure of the Disaccharide 0-g-D-sialyl
(2-6)-N-acetyI-D“galactosamine
(Pearse, 1968b).
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suggested that sialic acid (NANA) was an essential antigenic déterminant 
of cow submaxillary mucin, because when it was removed by neuraminidase 
digestion, there occurred a corresponding failure of cow submaxillary 
mucin to react with specific conjugated antibody to cow submaxillary 
mucin. The earlier findings of Spicer and Warren (1960) and Quintarelli 
et al (1961) concerning loss of Alcian blue staining following neuramini­
dase pretreatment were confirmed by Gad (1969), A more recent histo­
logical investigation that dealt with the effects of neuraminidase pre­
treatment utilised a peroxidase-labelled lectin from Limulus polyphemus 
(specific for sialic acid moieties) (Yamada and Shimazu, 1979), The 
loss of sialic acid from tissue sections due to enzymatic pretreatment 
seen by earlier investigators (Spicer and Warren, 1960; Quintarelli 
et al, 1961; Kent, 1963; Gad, 1969) as a loss in Alcian blue, was 
observed more recently as a loss in peroxidase-labelled Limulus polyphemus 
lectin (Yamada and Shimazu, 1979),
Neuraminidase has been utilised in a variety of biological and 
biochemical applications. One of the earliest applications was to 
remove influenza virus receptors from red blood cells (Burnet and Stone, 
1947b), The enzyme was utilised to bring an increase in the production 
of corticosterone and cyclic AMP when adrenal cells were first pretreated 
with it before being exposed to cholera enterotoxin (Haksar, Maudsley 
and Person, 1974). When V. cholerae neuraminidase was added to a weakly 
enterotoxigenic strain of V. cholerae biovar eltor, the enterotoxigenic 
activity of the organism was intensified (Soloviev et al, 1976), 
Inactivation of endogenous follicle stimulating hormone (FSH) was brought 
about by pretreating the animal ovaries with neuraminidase (Finné, 1978b),
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Pretreatment of frozen sections of mouse spleen cell follicle with 
V, cholerae neuraminidase amplified the adhesion reaction of erythro­
cytes to the tissue (Radaszkiewicz, Weirich and Denk, 1979), Pre­
treatment of unfixed human neutrophils with V, cholerae neuraminidase 
caused increased binding of fluorescein-labelled cholera enterotoxin 
(Figure 5) (Ackerman, Wblk'en and Gelder, 1980). Rnop ( 1980a,b) found 
that V» cholerae neuraminidase affected Con-A induced T-cell prolifer­
ation by increasing the efficiency of macrophage T-cell cooperation,
A review of the current concepts on neuraminidases and their 
activity was made by Hutchinson and Kabayo (1977), Neuraminidase has
been found in most myxo-viruses but not in other classes of virus, and 
es
so myxovirusjwere formerly defined as having an affinity for mucin 
(Hutchinson and Kabayo, 1977), It was noted that in budding viruses 
such as influenza which possess surface neuraminidase, there was a lack 
of surface sialic acids. By contrast, those viruses such as Sindbis 
or Rabies which lack surface neuraminidase possess surface sialic 
acid. In addition, neuraminidases account for as much as 10% of the 
total virus protein (Hutchinson and KabSyo^1977), In bacteria, the 
neuraminidases were either cell bound components or were excreted into 
culture filtrates. In higher vertebrates, neuraminidases were 
associated with lysosomes and other cellular organelles. These 
cellular neuraminidases could perhaps regulate the survival of glyco­
proteins circulating in the serum. The survey reached the conclusion 
that little was known about the function of bacterial neuraminidase, and 
proposed that when V, cholerae neuraminidase cleaved sialic acid 
residues from complex glycoproteins it prevented non-specific inter­
actions with enterotoxin from taking place. Other investigators
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(Soloviev e_t ai, 1975) held the view that V. cholerae neuraminidase 
might play an important role during the early phase of V. cholerae 
pathogenesis, namely, in the adhesion process,
3,3c Proteinase
The proteinases make up the third major category of extracellular 
enzymes produced by V, cholerae organisms. When Inaba 56*^B and Ogawa 
B 1307 strains were grown in shaken Casamino acid-yeast extract 
glucose medium for 4 days at 30^C and 37^G (Kusama and Craig, 1970), no 
detectable proteinase activity was measured for filtrates of strain 569B 
with the proteinase assay procedure devised by Kunitz (1947), In 
filtrates from strain B 1307, however, detectable levels of proteinase 
activity were measured with the Kunitz procedure at 10 h post-inoculation 
at 37°C and at 24 h post-inoculation at 30°C, In addition, strain 
B 1307 produced gradual increases in detectable proteinase activity.
The levels of detectable proteinase were found to be higher at 37°C 
than 30°C during the period of observation (Kusama and Craig, 1970),
There occurred one or two proteinase fractions when 5 strains of 
V, comma organisms were examined with the zymogram technique for pro­
teinase activity (Dahle and Sandvik, 1971), Most of the proteinase 
fractions studied tended to move more to the cathode but some did, 
however, migrate in the direction of the anode at pH 6,2 (Dahle and 
Sandvik, 1971), There occurred serological cross-reactions between 
the proteinase A fractions by a strain of Aeromonas liquefaciens and 
2 strains of V, comma. In addition, proteinase A fraction from 
Ae, liquefaciens was found to be enzymoserologically identical or 
closely related to one of the proteinase fractions of V, comma. The
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proteinase B fraction of Ae, liquefaciens, however, was not enzymo- 
serologically related to that of V. comma (Dahle and Sandvik, 1971).
Schneider and Parker (1978) isolated mutants of strains Inaba 
CA401 and Ogawa CA411 of V, cholerae which were deficient in proteinase 
production. This deficient proteinase production was linked with a 
reduction in neuraminidase production. These deficiencies in 
proteinase and neuraminidase production were associated with a marked 
loss of virulence for infant mice despite the fact that enterotoxin 
was produced. When partial reversion to proteinase production 
occurred in the mutants, there was a corresponding increase in neuramini­
dase activity and an increased virulence for infant mice,
A single procedure for the analysis of V, cholerae proteinases 
was developed in which the catalytic specificity of the enzyme served 
as a basis for typing of V. cholerae strains (Schneider, Sigel and 
Parker, 1981), The procedure for analysis of proteinase typing 
utilised a standard protein (serum albumin) as a substrate for the 
enzyme which was found in the culture supernate. The peptides which 
were generated due to the action of the enzyme were separated on the 
basis of relative molecular weight by SDS-PAGE gel electrophoresis.
The resulting bonding patterns in the gel were then used as the basis 
for the catalytic typing of proteinases.
When the culture supernate of V, cholerae biovar eltor 1621 and 
a mutant strain 1621 hip were subjected to isoelectric focusing, 3 
different types of extracellular proteinases were revealed (Young and 
Broadbent, 1982), The first type was found to be the major activity 
in the parent strain, and was inhibited by phenylmethylsulfonyl 
fluoride and lima bean trypsin inhibitor. The second type was also
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present in the parent strain but was also present in the mutant strain 
as well. This second type of proteinase was resistant to the 
inhibitors of metalloproteins and serine proteinases. A third type of 
proteinase was found to be present in the mutant strain, and was 
inhibited by EDTA.
Recent studies by Schneider and Parker (1982) have revealed 
that when mucinase was purified from V. cholerae strain GA401 by ammonium 
sulphate precipitation and column chromatography on Bio Gel P-100, 
proteinase activity was present, with the optimum pH at 9.0, and the 
activity occurring over a pH range of 6,2 to 9,6.
As has been the case for the other exocellular enzymes produced 
by V, cholerae organisms, the role of the proteinases still remains 
unclear as regards cholera pathology,
3,4 Adhesion
The outcome of the interaction between the host and the invading 
microbe depends on a combination of both virulence and the suscept­
ibility of the host (Arbuthnott and Smyth, 1979), A  correlation exists 
between the ability of organisms to adhere and their distribution on 
the epithelial surface (Gibbons and Van Houte, 1971), In a pathological 
process involving the small intestine the first event would be the 
attachment of the organism to the host epithelial surface in order to 
give it resistance to the mechanical flushing in the lumen (La Brec 
et al, 1964; Reed and Williams, 1978; Arbuthnott and Smyth, 1979),
By achieving attachment, the pathogenic organism would survive and 
multiply on the surface of the host tissue in competition with commensal
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organisms (La Brec et al, 1964; Arbuthnott and Smyth, 1979). Most 
often these organisms which had lost virulence (e.g. mutant strains) 
were no longer able to penetrate the epithelial barrier of the 
intestinal mucosa (La Brec e_t al, 1964), ,
Most enteric organisms have to overcome the effective barrier of the 
epithelial layer by bd.ng able to colonise various regions of the 
intestine (Erlandsen and Chase, 1974), The intestinal protozoan oF rat's 
Hexamita muris occupied the blind invaginations of the small intestine, 
while certain spiral-shaped organisms succeeded in establishing contact 
with the epithelium in the region of the crypts of LieberkUhn. In the 
case of the lactobacilli, the organisms adhered to the keratin layers of 
the stratified squamous epithelium of the rat stomach. Segmented 
filamentous bacteria have a more direct physical association between 
the host microvillous border of the intestinal epithelial cells and a 
specialised attachment segment or holdfast of the organism. In E, coli 
a pilus-like structure called the K - 8 8  antigen has been found to be 
responsible for adhesion (Nagy, Moon and Issaacson, 1977),
Freter (1969) found that cholera vibrios in infected ileal loops 
of rabbits were distributed such that approximately one half were in 
the lumen while the other half were adsorbed to the mucosa. When 
rabbit anti-cholera serum was given to the infected loops there was a 
marked decrease in the percentage of vibrios adsorbed to the mucosa,
A hypothesis formulated to explain this decrease in adherent organisms 
stated that the mechanism by which intestinal antibodies afford 
protection was by decreasing the adsorption of V, cholerae organisms 
(Freter, 1970), The principal immunoglobulin in the small intestine 
s-IgA (secretory IgA) agglutinated bacteria but was considered not to
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be bactericidal, able to mediate complement dependent lysis, bind 
macrophages, or enhance phagocytosis (Williams and Gibbons, 1972),
It was therefore postulated that the protective role of s-IgA was 
expressed by its ability to bind and aggregat^(Williams and Gibbons, 
1972), The hypothesis first formulated by Freter (1970) which 
proposed that intestinal antibodies afford protection to the intestinal 
mucosa by decreasing the number of adherent organisms, was confirmed by 
other investigations (Freter, 1972; Fubara and Freter, 1972; Freter, 
1974; Freter and Jones, 1976),
Studies with frozen sections (Schrank and Verwey, 1976) observed 
cholera vibrios to be in close contact with the mucosa of the small 
intestine (Schrank and Verwey, 1976; Allweiss et. &1, 1977), A 
clumping of the cholera vibrios was observed within the mucus layer 
(Schrank and Verwey, 1976; Jones and Freter, 1976a), The V, cholerae 
organisms were found to move along tracks which were parallel to the 
lines of strain created within the stretched mucus layer of rabbit small 
intestine (Jones and Freter, 1976a), The presence of calcium ions was 
required fox the adhesion of V, cholerae vibrios to rabbit brush border 
membranes but W2^s not required for adhesion to take place in intact 
rabbit intestinal slices (Jones and Freter, 1976a). It was suggested 
that the calcium ions required for adhesion to occur in the rabbit 
brush border membrane were not needed in the intact rabbit intestinal 
slices simply because calcium ions which were already present in the 
buffer solution had diffused into these intact tissue slices. The 
colonisation of rabbit intestinal epithelium by V, cholerae organisms 
in experimental systems which utilised ligated loops of adult rabbits 
and non-ligated intestine of infant rabbits was done with scanning and
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transmission electron microscopy (Nelson, Clements and Finkelstein,
1976), The investigators noted that there was a time lag period of 
up to 1  h before a significant degree of attachment of large numbers 
of vibrios occurred. The organisms were initially on the sides of the 
villi adhering by their surface coats directly to the tips of the 
microvilli; a few organisms were partially embedded in the brush 
border. Cultures of non-motile strains of V, cholerae were not able 
to adhere to rabbit brush border membranes (Jones and Freter, 1976b), 
Non-chemotactic mutant strains of V. cholerae also did not accumulate 
at the surface of intestinal tissue (Allweiss at al, 1977),
A study was made to examine the role of mannose-sensitive 
haemagglutinins in the adherence of V, cholerae strain KB207, biovar 
eltor, serotype Ogawa to rabbit small intestinal discs (Bhattacharjee 
and Srivastava, 1978), The haemagglutinins from agar cultures were 
mannose-sensitive, while the shaken or static broth cultures consist­
ently gave mannose-resis tant haemagglutination. Organisms from the 
broth culture of strain KB207 were less adhesive to freshly isolated 
rabbit intestinal discs ( 1 0  mm diam) than those from agar culture, 
despite the fact that haemagglutinins were present in both, D-mannose 
inhibited the adherence of organisms from the agar culture to rabbit 
intestinal discs, while the organisms from broth cultures which were 
less adhesive, and produced mannose-resistant haemagglutinins were not 
affected by D-mannose, When the intestinal discs were first exposed 
to D-mannose for 15 min prior to exposure to vibrios, there was no 
inhibition of adherence. Several non-motile strains produced haema­
gglutinins, and those non-adhesive strains derived from KB 207, both 
motile and non-motile, possessed haemagglutinating activity. Therefore
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it was concluded that there was no relationship between haemagglutinins 
and adherence of V. cholerae to rabbit small intestine.
The role of chemotaxis in bacterial association to rabbit ileal 
tissue was further investigated by Freter, O'Brien and Halstead (1978), 
When slices of rabbit ileum were incubated in a suspension of 
V, cholerae organisms (in 0,1 M Krebs-Ringer-Tris buffer pH 7,4) for 
a period of 8  min, the non-chemotactic mutant strains were less adhesive 
when compared with parent strains. However, when slices of ileal 
tissue were placed directly against a thick paste of non-chemotactic 
vibrios, the advantage of the chemotactic parent strain over the 
mutant non-chemotacjiic strain was abolished. Therefore, the 
importance of chemotaxis was only in the process of delivering the 
vibrios to the surface of the mucus gel (Freter, O'Brien and Halstead, 
1978),
Additional studies were made on the effects of chemotaxis on 
interaction of cholera vibrios with intestinal mucosa (Freter, O'Brien
I:
and Macsai, 1979), Rabbit intestinal slices were exposed to a 
suspension (in 0,01 M Krebs-Ringer-Tris buffer pH 7,4) which contained 
a mixture of polystyrene particles (1.1 pm diam), S, cerevisiae and 
vibrios of either parent or nonchemotactic mutant 31 strains for a 
period of 8  min. The intestinal slices were washed in 0,01 M Krebs- 
Ringer-Tris buffer pH 7,4, and frozen in liquid nitrogen. Sections 
of the slices were prepared in a cryostat at 12p thickness. The 
sections were stained by 1 ,0 % (w/v) giemsa stain, in order to determine 
the penetration of vibrios and other particles into the mucus gel of 
the rabbit intestinal slices, A count of the micro-organisms in 40 
areas (as defined by the partially closed microscope diaphragm) was made,
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Because of the difficulty in exactly quantitating the bacteria
histologically, a ratio between the number of vibrios and polystyrene
particles was utilised as a parameter for comparing the number of
parent or non-chemotactic mutant 31 vibrios that had penetrated into
the mucus gel. The findings shown in Table 4 indicated that while
the chemotactic strain was relatively efficient in deeply penetrating
the mucus gel of the rabbit intestinal slice (as seen by an increasing
vibrio ; particle ratio value), the nonchemotactic mutant 31 was, by
contrast, inefficient in deeply penetrating the mucus gel (as seen by
a decreasing vibrio : particle ratio value).
Both wild-type and mutant strains of V, cholerae were utilised
in order to determine their ability to adhere to freshly isolated rabbit
intestinal discs (Bhattacharjee and Srivastava, 1979), The optimum
time for the exposure of organisms to tissue was 30 min at 37°C, and
the optimum concentration of organisms per 5,0 ml phosphate buffered
5 7
saline suspension was 10 -10 vibrios, Non-motile, and weakly motile
organisms were incapable of adhesion, but one of the motile strains
(KB381) also showed limited adherent capacity. When phosphate
buffered saline suspensions of cholera vibrios were first pretreated
-1
with 1 0 0  ng chloramphenicol ml , and then exposed to rabbit intestinal 
'fcisSU.Ê c(iscS in the presence of the antibiotic (chloramphenicol), a 
significant reduction in the number of adherent wild-type organisms 
occurred. By contrast, the same pretreatment did not have any 
effect on the number of adherent organisms of a non-motile strain or 
a poorly adherent strain. When the V, cholerae organisms were exposed 
to rabbit intestinal tissue discs which had been previously immunised 
either parenterally (heat-killed strains KB92 and CD 1; live or
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Vibrio
strain
Initial
suspension Mucus gel
Above
villi
Between 
villi 
(luminal 
half)
Between 
villi 
(bas al 
half)
Parent
strain
Nonchemo­
1.03 1.16 4.00 11.34
tactic
mutant
31
1.19 0.99 2.38 1.75
Table 4 ; Penetration of parent strain and nonchemotactic 
mutant into mucus gel.
(Freter, O'Brien and Macsai, 1979).
Legend: numbers indicated in the table are that of
a ratio;
no. of vibrios/no. polystyrene particles.
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attenuated strain CD 1) or orally immunised (live strain CD 1), there 
was a significant reduction in the numbers of organisms which adhered 
to the immunised tissue.
A non-cholera vibrio, Kanagawa-Positive V. parahaemolyticus was 
examined in order to ascertain how its adhesion to human foetal 
intestinal cell monolayers would be affected by potential inhibitors 
of adherence (negatively charged glycoproteins, mono, di, tri, oligo 
and polysaccharides, lectins, enzymes, mono and dissaccharide components 
of chondroitin sulphate and xanthan; Carruthers and Anderson, 1979), 
When the monolayers were first exposed to 500 p.g of the potential 
inhibitor in 0,5 ml of Earle’s Balanced Salt Solution (EBSS) pH 7,2 
for 15 min at 37^C, and then exposed to a suspension of 5,0 x 10^
V. parahaemolyticus organisms, there occurred differences in the 
bacterial adherence when compared to the control or nontreated cells 
(Table 5), The results cited in Table 5 demonstrated that alterations 
in surface charge may contribute to the varying degrees of adherence 
by V. parahaemolyticus,
Srivastava, Sinha and Srivastava (1980) inoculated pathogenic, 
laboratory (non-adherent, streptomycin-dependent), and attenuated 
strains of V. cholerae into the ligated loops of rabbit (immunised and
5
non-immunised against V, cholerae organisms) at a concentration of 10 
-1
cells ml for a period of 18 h« No trace of cholera enterotoxin was 
found in those loops (non-immunised) inoculated with poorly adherent 
strains. The adhesive strains adhered quite well in the ligated 
intestinal loops of those rabbits that had not been immunised against 
V, cholerae organisms, but poorly in the ligated loops of immunised 
rabbits.
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Inhibitor
Percentage
adherence
None 1 0 0
Chrondroitin 24
sulphate
Bovine proteoglycan
preparations
Cartilage
Aggregate 2 1
Monomer 2 0
Nucleus pulposus 30
Skin 34
Aorta 27
Chondroitinase ABC digest
Chondroitin sulphate 53
Proteoglycan aggregate 54
Heparin 51
Heparin sulphate 62
Pentosan sulphate 25
Dextran sulphate 1 2
(mo. wt, 500 k. Dal.)
Xanthan 1 0
Inositol hexasulphate 1
Polygalacturonic acid 41
Glucose-6 -phosphate 18
Table 5 ; Inhibition of adherence of Kanagawa-positive strains
bv potential inhibitors (Carruthers and Anderson, 1979)
Legend: Bacterial adherence in the presence of a
potential inhibitor calculated as a percentage 
of the adherence in its absence (control).
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The adhesive properties of two V, cholerae strains, a wild-type
pathogen KB207 and a mutant strain GDll (derived from the wild-type
pathogen by N-methyl-N*nitro-N-nitrosoguanidine treatment), were
compared (Srivastava and Srivastava, 1980). The mutant strain CD 11
was both chemotactic and motile but was poorly adherent to rabbit
intestinal mucosa. Exposure of the wild-type strain KB207 and the
mutant strain CD 11 to D-mannose (10 mg ml ^), followed by exposure to
freshly isolated rabbit intestinal discs (previously treated with 1 0 0  m
mol of sodium metaperiodate for 15 min) inhibited the adherence of the
wild-type strain but did not affect the mutant strain,
Chemotactic and non-chemotactic strains of V. cholerae were
exposed to a variety of substances to determine whether these reagents
were chemotactically active for the vibrios (Freter and O ’Brien, 1981a),
Test tubes which contained bacterial suspensions (in 0,01 M Krebs-Ringer-
Tris buffer pH 7,4) composed of mixtures of V, cholerae parent strain
(6,0 X 10^ cells ml ^) and V, cholerae nonchemotactic mutant strain 31 
5 -1
(2,4 X 10 cells ml ), were exposed to capillary tubes (0,27 mm diam) 
each filled with one of 20 L-amino acids (Alanine, Arginine, Asparagine, 
Cysteine, Glutamic acid. Glutamine, Histidine, Isoleucine, Lysine, 
Methionine, Phenylalanine, Proline. Serine, Threonine, Tryptophan, 
Tyrosine and Valine), Vibrio suspensions were exposed to concen­
trations of the L-amino acids (varied from 10 ^ - 10 ^ M) for a period 
of 1 h at 37°C in order to determine if these L-amino acids were taxins 
(chemotactically active substances). The criteria for taxins were:
(a) the substance attracted an average of 1 0  chemotactic parent strain 
vibrios in the taxin filled capillary- and (b) the ratio of chemotactic 
parent strain : non-chemotactic strain vibrios in the capillary was 3
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times higher than in the control capillary which contained only buffer.- 
The chemotactic parent strain was found to be attracted to all 20 
L-amino acids. When the experiment was performed with 8  different
carbohydrates (D-Fucose, L-Fucose, D-Glucose, D-Galactose, D-Mannose, 
N-Acetylneuraminic acid, N-acetyl-D-glucosamine and N-Acetyl-galactosamine) 
in place of the L-amino acids, the chemotactic parent strain was 
attracted to only D-glucose, D-mannose, N-Acetylneuraminic acid, N-acetyl- 
D-glucosamine and N-Acetyl-D-galactosamine. The results obtained from 
the experiments with the carbohydrates contrasted with those obtained 
for the L-amino acids, namely, that the maximum number of vibrios which 
entered into the capillary was much lower for the capillaries containing 
carbohydrates than those containing amino acids (e.g. response to 
proline was 220 vibrios as opposed to 12 vibrios for galactose). When 
the experiment was performed using pepsin digest of rabbit mucosal 
scrappings or tryptone, the vibrios were attracted as strongly as was 
the case with amino acids. Finally, when bacterial suspensions of 
chemotactic parent or non-chemotactic strains were exposed to isolated 
rabbit brush border membranes for 15 min at 37^C, the nonchemotactic 
mutant could not be distinguished from the chemotactic strain with 
regard to their ability to adhere vitro to rabbit brush border 
membranes,
The role of chemotaxis in the association of V, cholerae
organisms to tissues was re-assessed (Freter and O'Brien, 1981b) by
5
injecting 0,05 ml vibrios (4,0 x 10 vibrios each of parent or non­
chemotactic mutant strain 31 suspended in Trypticase Soy Broth plus 
0,01% (w/v) Evans Blue) into the stomach of 5-6 day old BALB-Cwm mice.
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The mice were sacrificed at an interval of 4 h after infection, and at 
intervals of 18-22 h after infection. The entire small intestine was 
then removed and homogenized in 25 ml of sterile Trypticase Soy Broth, 
and dilutions of the homogenates were plated out in pour plates of 
semisolid agar (1,0% (w/v) tryptone, 0.5% (w/v) NaCl, 0,4% (w/v) agar, 
0 ,0 1 % (w/v) 2 ,3,5-triphenyl tétrazolium chloride and 1 , 0  mg strepto­
mycin ml ^), Despite previous vivo and ijn. vitro studies with 
cholera vibrios, the non-chemotactic mutant strain showed a greater 
fitness in 5 day old mice as seen by a higher percentage of nonchemo­
tactic mutants recovered from the small intestine (after 4 h parent 
strain : 0,0299%; mutant strain : 0,167%, and after 18-22 h parent 
strain ; 26,2%; mutant strain : 132,2%), The histological studies 
showed, however, that there occurred a greater penetration of the 
chemotactic parent vibrios into the mucus gel,
32 35
In experiments where radioactively labelled (either P, S, or
3
H thymidine) chemotactic parent or non-chemotactic strains of
32
V, cholerae were injected into mouse small intestine, the P labelled
organisms gave results that were in accord with the notion of an
accelerated rate of death of the chemotactic parent strain in the
infant mouse small intestine (Freter and O ’Brien, 1981b), Where the
35
vibrios (both chemotactic and non-chemotactic) were labelled with S
3
or H thymidine, however, the amount of radioactivity retained in the 
small intestine after the feeding of radioactive labelled V, cholerae 
organisms, more closely correlated with the isotope rather than with 
the strain of vibrio under scrutiny. Therefore, Freter and O ’Brien 
(1981b) expressed grave misgivings on the validity of experimental 
techniques which solely relied on radioisotopes to determine the
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in vivo location and the death or survival of radioactively labelled 
bacteria,
A follow up study was made to focus more clearly upon the role 
of chemotaxis in rabbit ileal loops with chemotactic parent, non­
chemotactic mutant 31, and nonmotile strains of V, cholerae organisms 
(Freter, O ’Brien and Macsai, 1981), As in an earlier investigation 
(Freter, O ’Brien and Macsai, 1979), a suspension which contained a 
mixture of three components (polystyrene particles, S, cerevisiae and 
V, cholerae chemotactic parent, or nonchemotactic mutant 31 or nonmotile 
mutant organisms) was utilised for adhesion experiments, A volume of
g
0,25 ml of the suspension mixture (contained 7,5 x 10 organisms of 
each of the three major components) was injected into the ligated 
small intestinal loops of Dutch belted male rabbits. The loops were 
exposed for 15 min to the suspension mixtures and were then removed 
from the animals. Frozen sections were stained (1.0% (w/v) giemsa) 
without fixation, and a count (40 fields) of the microorganisms and 
particles in mucus gel, the overlying villi and the spaces between 
the villi (Table 6 ) of the frozen sections at 500 X under the optical 
microscope. The chemotactic parent had a vibrio : particle ratio of 
1  in the lumen of the rabbit intestinal loop, which increased to 1 0  
in the deep intervillous spaces. Both the nonchemotactic mutant and 
the nonmotile mutant, however, showed no changes in the vibrio : 
particle ratio. It was therefore stated that the superior ability of 
the parent strain to penetrate the intestinal mucus gel vivo was 
related to its active motility which was guided by chemotaxis along a 
taxin gradient (a gradient of chemotactically active substances) which 
extended deeply into the mucus gel.
The inhibitory activity of Gl5 Sephadex purified mucosal extracts 
was tested on 1.0 ml (0.01 M Krebs-Ringer-Tris buffer pH 7.4 suspended
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Mucus gel
Strain
Initial
suspension
Above
villi
Between 
villi 
(luminal 
half)
Between
villi
(basal
half)
Parent
(chemotactic)
1.03 1 . 2 2 4.62 9.99
Mutant 31 1 07 
(nonchemotactic)
1 . 0 0 3.08 1.72
Mutant
(nonmotile)
0.97 1.08 1.25 1.09
Table 6  : Comparison of penetration of vibrios into mucus gel
(Freter, O'Brien and Macsai, 1981) .
Legend: numbers in the table indicate vibrio/particle
rat io.
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organisms) suspensions of V, cholerae chemotactic parent strain (5,0 x
5 3
10 vibrios labelled with H thymidine) plus rabbit ileal slices for
15 min at 37^C (Freter et al, 1981), The slices were rinsed twice in
sterile saline and finally digested with protosol. Radioactivity
was counted by a liquid scintillation counter. Exposure to the G15
Sephadex purified mucosal extracts brought about Inhibition of
V, cholerae chemotactic strains in the vitro adherence to rabbit
ileal slices. This supported the theory that inhibition of mucosal
association by the pepsin digested mucosal extracts was the result of
the blocking of taxin receptors on the surface of the vibrio.
The penetration of bacteria and inert particles into mucus gel
was once more investigated by exposing a 1 , 0  ml mixture containing
9 9
polystyrene particles (1,0 x 10 ) plus S, cerevisiae cells (1,0 x 10 )
plus V, cholerae chemotactic parent or non-chemotactic mutant vibrios
9 o
(1,0 X 10 ) to slices of rabbit ileum for 15 min at 37 C, These were
rinsed in buffer (0,01 M Krebs-Ringer-Tris buffer pH 7,4), frozen in
liquid nitrogen, sectioned, and finally stained in 1,0% (w/v) Giemsa 
stain. The sections were viewed under the optical microscope at 
500X magnification, and the particles and microorganisms were counted 
(in 40 areas which were defined by the partially closed microscope 
diaphragm). The vast majority of the organisms predominantly 
associated with the mucus gel of the rabbit ileal slices rather than 
the mucosal epithelium. The polystyrene particles and the non­
chemotactic mutant vibrios penetrated the mucus gel of the rabbit ileal
slice poorly, but the chemotactic parent vibrios did, by contrast, reach 
the deep intervillous spaces in significantly higher numbers. From 
this result it was stated that though the mucus gel represented a
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barrier, it could be penetrated by both inert particles and non-chemo­
tactic mutants rather inefficiently, but, where the vibrio is both 
motile and guided by chemotactic gradients, it could efficiently 
penetrate into the deeper layers of the intervillous spaces within a 
period of minutes. It was further stated that the association between 
mucus gel and organisms is reversible to some degree, and that the 
motile organisms must keep moving rapidly just to stay in place against 
the natural flow of mucus.
The relationship between bacterial pdhesion and pathogenesis of 
cholera was recently examined again by Chitnis, Sharma and Kamat (1982), 
Anti-serum to V, cholerae lipopolysaccharide was raised in rabbits by 
intravenous injections (0,5, 1,0, 1,5 and 2,0 ml volumes) of a suspension
9
of boiled cells (1,0 x 10 ) V, cholerae strain 569B at intervals of 3 to 
4 days. The rabbits were then bled 1 week after the final injection.
To test the effect of antibacterial antibody on vivo adhesion and 
toxin production, ligated small intestinal loops of 1 0 . 0  cm in length 
made in adult rabbits were utilised. Alternate ligated loops were 
given 1:80 dilution of normal rabbit serum (decomplemented) or 1:80 
dilution of the anti-serum against boiled cells of V, cholerae strain 
569B, After a period of 30 min the loops were challenged with
5
1,0 X 10 cells of V, cholerae strain 569B, and after an interval of 
8  h the loops were opened and the volume of each loop was measured.
The contents of the loops were subjected to viable vibrio counts and 
assayed for cholera enterotoxin (cutaneous vascular permeability 
procedure of Craig, 1965), The intestinal loops were rinsed in 
sterile phosphate buffered saline, homogenised, and the homogenate was
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plated out on nutrient agar in order to determine the number of 
organisms adherent to the mucus membrane by viable bacterial count 
(Table 7), The loops treated with the anti-serum had fluid 
accumulation that varied from between 0-1,5 ml, whereas those loops 
that received the normal serum showed fluid accumulations of 5,0-7,0 ml. 
Those loops that were treated with either anti-serum or normal serum 
showed approximately the same number of organisms (organisms in the 
lumen plus organisms adhering to the mucosa). The total amount of 
biologically-active cholera enterotoxin produced in both anti-serum and 
normal serum treated loops were again virtually the same, namely 
1600-3200 units. The same amounts of cholera enterotoxin, however, 
produced greater fluid accumulations in the normal serum treated loops 
where the numbers of adherent vibrios rose 10-15 fold. The findings 
of this investigation presented evidence to support the view that 
adherence of cholera vibrios to the mucus membrane is an important 
step in V, cholerae pathogenesis. The reason for this is that the 
level of cholera enterotoxin produced by the vibrio is not adequate 
to induce fluid section, unless the enterotoxin is released by the 
adherent organisms in the highest concentration at the correct site on 
the small intestinal epithelium,
Holmgren, Svennerholm and Lindblad (1983) stated that 12 
Classical biovar strains of V, cholerae (either serotype Inaba or 
Ogawa) caused agglutination (bacterial cell adhesion) of human erythro­
cytes, and that the addition of L-fucose brought about an inhibition of 
agglutination. By contrast, the agglutination of chicken erythrocytes 
by 12 eltor biovar strains of V, cholerae, was reversed by the addition 
of D-mannose or one of the following carbohydrates: D-fructose,
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D-glucose, bnethyl mannoside and sucrose* In an earlier investigation 
(Holmgren, Svennerholm and Rhren, 1981), it was found that milk from 
Swedish women brought about an inhibition of cell adherence (haemagglut­
ination) in both classical and eltor biovar strains of V, cholerae.
It was also noted that the main inhibitory activity of human milk was 
separate from the immunoglobulin fraction of the human milk. Therefore 
it was hypothesised that the capacity of the non-immunoglobulin fraction 
of the human milk to bring about the inhibition of haemagglutination 
could be due to the presence of structure analogs (oligosaccharides 
or glycoconjugate cell receptors) for specific bacterial adhesins and 
enterotoxins. This hypothesis was re-examined in 1983 by Holmgren, 
Svennerholm and Lindblad who first fractionated human milk.
The human milk was first fractionated by ultrafiltration with 
a PM-10 membrane, which separated the milk into three fractions. The 
first of these milk fractions was the high molecular weight fraction A, 
the second fraction was a low molecular weight fraction B and the 
third fraction was also a low molecular weight fraction C, Fraction A  
was passed through an immunosorbent column which contained anti-human 
immunoglobulin a chain specific antibody, and anti-human total immuno­
globulin to remove the immunoglobulin components. Caseins were 
removed from both whole human milk and fraction A by precipitation at 
pH 4,5 with 0,1 M NaAc, Both the A and B fractions were further 
fractionated by ammonium sulphate precipitation (40-100% saturation) 
in the cold for 60 min, followed by centrifugation at 1 0 , 0 0 0  ^  for 
2 min. The precipitates were resuspended in 50 volumes of Krebs- 
Ringer-Tris buffer pH 7,4, and concentrated to their original volume
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(fraction suspended in 10 volumes of Krebs-Ringer-Tris buffer pH 7*4), 
The addition of sodium periodate (to a final concentration of 0,05 M) 
followed by the boiling of the sample (fraction A or fraction B), and 
the incubation of the sample at 37°C for 24 h was necessary in order 
to destroy the haemagglutinating capacity of the oligosaccharides 
present in the human milk. To remove the structure analogs (glyco- 
compounds) from the milk, 1,0 ml volumes of fraction A and B were added 
to a concanavalin A column. The glycocompounds which were bound to 
the column were eluted with 0,5M omethyl-D-glycopyranoside, Fraction 
A was subjected to pronase digestion (2,3 mg (ml fraction A) )^ to see 
if such a treatment had any effect on the high molecular weight 
haemagglutinating capacity of fraction A, Lipids were removed from 
pooled human milk by methano1-water extraction. The lipid extracts 
were further separated into acidic and neutral lipids by ion exchange.
The capacity of the glycocompounds to cause haemagglutination 
was tested by adding 10 |al of 3% erythrocyte suspension to 10 pi of 
two serial dilutions of V, cholerae suspension (either classical or 
eltor biovar) on a glass microscope slide in the presence of glyco- 
compound (Holmgren, Svennerholm and Lindblad, 1983), These glyco­
compounds did possess the capacity to inhibit haemagglutination of 
erythrocytes by either the classical or eltor biovar of V, cholerae 
organisms.
The relevance of the investigation of Holmgren, Svennerholm 
and Lindblad (1983) was expressed in three ways; (a) that isolation 
and characterisation of the inhibitory carbohydrates from milk and 
other secretions could be useful to identify the natural cell bound
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receptors for classical and eltor V. cholerae organisms, (b) that 
these structure analogs may be of relevance in relation to host defence 
in newborn infants because enteric infections were more prevalent in 
infants not weaned on human milk and finally, (c) if the inhibitory 
receptor-like glycoproteins are also present in saliva and gastro­
intestinal juice, these could perhaps be utilised as the basis for a 
defence against mucosal infections.
Recently, Attridge and Rowley (1983) noted that V, cholerae 
strain 017, biovar eltor, attached equally well to the serosal and 
mucosal surfaces of 6  month old Swiss mouse intestinal tissue segments. 
In addition, the binding of cholera vibrios to these intestinal tissue 
segments remained undiminished even when the tissue segments were 
first boiled before being exposed to the organisms. Therefore 
Attridge and Rowley stated that receptor structures for cholera vibrios 
would have to be heat stable and abundant over both mucosal and serosal 
surfaces.
Despite the fact that many parameters have been found 
experimentally to increase, decrease and inhibit the adhesion of 
V, cholerae organisms to intestinal mucosa, there are still conflicting 
descriptions of vibrio adherence. These conflicting reports could 
be perhaps due to differences in methodology used to measure vibrio 
adhesion (Attridge and Rowley, 1983), The precise mechanism by 
which vibrio adhesion is achieved, however, still remains unresolved.
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IV BASIC INTESTINAL ECOLOGY
Infections which are localised within, or invade by the gastro­
intestinal tract are important causes of morbidity and mortality in 
humans and animals (McClelland, 1979), The relationships therefore 
between the gastrointestinal tract and pathogens cannot be easily 
separated from the relationship of host to its normal intestinal flora.
The composition, distribution and activity of the intestinal 
flora is dependent upon the composition of the intestinal contents in 
the various regions of the gut and on the antibacterial systems of 
the host (Drasar, 1974), Further factors affecting the antibacterial 
systems of the host are diet, physiology of the host and the interaction 
between bacteria in some parts of the intestine (Drasar, 1974; Table 
8 ), The gut is able to control the normal and abnormal microbial 
flora by two major types of defence mechanism which utilise (a) Non 
Immunological Factors, and (b) Immunological Factors),
4,1 Non-Immunological Factors
The Non-Immunological Factors have an important role to play in 
determining the intestinal microflora (McClelland, 1979), The low 
pH of the stomach, peristalsis, movement of the villi and the toxicity 
of conjugated and deconjugated bile acids all serve as non-immunological 
factors which restrict bacterial growth in the intestine (Franklin and 
Skoryna, 1971; Binder, Filburn and Floch, 1975), Those bacteria 
which are part of the normal flora are able to deconjugate bile acids, 
and therefore able to restrict the growth of pathogenic bacteria
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Table 8  : Local host factors influencing the
intestinal flora
(1) Host physiology
(a) Intestinal secretions
(b) Intestinal mucosa
(c) Immune mechanisms
(2) Environmental factors
(a) Bacterial contamination
(b) Diet
(c) Antibacterial drugs
(3) Bacterial interactions
(Drasar, 1974)
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(Binder, Filburn and Floch, 1975), Mucin acts as an important
component of the non-immunological host resistance because of its 
ability to trap particles, and then with the peristaltic contraction in 
the stomach and the intestine to remove it (Florey, 1933; see 
section on Mucin),
The Paneth cells have been found to function as phagocytes
(Erlandson and Chase, 1972), and perhaps these cells keep the crypts of
LieberkUhn free from bacteria and other microbes. At present, however, 
there does not exist enough evidence to support the hypothesis that 
polymorphonuclear leukocytes and macrophages function as effective
phagocytes either in the gut lumen or at the epithelial surface of the
intestinal tract (Smith, 1977),
Indigenous microorganisms which are normally part of the 
intestinal flora prevent or perhaps limit the growth of pathogenic 
microorganisms in the gastrointestinal tract (Savage, 1972, 1977),
The mechanism of microbial interference is complex, but it has been 
observed that when the ecosystem in the gup of the host has been 
disturbed by antimicrobial and other drugs, starvation or stress, the 
system of microbial interference does not function properly (Freter, 
1956; Savage, 1972; Tannock and Savage, 1974; Holdeman, Good and 
Moore, 1976), The stress factor that travellers encounter would 
also disturb the gut ecosystem, thus making them susceptible to 
diarrhoeal diseases (Shore et al, 1974),
4.2 Immunological Factors 
In a host which has had prior contact with antigens of a
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particular microbial pathogen, the organisms would encounter immuno- 
specific as well as non-immunological host resistance factors 
(McClelland, 1979; Thomas and Jewell, 1979), An elicited immune 
response due to a particular antigen could have come about because it 
shared antigen similarity with another pathogen which the host had 
previously encountered (Myerowitz, Gordon and Robbins, 1973), In 
addition, it is often the case that the host elicited an immune response 
to a particular antigen because it shared antigens with non-pathogenic 
organisms which normally make up part of the intestinal flora (Myerowitz 
and Norden, 1977),
The antibodies that play an influential role in dealing with 
intestinal surfaces are those secreted onto these surfaces (Tomasi 
and Grey, 1973; Fubara and Freter, 1973), One of the tasks 
attributed to these secretory antibodies is to prevent bacterial 
pathogens from attaching to the intestinal epithelium (Fubara and 
Freter, 1973), The secretory antibodies Which predominate in the normal 
small and large intestine are of the IgA class (Bienenstock, 1979; 
McClelland, 1979), This IgA molecule produced by the lymphoid system 
of the gastrointestinal tract differs from the IgA found in other parts 
of the mammalian body because it is associated with an additional 
structure called the secretory piece (Thomas and Jewell, 1979), This 
secretory piece is produced by the glandular epithelial cells of the 
intestinal tract but not by goblet cells (Poger and Lamm, 1974; 
Brandtzaeg, 1974), The secretory piece or secretory component is a 
glycoprotein which is attached to IgA dimers and which enable the IgA 
to be actively transported across the mucosa to the intestinal lumen.
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and also serves to protect the IgA molecule from proteolysis in the 
intestinal lumen (Thomas and Jewell, 1979), Despite the extensive 
information about the physiological functions of s-IgA (secretory IgA) 
many functions are still in dispute (Table 9),
The ecological environment of the gastrointestinal tract is 
constantly being exposed to liquids which contain food, microbial 
antigens and pathogenic organisms, and thus exerts both physical and 
immunological mechanisms to maintain ecological stability.
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Table 9 : Functions of IgA antibody
Viral neutralisation 
Bacterial agglutination 
Inhibition of bacterial motility 
Bacterial killing (with co-factors)
Alteration of bacterial growth 
Antitoxin activity
Inhibition of bacterial adherence to mucosal 
surfaces
Opsonisation ( ? )
Complement fixation ( ? )
Binding to mucin ( ? )
Non-antibody binding of proteins (antitrypsins) 
Inhibition of bacterial enzymes 
Inhibition of antigen uptake
(McClelland, 1979)
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OBJECT OF RESEARCH
At present, the actual function or functions of Vibrio cholerae 
neuraminidase in cholera infection are not clear. This is despite 
the extensive knowledge of the biochemical properties of the enzyme 
itself.
The specific objects of this investigation were to determine the 
effects of V, cholerae neuraminidase on the sialomucin of the small 
intestine, on the ability of antineuraminidase antiserum to neutralise 
the activity, and finally to throw light on the possible functions 
of the enzyme in the pathological processes associated with cholera.
MATERIALS AND METHODS
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X  STRAINS OF VIBRIO CHOLERAS
V. cholerae NCTC 10732, Classical Biovar, Serotype Inaba, was 
obtained from the National Collection Type Culture (NCTC).
V. cholerae SL I, Classical Biovar, Serotype Inaba, was obtained 
from Dr, J.P, Craig, Downstate University and original was isolated 
by Dr. Rolf Freter, University of Michigan.
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n  p r o d u c t i o n  OF V. CHOLERAE NEURAMINIDASE
The 15 litres of Proteose peptone - Colostrum medium (pp215-216 
Appendix II) in the fermenter vessel were inoculated with an overnight 
culture of V. cholerae 10732 grown in 250 ml of 2% proteose peptone 
broth. The overnight culture was introduced into the fermenter 
vessel by the filling port (pp 223-227, Appendix IV.) The anti-foam
mixture was 1% Silcolapse. The fermenter was run at 37°C with an
-1 -1
air-flow of 5 litres min and stirred at 300 rev min , The air
outlet hose was connected to a condenser and to two 2  litre flasks in
series which contained 1.0% (v/v) hibitane. After 24 h the organisms 
were killed ^  situ by increasing the temperature to 56°C for 2 h.
The culture was transferred to a presterilised 20 litre jar with 
positive pressure to force the culture through the sampling port hose 
into the jar* Calcium chloride (CaCl2  anhydrous; 75,0 g) was added to 
flocculate the cells. In some experiments the presence of too much 
anti-foam prevented salting out and therefore it was necessary to 
centrifuge the culture fluid at 7000 rev min  ^ (9000 ^) to remove cells 
in an M.S.E. 25 centrifuge.
H X  METHANOLIC PRECIPITATION OF PROTEIN
The culture supernate (800 ml) was placed in each of 18 
winchester bottles (2.5 litres) and 240 ml of methanol, precooled to 
-30^C, was added# Similar quantities were added each hour during a
5 h period, thus giving a total volume of 1200 ml methanol. Methan-
olic precipitation occurred within 48 h at 4°C. The supernate was
I
decanted and discarded and the protein was harvested by centrifugation
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for 15 min at 9000 rev min  ^ (12000 . The pellets from the 18
Winchesters were pooled and resuspended in 100 ml 0*05 M NaAc buffer 
pH 5.5. The suspension was dialysed against 0.05 M NaAc (pH 5.5) 
buffer for 2-3 days at 4°C. The dialysed suspension was centrifuged 
for 15 min at 9000 rev min  ^ (12000 ^) and the supernate was retained. 
The residue was washed once with buffer and the supernates containing 
the crude neuraminidase were pooled* The crude neuraminidase (200 ml) 
was concentrated with Garbowax (polyethylene glycol 4000; B.D.H.,
Poole, England) to a final volume of 50 ml. This neuraminidase 
concentrate was used as the starting material for further enzyme 
purification by gel filtration or ion exchange chromatography.
IS* PURIFICATION OF NEURAMINIDASE
I» Gel filtration
The most suitable Sephadex for the semi-purification of crude 
enzyme preparation was determined. Sephadex G75, 100 and 200 (3.0 g) 
were allowed to swell for 5 h in a boiling-water bath. The gels were 
each resuspended in 0.05 M NaAc buffer pH 5.5, A  column (20 x 2,0 cm) 
was poured with each grade and equilibrated with 0,05 M NaAc buffer 
pH 5.5, The columns were run at a flow rate of 1,4 ml min"^ and
2.0 ml fractions were collected. A sample of 1,0 ml of crude enzyme 
preparation was added to each column. Peak fractions (EggQ were 
pooled and concentrated down to the initial volume of 1 . 0  ml against 
Carbowax at 4^C. The pooled fractions were tested for neuraminidase 
activity by the thiobarbituric acid assay (T.B.A.). These peak 
samples were stored at -20°C,
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The GlOO (7,0 g) was allowed to swell for 5 h in a boiling-
water bath. The gel was resuspended in 0.05 M NaAc buffer pH 5,5,
A column 1,5 x 81 cm (Whatman I.E.C, Column of 1,5 x 100 cm dimensions)
was poured and equilibrated with 0,05 M NaAc buffer pH 5,5, The
crude enzyme preparation (2 , 0  ml) was pipetted onto the column.
Fractions (2.0 ml) were eluted from the column at a flow of 0,8 ml
min  ^with 0,05 M NaAc buffer pH 5.5, The E«q „ value and Lowry 
—  280 nm
protein value were determined for each fraction to detect the protein 
peaks. In addition, a T.B.A, assay and a methoxyphenyl-neuraminate 
assay (M.P.N.) were done to determine the peak of enzyme activity. 
Fractions with strong T.B.A, and M.P.N, neuraminidase activity were 
pooled, concentrated down to the initial volume of 2 ml with Carbowax 
at 4*^ C and stored at -20°C,
In order to obtain a supply of enzyme, activity peaks were 
pooled from groups of six gel filtration runs. These neuraminidase pre- 
■parations were designated as follows :
« 1  -
8 , 0  ml
" 2  - 31,0 ml
«3 -
14.0 ml
«4 - 2 0 . 0 ml
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I o M - e % c k a n j &  c k k ; ; h ta to g
Both diethylaminoethyl cellulose (DEAE) and carboxymethyl 
cellulose (CM) (Whatman Ltd., Maidstone, Kent, England) were used in 
the purification of neuraminidase.
Udi GM-cellulose ion exchange chromatography
Fines were removed from 80 g CM cellulose (Whatman, Grade 
CM-32, micro-granular, cationic exchanger) by washing with water and 
decanting the fines at each wash. The cationic exchanger was pre­
cycled with first 15 volumes of 0.5 N NaOH for 30 min and subsequently 
washed with 0.1 M NaAc buffer (pH 5,5) until the effluent reached the 
intermediate pH of 8.0. Secondly, 15 volumes of 0.5 N HCl were added 
for 30 min followed by repeated washing with 0.1 M NaAc buffer (pH 
5.5) until the effluent reached pH 5.5. The CM-cellulose was 
suspended in this buffer to give a pourable slurry. A column (2 x 78 cm)
was poured and equilibrated with 0.1 M NaAc buffer pH 5,5. Two ml of
the crude neuraminidase preparation (N79625) was run through the 
column and 2,0 ml fractions were collected. Peak fractions were
pooled, placed in dialysis tubing (Visking, Medicell Int. Ltd.,
Liverpool, England) and concentrated down to the initial volume of 
2 ml with Carbowax. The peak sample was tested for neuraminidase 
activity by the T.B.A, assay and stored at -20°C.
‘llf, DEAE-cellulose ion exchange chromatography
Fines were removed from the DEAE-cellulose (Whatman, Grade 
DE-52, microgranular, anionic exchanger) and 80.0 g were suspended in
0.05 M NaAc buffer (pH 4.4) to form a slurry. The DE-52 DEAE-
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cellulose was already precycled, A column (2 x 80 cm; Pharmacia,
Uppsala, Sweden) was poured and equilibrated with 0,05 M NaAc buffer
pH 4.4. The neuraminidase concentrate (2,0 ml) was pipetted onto the
column and proteins were eluted from the column by stepwise gradient
elution with 0.05 M and 0.1 M NaAc buffer pH 4.4, and 1.0 M NaCl.
Fractions (2.0 ml) were eluted from the column at a flow rate of 0.8 ml
min”^. The E„on values for each fraction were used to detect the 
2oU nm
protein peaks. Peak fractions were pooled, placed in dialysis 
tubing and concentrated with Carbowax to the original starting volume 
of 2 ml. Finally the concentrates were again placed in dialysis 
tubing and dialysed overnight at 4°C against 0.05 M NaAc buffer pH 5,5. 
A T.B.A. assay was done to detect concentrates enzymatic activity.
The peak samples were stored at -20^C.
1c. Further purification of neuraminidase preparations by 
DEAE cellulose ion exchange chromatography
The column was equilibrated with 1.0 M NaCl. The neuramini­
dase-containing peak VI (2.0 ml) was pipetted onto the column and 
fractions (2.0 ml) were eluted from the column with 1.0 M NaCl at a 
flow rate of 0,8 ml min The peak fractions were pooled, placed in
dialysis tubing and concentrated with Carbowax at 4°C to bring the 
volume down to the initial volume. The concentrates were dialysed 
overnight against 0.05 M  NaAc buffer pH 5.5 and a T.B.A. assay was done 
to determine the level of neuraminidase activity. The peak samples 
were stored at -20°C.
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Samples of 0.05 M NaAc buffer pH 5.5, Galbiochem V. cholerae 
neuraminidase 1.0 I.U. ml Borate Gelatin Buffer pH 7.5, and 
Sephadex G 100 1 x purified cholera enterotoxin (0.1 ml) were 
analysed for neuraminidase activity by the T.B.A. and M.P.N. assays.
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3 T  PROTEIN ESTIMATION
I, Lowry procedure (B.S.A. as protein standard) (Lowry ^  al, 1951)
A standard protein solution was prepared by dissolving 2 mg
BSA ml  ^ distilled water. For the standard curve 40, 80, 120, 160
and 200 pg BSA were used; the total volume was adjusted in each tube 
to 1,0 ml with distilled water. The semi-purified neuraminidase 
preparations N^-N^ from Sephadex GlOO were analysed by taking 0.1 ml 
of neat preparation. To all preparations 5,0 ml Folin C reagent
(p 218, Appendix III) was added. The preparations were allowed to
stand at room temperature for 10 min. Folin D reagent (p 218, Appen­
dix III; 0.5 ml) was added and the samples were allowed to stand for
30 min. The mixtures were read against a blank of distilled water
at To obtain the protein content of the preparation
expressed as pg B.S.A., the following calculation was utilised;
^B.S.A. ^ ^750 am * protein ml"^ as B.S.A.
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Q,. Micro-^biuret procedure (Ovalbumin as protein standard)
(Modification of method of Leven and Brauer, 1951)
A protein standard solution was prepared by dissolving 1,5 mg 
ovalbumin ml distilled water. The concentrations used for the 
preparation of the standard curve were, 150, 300, 450 and 600 micro­
grams and the total volume of the samples in distilled water was 1 , 0  ml. 
In addition, the protein content of semi-purified neuraminidase 
preparations N^-N^ from GlOO Sephadex were analysed, 1,0 ml of the neat 
preparation was used, 3 N NaOH (0,3 ml) was added to tubes containing 
the samples, and the mixtures were placed in a heating block at 100°C 
for 5 min. The tubes were cooled to room temperature, A solution 
of 2.5% (w/v) CuS0 ^,5 H 2 0  (0,2 ml) was added, the tubes were shaken 
and left to stand for 5 min at room temperature. The mixtures were 
centrifuged for 3 min at 3000 rev min (1200 g^ ) in a bench top centri­
fuge (M.S.E, Minor) and the samples were read against a distilled
water blank at Eccc in an SP 500 spectrophotometer, ta?0 0  run f
To obtain the protein content of the preparation expressed 
as pg ovalbumin, the following calculation was utilised;
^oval ^ B5 5 5  nm “ protein ml ^ as ovalbumin.
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ENZYME ASSÀYS
I. T.B.A. procedure for neuraminidase activity (Warren, 1959)
A stock solution of N-acetylneuraminic acid (Sigma) was 
prepared by suspending 6,18 mg in 10 ml of 0.05 M  NaAc buffer, pH 5,5.
The stock solution was diluted to give a series of concentrations from 
6,18 pg to 37,116 pg (i.e. 0,02 pmoles - 0,12 pmoles ml ^). It was 
necessary to double the initial concentrations to achieve final 
concentrations of 0 . 0 2  pmoles - 0.06 pmoles ml  ^ as the assay measures 
0.5 ml of the original 1 ml. These concentrations of N-acetylneuraminic 
acid were incubated in a water-bath at 37^C for 30 min. Phospho- 
tungstic acid, 1.0 ml (5.0 g in 100 ml 2.0 N HCl) was then added to
the tubes which were mixed in a Whirlimixer and then centrifuged in a
benchtop centrifuge, A 0,5 ml volume of supernate was pipetted from
each tube and placed into clean tubes. Periodate solution, 0.1 ml
(4.27 g in 38.3 ml H^O +  61,7 ml phosphoric acid (Analar) ) was added 
and the tubes were allowed to stand for 2 0  min at room temperature. 
Subsequently, 1 ml of arsenite solution (17,75 g Na 2 S0 ^ in 250 ml 
H 2 O +  5 ml 5 N H 2 S0 ^ +  25 g sodium arsenite) was added and the tubes 
were shaken until the yellow colour disappeared; this indicated 
that unreacted iodides had been removed. This was followed by the 
quick addition of 3.0 ml of thiobarbituric acid (4.5 g of 2 X 
recrystallised thiobarbituric acid (p 221, Appendix III) in 750 ml 
0,5 M NagSO^). The tubes were placed in a heating block at lOO^C 
for 15 min and cooled for 5 min. Distilled cyclohexanone (4.6 ml, 
B.DoHo) was added to each tube, and after shaking, centrifuged for 
3 min at 3000 rev min  ^ (1200 ^) in 30 ml glass bottles (Universels),
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It was also possible to use n-butanol as an alternative organic phase 
to cyclohexanone. The n-butanol was less toxic to use. The organic 
phase was removed, and read against a buffer blank at ^  in an
SP 500 spectrophotometer.
When testing the neuraminidase activity of actual enzyme 
preparations, a substrate of bovine submaxillary mucin was prepared 
by dissolving 20 mg in 5,0 ml of 0,05 M sodium acetate buffer pH 5,5 
containing 0.1% CaClg (w/v) and 1% NaCl (w/v); 0,4 ml of this mixture
was used in the actual assay. Two commercial enzyme preparations 
were tested, as well as semi-purified GlOO pooled column preparations 
N^-N^. The commercial enzymes were Clostridium perfringens neuramini­
dase (Sigma), and V. cholerae neuraminidase (Koch-Light), The Sigma 
enzyme was prepared by dissolving 1 mg in 5.0 ml of 0.05 M NaAc 
buffer pH 5.0. The Koch-Light enzyme was prepared by diluting the 
stock solution (200 ImU ml ^ 1:5 in 0,05 M NaAc buffer pH 5.5 
containing 0.1% CaClg (w/v) and 1% NaCl (w/v). In the assay 0.1 ml
samples were utilised thus, 3.4 ImU of the Sigma enzyme and 4.0 ImU
of the Koch-Light enzyme were used in the assay. The semi-purified 
GlOO pooled fractions N^-N^ were added to the substrate undiluted in 
0.1 ml aliquots. The volume of the enzyme substrate preparations 
was made up to 1.0 ml by adding 0,5 M NaAc buffer (in the case of the
V. cholerae neuraminidase at pH 5.5 +  0.1% CaCl2  and 1% NaCl; in the
case of the Cl. perfringens neuraminidase at pH 5.0 without additional 
ions). The preparations were incubated for 30 min. The assay 
procedure followed was the same as that cited in the standard curve 
procedure above.
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One I.U. (1000 ImU) of neuraminidase liberates 309.3 |ig NANA min ^
- 1
or 9279 pg (9.28 mg) NANA (30 min) . In obtaining the activity 
levels of neuraminidase the following calculations were utilised;
•SqANA *  S 4 9  nm *  °  re leased  ml"^
t l t l f m i c r o 'b i u r e r p L t e i r ^  = *^8 re leased  (mg p ro te in )*^
in sample = A
Specific activity p= x 1000 = ImU (mg protein)”^.
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M.P.N. procedure for neuraminidase activity (Palese, Bucher and 
Kilbourne, 1973)
3-Methoxyphenol (B.D.H.) was used to prepare a standard
curve. One ml of the commercial preparation of 3-methoxypheno1 
_ 1
(1.14 g ml 0,1 M PO^ buffer (B.D.H. Chemicals Ltd., Poole, England)
(p 219, Appendix III) +  2 mM CaCl^ pH 5.9) was diluted in 9.18 ml of
0.1 M PO^ buffer (B.D.H.) + 2 mM CaCl^ pH 5.9 (p 119,Appendix III)*
-1
this gave 100 pmoles (0 .1 m ) . The final concentration of methoxy-
phenol used was 100 nm (0.1 mD and 20, 40, 60, 80 and 100 nm of
3-methoxypheno1 were used for the standard curve, the volumes were 
adjusted to 0.1 ml with 0.1 M PO^ buffer. For the actual assay of 
neuraminidase activity a substrate of 2-(3'methoxyphend)-N-acetyl-a- 
neuraminic acid (Research Resources Branch of the National Institute 
of Allergy and Infectious Diseases, Bethesda, Maryland) was prepared 
by dissolving 50.0 mg (10 ^ M) in 11.82 ml 0.1 M sodium phosphate 
buffer (B.D.H.) pH 5.9. The neuraminidase activity of Cl. perfring­
ens neuraminidase (Sigma), V. cholerae neuraminidase (Koch-Light) 
and V. cholerae neuraminidase semi-purified Sephadex GlOO preparations
!
N^-N^ were tested.
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The Cl. perfringens neuraminidase (Sigma) was prepared by 
dissolving 1*0 mg in 5,0 ml 0,05 M NaAc buffer pH 5,0 and the 
V, cholerae neuraminidase (Koch-Light) was prepared by diluting the 
stock solution (200 ImU ml ^) 1:5 in 0,05.M NaAc buffer pH 5,5 contain­
ing 0.1% CaCl2  (w/v) and 1.0% NaCl (w/v). Aliquots (0.1 ml) were 
taken from the above enzyme preparations, from N 2 "N^ preparations and 
from the methoxyphenol standards and 0,1 ml of 0.1 M  PO^ buffer pH 5.9 +  
2 mM CaCl2  was added. The methoxypheno1 standards were placed in a 
waterbath at 37°C for 30 min. The enzyme preparations were preheated 
in the same waterbath for 2-3 min before the addition of 0,1 ml of 
2-(3*methoxyphenyl)-N-acetyl-a-neuraminic acid. They were reincubated 
for 30 min and the reaction was stopped by adding 25 pi of 1 M di-sodium 
E.D.T.A. (B.DoHo). The tubes were placed in an ice-bath for 30 min 
and 0,2 ml of diazonium salt of 4 amino - 2.5 di-methoxy-4* nitroazo- 
benzene (Koch-Light, prepared by adding 6.0 mg of diazonium salt
in 1.0 ml 0.4 M sodium phosphate buffer pH 7.0 - this must be 
prepared on the day used and filtered through a Whatman filter paper) 
was added. After 30 min a precipitate formed and 4 ml 0.5 N NaOH was 
added to each tube to solubilise the precipitate. The tubes were 
centrifuged for 3 min at 3000 rev min  ^ (1200 ^) in a benchtop centri­
fuge (M.S.E. Minor). The samples were read against a blank that
contained 0.1 M PC. buffer +  2 mM CaCl» pH 5,9 at E.g. .
4 z DoU nm
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One I.U. of neuraminidase liberates 121.14 Wg methoxyphenol, 1 Wmole 
min  ^or 3634.2 yg (3.64 mg) methoxyphenol (30 min) ^, or 1457.3 yg ? 
NANA (for 1 ymole MP in 30 min) when expressed as NANA. In obtaining 
the activity levels of neuraminidase the following calculations were 
utilised:
K, _ X E_o_ X 0,001 (conversion factor to convert nmole to ym) x 
M.P. 580 nm
121,14 yg (conversion to convert ym to yg) = yg M.P. released,
yg M.P, X 0.401 (the conversion factor from the ratio of the molecular
weight of 3-methoxyphenol 121,14 : the molecular weight of NANA 309,3)
—X
X 10 « yg NANA released ml
relea„d (mg protein)-^
in sample = A
Specific activity = 3  ^ 1000 = ImU (mg protein) ^
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3. Proteinase activity (Kunltz, 1947)
A trypsin (Sigma) solution used in the standard curve was
prepared by dissolving 2 mg ml  ^ in 0.05 M Tris (hydroxymethyl)
aminomethane (Tris) -hydrochloride (Sigma) buffer pH 9.0 (p 2l4,
Appendix I). A  standard curve was prepared with 20, 40, 60, 80 and
100 pg trypsin, the final volume was 1.0 ml in 0.05 M Tris-hydro-
chloride buffer pH 9.0. A stock solution of substrate consisted of
1.0 g casein (Hammarsten grade, B.D.H.) dissolved in 100 ml 0.1 M PO^
buffer pH 7.6. The suspension was heated for 15 min in boiling
water to bring about complete solution of the casein. Trypsin and
the V. cholerae preparations were assayed for proteinase
activity, by adding 1.0 ml of sample to 1.0 ml of 1.07. casein* A
control tube contained 1.0 ml of diluted trypsin +  3.0 ml of 57.
trichloroacetic acid (B.D.H.) before the 1.0 ml of 1.07. casein was
added. The reaction for all tests was done in a 37°C waterbath for
30 min. After this time the reaction was stopped by adding 3.0 ml
of 5.0% trichloroacetic acid (w/v) and incubating at 45°C for 15 min.
Undigested casein was removed by centrifugation. The samples were
read against a blank of 0.05 M Tris HCl buffer pH 9.0 at E^oa •
—  280 nm
One unit of proteinase is the amount of enzyme that released 1 pmole 
of tyrosine per min. For determining the presence of proteinase in 
the semi-purified preparations the following calculations were
utilised:
^trypsin ^ ^280 nm " ml"l proteinase (as trypsin) = A
A X total volume . . , . . v
 tStâï protein  = "^8 proteinase (as trypsin)
(mg microbiuret protein)
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.*-/• Phospholipabe-C activity (Boehringer Mannheim, 1983)
Phospholipase G (Boehringer-Mannheim, ex. Bacillus cereus;
“ 1
p 217,Appendix III) was obtained as a 2.0 ml ml suspension in 3*2 M 
ammonium sulphate* The enzyme was diluted 1:100 with ice cold 
redistilled water before use in the assay. The standard concen­
trations of phospholipase C used were: 200, 240, 280, 320, 360 and
400 ngrams and represented 8.0, 9,6, 11.2, 12,8 and 14.4 ImU respect­
ively. The total volume was adjusted to 20 pi with ice cold re­
distilled water. The semi-purified V. cholerae neuraminidase 
fractions N^-N^ were assayed for phospholipase C activity with 20 pi 
of neat fraction. The control consisted of a 20 pi aliquot which 
contained 240 ngrams phospholipase C +  0.3 ml trichloroacetic acid 
(1.5 M).
The following were pipetted into centrifuge tubes; 0.1 M 
triethanolamine buffer pH 7.5 +  20 mM CaCl^ (1.0 ml; p 214 Appendix 
I), freshly prepared lecithin suspension (p 220, Appendix III), 
redistilled water (0.5 ml), lipase suspension (0.05 ml) and finally 
the 20 pi sample. The mixtures were incubated for 15 min in a 37°C 
waterbath. The reaction was stopped by adding 0.3 ml of 1.5 M 
trichloroacetic acid. The tubes were placed in a boiling water bath 
for 2 min, cooled and centrifuged at 3000 rev min  ^ (1200 ^) for 5 min. 
The supernate (0.25 ml) was pipetted into a cuvette with 2,5 ml 0.3 M 
triethanolamine buffer pH 7.6 + 4 mM magnesium sulphate (p 214,Appen­
dix I) and 0.15 ml of a solution which consisted of ATP 32 mM/NADG 6 n^/ 
PEP 45 mM (p 220, Appendix III), lactate dehydrogenase (0.01 ml of 5.0 mg 
ml  ^ in 3.2 M  ammonium sulphate) and pyruvate kinase (0.01 ml of 2.0 mg
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in 3,2 M ammonium sulphate). The reagents were mixed and 
allowed to stand for 2 min at room temperature before reading against 
a blank of redistilled water at EL.. nm
This reading was designated or the E^^^ ^  reading prior to 
the addition of glycerol kinase. Finally, 0,04 ml of glycerol kinase 
(1,0 mg ml ^ in 3,2 M ammonium sulphate) was added. An reading was
taken after 10 min against a blank of distilled water. This reading 
was designated or the E^^^ ^  after the addition of glycerol kinase.
The value E^-Eg was equal to the relative phospholipase C activity.
One I.U, phospholipase-C hydrolyses 1 pmole lecithin (804,2 pg).
min or 12063 pg (12,063 mg) lecithin (15 min) The phospho-
lipase-C activity of the preparations were determined as follows:
EL._ „ prior to glycerol kinase treatment = E.: EL.. after340 nm 1 340 nm
glycerol kinase treatment - E 2 :
Ic
phospholipase-CxAE x. 0,001 (conversion factor to convert ngrams 
to pg) = pg lecithin hydrolysed 
pg hydrolysed lecithin x 50 (factor to convert to ml since 0.02 ml 
used in the assay) = pg lecithin hydrolysed ml ^
—  X total volume = pg lecithin hydrolysed
(mg protein)  ^ = A
Specific activity = x 1000 = ImU (rag protein)"^
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5. Endoglycosidase activity (Dubois, Gilles and Hamilton, 1956;
Chien £t 1975),
A  standard curve was prepared for the phenol sulphuric acid
assay for neutral sugar with glucose (1,5 mg ml ^ in distilled water)
as the neutral sugar. The total volume in each test was brought to
2,0 ml with distilled water, 50 pi of 80% (w/v) phenol (reagent
grade B,D,H,) and 0,5 ml cone, sulphuric acid (Analar)
(p 217, Appendix I I I ) ,  The reagents were mixed with a Whirlimixer,
and the tubes were placed in an ice bath for 30 min. The reaction
was measured at E,-A against a distilled water blank,4?u nm
The standard solution of endoglycosidase H (Seikagaku Kogyo 
Co. Ltd., Tokyo, Japan, freeze dried - ex Streptomyces griseus) was 
prepared by diluting 2.0 pi of enzyme with 100 pi of O'. 1 M NaCl 
containing 0,1% bovine serum albumin. Aliquots of 10 and 20 pi 
of this stock solution were used. The semi-purified V, cholerae 
neuraminidase preparations Ng-N^ were assayed as neat 20 pi volumes.
The substrate for the endoglycosidase activity was ovalbumin (Sigma 
Grade V 5,0 mg in 0,5 ml of 0,05 M sodium acetate buffer pH 5,5 which 
contained 0.5% (w/v) sodium dodecyl sulphate (B.D.H.)). The control 
was prepared by adding 12.5% (w/v) trichloroacetic acid to the oval­
bumin substrate before the addition of enzyme. The 20 pi sample was 
added to 0,5 ml of the ovalbumin substrate and incubated for 1 h in 
a 37°C waterbath. The reaction was stopped by adding an equal volume 
of cold 12,5% (w/v) trichloroacetic acid to inactivate endoglycosidase, 
the tubes were kept at 0°C for 15 min and centrifuged at 17,000 rev 
min  ^ (35,000 ^) in a 3 x 25 ml rotor with 3,0 ml tube adaptors in an
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M.S.E. 65 centrifuge. Aliquots of 0,2 ml of the clear supernate 
were assayed for total neutral sugar to determine endoglycosidase 
activity. After the addition of.50 pi of 80% phenol and 0.5 ml of 
cone, sulphuric acid (Analar, B,D.H,, PoOle, England), the samples 
were allowed to stand at room temperature for 30 min to allow for 
colour development, and read against a distilled water blank at
^490 nm*
One I.U, is that amount of enzyme capable of catalysing the hydrolysis 
of 1 pmole of ( man^ - GlcNAc^ - Asn- - Acetyl ) per minute at 
37^C. The endoglycosidase activity (m,u,) of the preparations
was measured by the release of neutral sugar (as glucose) from an ovalbumin 
substrate, and the level of activity was determined against the commercial 
enzyme preparation. The following calculations were utilised;
V e n o r “ 2®°4 *  ^490 am = ^8 glucose o f p re p a ra tio n  = A
A X 6,0 mu of commercial enzyme  ^ _
9,145 (pg glucose released by 6m.u.commercial enzyme) ^ ~
m.u.ml  ^of preparation;
*'"'t*tal°pr5tIl^T*^^°" ^ total ™ l ““a * 0.001**
- enzyme units (mg protein)"^
* conversion factor to express result ml ^
**conversion factor to express results as units (mg protein)"^.
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G, Aldolase activity (Beisenherz e^ al, 1953)
Aldolase (Boehringer-Mannheim, ex. rabbit muscle - p 217,
Appendix III) used in the preparation of the standard curve was
obtained from the manufacturer as a 20 mg crystalline suspension in
2,0 ml 3,2 M ammonium sulphate. The working stock solution was
diluted 1:100 in 0,1 M  triethanolamine hydrochloride buffer (Sigma)
pH 7,6 (0,9 ImU (1,0 pi) ^), The concentrations of aldolase in the
standard curve were 0,1, 0,2, 0,3, 0,4 and 0,5 pg, the final volume
was brought to 20 pi with 0,1 M triethanolamine hydrochloride buffer,
pH 7,6, The V, cholerae neuraminidase preparations N^-N2  were
assayed neat in 20 pi volumes because of the expected low aldolase
activity. The control was 0,5 pg aldolase without substrate. Into
a cuvette the following were added: 2,81 ml 0,1 M triethanolamine
hydrochloride buffer pH 7,6, 0,05 ml 3-nicotinamide-adenine dinucleotide
solution,(12 mM),0.1 ml fructose 1,6 di-phosphate solution(33 mj^ and
0,02 ml glycerol-3-phosphate dehydrogenase/triosephosphate isomerase
suspension (p 217, Appendix III), The reaction was started by the
addition of the 20 microlitre enzyme sample to the cuvette. The E„,_340 nm
was read at 1 min intervals for a period of 5 min and the extinction 
calculated at each time interval*
One I.U, will convert 1.0 pmole of fructose-1,6 diphosphate to dihydroxy- 
acetone phosphate and glyceraldehyde-3-phosphate per minute at 25°C,
The Eg^Q ^  was read at 1 min intervals for a period of 5 min, and A  E 
extinction was calculated at each time interval. The mean of all the 
A E  values was calculated. To obtain aldolase activity in each of 
the preparations the following calculations were carried out;
I
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1) X A of commercial enzyme X ImU (20 pi
*34 V THtl
commercial enzyme
X A  ^  of preparation
activity of preparation (ImU (20 pï)"^)
2) ImU (20 pi)  ^X 50 - activity of preparation ml”^
3) Specific activity of preparation = preparation^ml
mg of protein ml
-1
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Y E C  PRODUCTION OF ANTISERA
Anti-neuraminidase antisera used in this investigation were 
prepared by Dr. D.E, Stewart-Tull, Anti-neuraminidase antisera 
DST R76 and DST R77 were prepared by immunising rabbits intramuscu­
larly with 1,0 ml of a mixture which contained; 0,5 ml of Sephadex 
G75 semi-purified V, cholerae neuraminidase, 1,0 ml saline, 1,5 ml 
Bayol F Oil and 0,6 ml Arlacel A, Mixtures for injection into 
rabbits DST R78 and DST R79 were similar but Koch-Light V, cholerae 
neuraminidase (100 ImU (0,5 ml) ^) was used, A booster injection 
of 2,0 ml was given intraperitoneally after one month. Ten days 
later a trial bleed was taken from the ear vein. The serum was 
tested for the presence of anti-neuraminidase antibodies by an 
Ouchterlony double diffusion in gel test. Animals were exsanguinated 
and the serum was collected and stored at -20°C,
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I, Purification of IgG (by DEAE)
DEAE cellulose (Whatman, Grade DE 52, wet microgranular) was
equilibrated with 0.01 M PO^ buffer pH 7.5. A Whatman glass column
(1.5 X 45 cm) was filled with the DE 52 slurry such that the final bed
3
dimensions were 1,5 x 25 cm and the bed volume was 51,25 cm , The
column was connected to a buffer reservoir containing 0,01 M PO^ buffer
pH 7,5, The flow rate of the column was 0,8 ml min  ^ and 2,0 ml
fractions were collected. Rabbit anti-neuraminidase serum (DST R78 -
4,0 ml) was placed in Visking tubing and dialysed against 0,01 M PO^
buffer pH 7,5 overnight at 4°C, The equilibrated serum was pipetted
onto the column. The first protein peak, eluted with the starting
buffer, was the IgG, The fractions containing IgG were pooled and
concentrated with Carbowax to a volume of 4,0 ml. The column was
washed with 0,3 M phosphate buffer and re-equilibrated with 0,01 M  PO^
buffer pH 7,5, The 1 X purified IgG from serum DST R78 was purified
a second time on the DE 52 column in the same manner as cited above.
The IgG was also separated from normal rabbit serum by the
procedure described above with one variation, namely, the serum was
first fractionated with ammonium sulphate. In this procedure 4,0 ml
of normal rabbit serum was added to 4,0 ml of 1007,saturated (69.7g(NH^)2S0^
in 100 ml distilled water). The precipitate was spun down by
-1
centrifugation, at 3000 rev min (1200 g) for 10 min. The precipi­
tate was washed 5-6 times with 507, saturated (NH^)2 S0 ^ solution until 
haemoglobin was removed. The precipitate was re-suspended in 4,0 ml 
of 0,01 M  PO^ buffer pH 7,5 and dialysed against 0,01 M PO^ buffer 
pH 7.5 overnight at 4°C, This was added to the DE 52 anionic
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exchanger column and IgG prepared as cited above*
Rabbit anti-neuraminidase (DST R79) was prepared as described 
above for normal rabbit IgG*
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"Sur PURIFICATION OF CHOLERA ENTEROTOXIN
Sephadex GlOO (35 g) was suspended in 700 ml distilled water and
placed in a boiling-water bath for 5 h to allow the gel to swell*
The gel was re-suspended in borate gelatin buffer pH 7,5 (p 212,
Appendix I) previously degassed under vacuum, A column (2,6 x 81 cm;
L,K.B., Bromma, Sweden) was filled with the Sephadex GlOO, The column
was equilibrated with borate gelatin buffer pH 7,5, The flow rate of
this column was 0,8 ml min Crude cholera toxin (1,2 g N,I,A,I,D,
Batch 001 in 2,0 ml borate gelatin buffer pH 7,5) was pipetted onto
the column. The E„q^ of each fraction was measured to detect theZou tun
protein eluted. The first peak contained the toxin and a second 
larger peak contained non-toxic brown products of the medium and was 
discarded. The pooled peak toxin fractions were concentrated with 
Carbowax to 2 ml.
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I X  HISTOLOGICAL PROCEDURES
Rat small intestine was removed from sacrificed healthy rats. 
Segments of the ileum were wrapped in aluminium foil and quickly frozen 
in liquid nitrogen. The frozen tissue segments were stored at -70^C in 
universal bottles (30 ml). Subsequently, the tissue segment was 
quickly removed from the aluminium foil and was cut transversely into 
small lengths. Each segment was placed in a transverse orientation in 
an aluminium foil boat ( 2 x 3  cm) filled with Ames OCT freezing compound 
(Raymond Lamb Ltd., London), The aluminium foil boat was immersed in 
an isopentane (B.D.H.) slurry in a 250 ml beaker immersed in liquid 
nitrogen. The isopentane was kept in liquid nitrogen until it became 
viscous. The boat containing tissue was kept in the isopentane slurry 
until the tissue turned completely milky white. The aluminium foil 
boat was quickly removed from the tissue block, a drop of freezing 
compound was added to the back of the tissue block and the tissue was 
attached to a cryostat chuck face.
The cryostat (SLEE Medical Ltd., London) was set to -25°C. The 
chuck to which tissue block had been attached was precooled in liquid 
nitrogen before placing in the cryostat, A wedge-shaped microtome 
knife (SLEE), used to cut sections, was fitted with a Pearse knife cup 
which contained dry ice. The microtome knife was cooled for 10-15 min 
in the cryostat cabinet before sectioning the tissue block. Thick 
sections (10-12 |i) were cut until a tissue face was exposed. Serial 
tissue sections 8 |i in thickness were cut, placed on glass microscope 
slides (precleaned with 90% (v/v) ethanol and coated with egg albumin) 
and placed at 4°C to slowly thaw.
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L Preservation of mucosubstances by vapour fixation (Culling, 1974)
A litre desiccator was dried for 4-6 h at 80°C and a crucible 
containing 5.0 g paraformaldehyde powder (B.D.H.) was placed in the 
dessicator. The lid was closed and the vessel was heated in an oven 
at 80°C for 1 h. After 1 h at 80°C, the crucible was removed and 
replaced with frozen sections on glass slides. The lid was replaced 
and the desCCcator was left at 60°C for 1 h.
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IX: EFFECTS OF NEURAMINIDASE AND OTHER CHEMICAL TREATMENTS ON GOBLET 
CELL HISTOCHEMISTRY
Frozen transverse sections of rat ileum were cut 8 microns 
thick. These sections were fixed in paraformaldehyde vapour for 1 h 
at 60°C. In this series of experiments the fixed rat ileal sections 
were treated for 24 h at 37°C in a moistened chamber with 0,1 ml 
(or 0,2 ml) of the following: (1) Distilled water, (2) 0,05 M NaAc
buffer pH 5,0 or 0,05 M NaAc buffer pH 5,5, (3) Cl, perfringens 
neuraminidase (Worthington: 680 ImU ml ^), (4) Cl, perfringens neura- 
minidase (Sigma: 680 ImU ml ^), (5) V, cholerae semi-purified neura­
minidase (N2  : 55 ImU ml ^), (6) V, cholerae neuraminidase (Calbiochems
1.0 ImU ml ^), (7) Concentrated trypsin inhibitor (1,0 mg Sigma 
inhibitor; (10 ml 0.05 M NaAc buffer pH 5.5) ^), (8) Concentrated 
trypsin inhibitor (2,0 ml) + neuraminidase (N^; (0,1 ml) +  0,05 M NaAc 
buffer pH 5,5 (0,05 ml)), (9) Borate gelatin buffer pH 7.5, (10) 
Cholera enterotoxin, N.I.A.I.D, 001 (3,0 g (5,0 ml borate gelatin 
buffer pH 7,5) ^), (11) mixture of 0,05 M NaAc buffer pH 5,5 (0,3 ml)
+ 0,01 M PO^ buffer pH 7,5 (0.05 ml), (12) mixture of 0.05 M NaAc 
buffer pH 5,5 (0,05 ml) + 0,01 M PO^ buffer pH 7,5 (0,3 ml).
*Note: Because the maximal effect of the enzyme upon the tissue
section was required, each enzyme preparation was added 
undiluted.
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Two frozen sections were utilised for each treatment and two 
frozen sections were left untreated to serve as additional controls.
Where mixtures of whole rabbit serum or IgG + neuraminidase were 
utilised, the tubes that contained such mixtures were first incubated 
for 2 h at 37°C in a waterbath, allowed to stand overnight at 4°C, and 
finally centrifuged at 3000 rev min  ^ (1200 ^  in a bench top centrifuge 
for 5 min. After 24 h, sections were stained by Alcian Blue/PAS and 
Haematoxylin-Eosin staining procedures (p229, Appendix VI). The goblet 
cells were counted in 20 fields under the X 40 objective (i.e. a total area 
of 8,84 sq ram) as either Alcian Blue staining or PAS staining. The data 
were analysed statistically by a Student t-test (in its double-tailed form) 
which compared the goblet cell counts of the untreated or buffer treated 
sections with those treated with neuraminidase or other treatments. The 
values cited for the t-test throughout this thesis were obtained from the 
following formulae:
»i/‘w ]
2)
b) t = (x^ - x^) /
where: s = sample standard deviation; t = t distribution; x^ and x^
respectively = the first and second samples; x and x respectively = the
- 2 "2 _ 2 
mean of first and second samples; ^  (x . - x ) and 5" (x_. - x_)
1^1  ^ 2 
respectively - the sum of the squares for the first and second samples; and
finally n^ and n^ respectively = the number of observations for the first and 
second samples. These formulae were obtained from Pearson and Hartley (1966).
The counts of goblet cells in 20 fields and the average number 
in each field (0,442 sq mm) were presented as histograms.
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i. Effects of specific antisera
The effects of rabbit anti-neuraminidase sera, IgG fraction 
of rabbit anti-sera and normal rabbit sera were tested in order to 
find out their effects on neuraminidase activity and on the number of 
goblet cells staining Alcian blue and PAS, Constant amounts of 
neuraminidase were treated with a series of increasing volumes of 
sera in a final volume made up with 0,05 M NaAc buffer (pp 230-231, 
Appendix VII). Controls of enzyme plus buffer and sera plus buffer 
were included. Each of the mixtures of sera plus enzyme, and the
controls, were incubated for 2 h at 37^C in a waterbath. These
' b
mixtures were then held overnight at 4 C, They were centrifuged at 
3000 rev min  ^ (1200 g,) for 5 min in a bench top centrifuge. The 
supernates were removed to clean tubes.
Aliquots of 0,1 ml were taken from each of the mixtures and 
added to the tissue sections which were then handled as previously 
described (see pp 98, 99),
=1.
X T  THE EFFECT ON NEURAMINIDASE ACTIVITY BROUGHT ABOUT BY ABSORPTION WITH 
SPECIFIC RABBIT SERA AS MEASURED BY THE T.B,A. AND M,P,N. ASSAYS
*
The neuraminidase activity absorbing capacity of anti-neura­
minidase sera, IgG fraction of anti-neuraminidase sera, normal serum 
and the IgG fraction of normal rabbit serum were tested by spectro- 
photometric assays (T,B,A, and M,P,N,), The mixtures of enzyme plus 
specific sera as well as the controls were prepared as previously 
described (p230-231, AppendixVII), and a volume of 0,2 ml was taken from 
each of the mixtures in order to perform T,B,A, and M.P,N. assays of 
neuraminidase activity.
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SEE DILUENT RELATED SIALOMUCIN LOSS AND NEURAMINIDASE INDUCED NANA 
LIBERATION
a) Release of sialomucin from unfixed tissue by diluent
2 ‘
Six rat ileum segments (0*5 cm ) were placed in 1,0 ml of 
0,05 M NaAc buffer pH 5,5 for 1 h at room temperature. The super­
nates were tested in the T.B.A, assay in order to detect the spontan­
eous release of sialomucin. The tissue segments were placed in
1,0 ml of sterile casamino yeast extract broth (C,A,Y,E,) for 1 h at 
37°C, and the broth was tested in the T.B.A, assay. The tissue 
segments were homogenised in sterile tissue grinders in 1,0 ml of 
0,05 M NaAc buffer pH 5,5, The homogenate was centrifuged for 3 min 
at 3000 rev min  ^ (1200 , The volume of each supernate was
measured before NANA was measured by the T.B.A, assay. Three tissue 
segments served as controls and were washed with P.B.S, prior to 
washing in NaAc buffer,
b) Release of sialomucin from fixed tissue by diluent
!
I In further experiments a similar procedure was used but the
2
size of the segments was 1,0 cm and the tissue segments were fixed 
in paraformaldehyde vapour for 1 h at 60°C, Fixed segments were 
placed in 1,0 ml of 0,05 M NaAc buffer pH 5,5 for 1 h at temperature 
and the liquid assayed as before. The segments were placed in 1,0 ml 
of sterile C.A.Y.E, medium for 1 h at 37°C and the broth assayed as 
before,
c) Release of NANA from ileal segments by V, cholerae neuraminidase
The effect of neuraminidase was tested on six fixed segments.
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Each of the segments was placed in a tube which contained 1,0 ml of 
0,05 M NaAc buffer for a period of 30 min at 37^C, The supernates 
were tested in the T.B.A. assay. Three segments were placed in 0,9 ml 
of NaAc buffer and 0.1 ml of V, cholerae neuraminidase (Calbiochem,
1,0 ImU ml was added before incubation at 37°C for 30 min. The 
supernates were tested in the T.B.A, assay. Three segments were 
treated with 1,0 ml of 0,05 M NaAc buffer pH 5,5 alone for 1 h at 37°C,
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S Z T  EFFECT OF NEURAMINIDASE ON ADHESION OF V, CHOLERAE TO RAT ILEUM
T^N^ broth (p 216, Appendix II) was inoculated with V. cholerae
strain 10732 and incubated at 37°C overnight, C.A.Y.E, broth (14.7 ml)
was inoculated with 0,3 ml of this overnight growth (1:50 dilution of
the overnight growth) and incubated for 6-8 h at 37°C, Nine fixed rat
2
ileal segments (1,0 cm ) were treated by the procedures shown in the 
flow diagram, Figure 6,
TESTS
1U4
CONTROLS CONTROLS
□ □ □  □ □ □  □ □ □
The 5 cissue segments were washed in 1.0 ml of sterile 
0.05 M  NaAc buffer pH 5.5 for 30 min at room temperature
□ □ □  □ □ □  □ □ □
Segments were washed in 0,05 M 
NaAc buffer pH 5.5 plus 0.1 mT 
V. cholerae neuraminidase 
(Calbiochem 100 ImU) for 30 min 
at 37°C. A T.B.A. assay was 
performed on the supernate.
Segments were washed in 1.0 
buffer pH 5.5 for 30 min at 
performed on the liquid.
ml of sterile 0.05 M NaAc 
37°C and a T.B.A. assay was
□ □ □  □ □ □  □ □ □
Segments.were washed in 1,0 ml of V. cholerae suspension in 
C.A.Y.E. medium for 30 min at 37oC. A T.B.A. assay was 
performed on the supernate after heating for 
30 min at 56°C.
%
Segments were washed in 1.0 ml of 
sterile C.A.Y.E. medium for 30 min 
at 37°C. A  T.B.A. assay was 
performed on the supernate.
□ □ □  □ □ □  □ □ □
Segments were rinsed two times with 10 ml of sterile P.B.S.
;
□ □ □ □ □ □ □ □ □
Tissues were homogenised in 8.0 ml of sterile P.B.S. The 
volume of the homogenate was adjusted to 10 ml with P.B.S.
Tissue homogenates were diluted serially in P . B . S . , 
tenfold dilutions. A volume of 0.02 ml was pipetted 
from each serial dilution onto the surface of Thiosulfate 
citrate bile salts sucrose agar plates in order to obtain 
viable plate counts. Duplicate counts were made* and 
incubated at 37°C overnight.
Figure 6'. Enzymic treatment of rac ileal segments before 
V, cholerae adhesion
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XZX' EFFECT OF NEURAMINIDASE ON ADSORPTION OF CHOLERA ENTEROTOXIN TO 
RAT ILEUM
The effect of neuraminidase pretreatment on the adsorption of 
cholera enterotoxin was done by comparing neuraminidase pretreated 
with 0.05 M NaAc buffer pH 5,5 pretreated fixed rat ileal segments 
(Figure 7),
I. Testing for cholera enterotoxin
The cholera enterotoxin (600 BD) which had been exposed to
the ileal segments was diluted 1:10 (300 jig ml  ^s 60 BD), 1:20
(150 |ig ml ^ s 30 BD) and 1:40 (75 |ig ml ^ s 15 BD) in B.G.B.S, buffer
pH 7,5, The Limit of Blueing Dose Assay was done by Dr, Stewart-Tull,
Volumes of 0,1 ml of the enterotoxin dilutions were injected intra-
dermally into the back of a rabbit, i,e, 6,0, 3,0 and 1.5 BD,
respectively. After 24 h 3,0 ml of a 5% (w/v) Pontamine skyblue
solution were injected into an ear vein. After I h, the zones of
blueing at the site of enterotoxin injections were measured. One
cholera enterotoxin Blueing Dose (B,D,) is equal to 64 m m , A n  exact
number of Blueing doses cannot be obtained from the area of blueing 
2
(mm ) because not all the enterotoxin injected i,d, into the shaved 
rabbit skin elicit a tissue reaction (Craig, 1965), Therefore, the 
approximate number of cholera enterotoxin B,D, adsorbed to ileal 
tissue was calculated as a range from the blueing reaction produced 
by thé dilutions of toxin solution after exposure to the tissue.
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t e s t s CONTROLS
□ □ □ □ □  □ □ □ □ □
Segments were washed in 0.5 ml of 0.05 M 
NaAc buffer pH 5.5 plus 0.1 ml V . cholerae 
neuraminidase (Calbiochem 100 ImU) for 1 hr 
at 3 7 0 c.
Segments were washed in 1.0 ml of 0.5 M 
NaAc buffer pH 5.5 for 1 hr at, 37*^C.
□ □ □ □ □  □ □ □ □ □
Segments were washed in 1.0 ml of Cholera 
Toxin, N.A.I.D. 3 mg ml"^, borate gelatin 
buffer pH 7.5, for 1 hr at 37°C.
I
□ □ □ □ □  □ □ □ □ □
The segments were rinsed in 10 ml B.G.B. 
buffer pH 7.5.
I□ □ □ □ n  □ □ □ □ □
The cissue segments were homogenised in 
0.5 ml of sterile B.G.B. buffer pH 7.5.
The volume of the homogenate was adjusted 
to 10 ml with B.G.B. buffer pH 7.5.
The homogenates were transferred to centri­
fuge tubes and centrifuged at 3000 rev min 
(1200 ^ ) . The supernate was tested for
the presence of toxin. . .
KJ e-Ut-AVnn 1 v> 1 J Ase- Heàrl Hr» O H
oS c . H " t e ^
Figure 7. Flow diagram to show the procedure for neuraminidase 
ureatmenc of enterotoxin to rat ileal tissue.
RESULTS
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X  NEURAMINIDASE
I, Production of crude neuraminidase
Fifteen volumes of protease peptone-colostrura medium (Ada, 
French and Lind, 1961) in the batch fermenter yielded 186,35 I,U, of 
neuraminidase as measured by the thiobarbituric acid assay for the 
release of neuraminic acid (sialic acid) from bovine submaxillary 
mucin. In view of the high yield of enzyme, the batch fermenter was 
used in the preparation of all crude neuraminidase.
The neuraminidase was precipitated from the culture supernate 
with methanol. The precipitate was harvested by centrifugation and 
this material was designated ’crude neuraminidase*,
G 100 Gel filtration
Initial experiments indicated that two distinct protein peaks 
were separated on Sephadex GlOO, The second peak contained brown 
coloured residues from the methanolic precipitate of the proteose- 
peptone-colostrum culture fluid (Figure 8), The assays for neura­
minidase activity showed that with G75 and G200 more protein and 
more enzyme we associated with the second brown peak fractions
(Figure 8), Filtration on Sephadex GlOO gave an EggQ ^  elution 
profile shown in Figure 9. The first peak contained an enzyme 
^ activity of 5,4 ImU (mg protein)  ^ and the second Eggg ^  peak 
contained an enzyme activity of 0.78 ImU (mg protein) The
fractions between the two peaks contained 9,3 ImU (mg protein) ,
The Lowry protein, T,B,A, and M,P,N, assays,that were done on each 
fraction showed the location of the enzyme, It was found that the
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Legend:
Gel filtration of crude neuraminidase.
0 :  Total protein value of peak in mg
(based upon E readings)
zoU nm
Q :  Total neuraminidase activity value in ImU
(based upon T.Ç.A. assay).
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major peak of neuraminidase was located between the first and second 
protein peaks. Much higher protein levels were present than found 
in the first peak. Protein estimation by the Lowry method showed 
that the protein value in peak 2 was twice that of peak 1,
In view of the finding that the peak of neuraminidase activity 
did not coincide with the protein peak in all semi-purification steps 
of the crude neuraminidase, the column fractions were examined by 
various methods, A  typical result is shown in Figure 10, It will 
be noticed that the neuraminidase was eluted from the column between 
peaks I and II detected at However, the enzyme peak
correlated reasonably with the protein peak obtained by the Lowry 
method. Consequently, the fractions between 78 and 110 ml of 
eluate containing the maximum neuraminidase activity were pooled.
Such neuraminidase preparations obtained at different times were 
designated as
Ia
•g
(U
u
I
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280 nra 
2.25-
1.75
II
72
48
0.75r36
0.25'
Neuraminidase fractions N , N , N , N36
75 100 200125 150
Figure 10
eluate (ml)
Locating neuraminidase activity (GlOO column eluates).
* 1 
Column dimensions; 1.5 x 81 cm; Flow rate: 0.8 ml min
Sample volume: 3.0 ml; Eluate: 0.05MNaAc buffer pH 5,5 
Legend: a) E^gQ ^  elution profile (— )
b) Lowry protein estimation (yg protein as B.S.Â.)
(
c) Neuraminidase activity measured by the 
determination of:
i) yg NANA liberated in the T.B.A. assay (
ii) nmoles of methoxyphenol liberated in 
the M.P.N. assay (#-#) .
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3 , CM"cellulose chromatography
Ion exchange chromatography on CM-cellulose gave the typical 
elution profile shown in Figure 11, The. first E^q q ^  peak showed 
a neuraminidase content of 6,8 ImU and the second one of 1.38 ImU by 
the T.B.A, assay. It was not possible to separate the enzyme from 
the brown pigment with the cationic exchanger, therefore it was not 
utilised further in the purification of crude enzyme preparations.
113
E
280 nm
138 ImU
0
6
2
8
6.8 ImU
0.4
0
50 100 150 200
Figure 11 ; CM-cellulose ion exchange chromatography 
of crude neuraminidase
eluate (ml)
Legend ; The total neuraminidase activity contained in the
pooled peak fractions is shown.
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DEAE cellulose chromatography
Ion exchange chromatography on DEAE-celInlose produced the 
typical elution profile, Figure 12, in which seven ^  peaks were
separated with a stepwise gradient of NaAc buffer pH 4.4. Peaks VI 
and VII were the only peaks with neuraminidase activity when assayed 
by the T.B.A, assay. In addition, Peak VI was pigmented and Peak 
VII was non-pigmented. The activity level of Peak VI was 3,6 ImU 
mg and that of Peak VII was 3.5 ImU mg” .^
Peak VI was re-chromatographed on DEAE, and three peaks.were 
obtained after elution from the column with 1.0 M NaCl, Figure 13, 
Peaks were non-pigmented while Peak III was pigmented. Peaks I-IIX 
had neuraminidase activity levels of 1.7 ImU, 0,57 ImU and 1,0 ImU 
respectively.
M
>
. "N
r4
S
<u
w
ro
Pr—< 
0)
> c:
>
M
M
7^*^ 7 asggnq OV^N W OI'O
t-4
M
f 4
M
i7’i7 p d  a s j j n q  o y ^ N  ÏÏ Ç 0 ‘ 0
sO
ro oro <rC'J 00p-l
o
S!
tOi
."S
c•Hs
n}
k
3
0)
S
0)
T3
3
k
V
k4
O
ïo
• i
2
oO
O
k
(0
§
k
j:
u
O)
OOc
co
•s
£ .
co
• H
0)
tû
0
5)
U
É
W
k
3
OA
1
y s
n >>
bO ao k
E a •H
• H >
C "3 • H ï o
‘ k CO k a
Q) U to
k a w
(0 a
0) E a)
a - C to
a <
O "O
o 0 0 ■ H A
(N a
c W • H H
• H E
m a (0 a
k 0 k 0
o a 3 a .
k 3 (U 3
a a
ro "3
<—4 0) r—4 a
ca W a »
k CO k a
0 JO o J3
H H
O
•o
G
0)
bû
(U
k)
\D
O
O
116
^280 nm 
0.49 .
0.42 -
0.35 
0.28 -
0.21 -
0.14 - 
0.07 _
10.1 ImU 
III
0.57 ImU
1.7 ImU
II
h -
120
— r
160
TT TTT
140
eluate (ml)
Figure 13 ; Re-chromatographing' of DEAE active peaks VI and VII
Peaks VI and VII from DEAE cellulose (see Figure 12)
were pooled and rechromatographed with 1.0 M NaCl as eluate.
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^  Protein estimation
A  standard curve was obtained in the Lowry method by plotting 
protein (B*S.A.) against the ^  values (Figure 14). The
constant k obtained from the standard curve was 407, The protein 
content of each of the semi-purified Sephadex G 100 neuraminidase 
preparations (N^-N^) was expressed as jig of protein mf  ^ as B.S.A. 
(Table 10),
A standard curve for the Micro-biuret method was obtained by 
plotting (ig of protein (ovalbumin), against E^g^ ^  values (Figure 15) 
The constant k obtained from the standard curve was 4687,5, The 
protein content of each of the semi-purified Sephadex G 100 neura­
minidase preparations (N^-N^) was expressed as |ag of protein ml"^ as 
ovalbumin (Table 10), The protein content of the semi-purified 
Sephadex G 100 neuraminidase preparations (N^-N^) were compared by 
using both Lowry and Micro-biuret methods (Table 10),
118
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r«.
.5
0.4
.3
1
.40 80 120 160 200
* X
Micrograms ml bovine serum albumin
Figure 14 : Standard curve for protein estimation
(Lowry method).
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0,15
Ê
0,10
0,05
600450300150
Micrograms ovalbumin
Figure 15 : Standard .curve for Micro-biuret protein
estimation.
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Semi-purified 
G 100 Neuraminidase 
Preparation
-1
Protein (yg ml ) as measured by
Lowry 
(B.S.A. Std.)
Micro-Biuret 
(Oval. Std.)
N, 562.0 319.0
N,
N.
134.0
37.0
108.0
32.8
167.0 136.0
Table 10 : Protein estimation of neuraminidase active preparations.
Lowry Bovine serum albumin k value * 407
, X 407 X .10 - yg protein ml
tnm.'-
-1
Microbiuret ovalbumin k value = 4688
. . E-cc X 4688 = yg protein ml 
555 nm
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m  ENZYME ASSAŸS
/. T.B.A. procedure for neuraminidase
A standard curve was obtained by plotting the concentration 
of NANA (limoles of N-acetylneuraminic acid) against the values at 
^549 nm (figure 16). Two different standard curves were produced, 
namely, one for N-butanol and one for cyclohexanone as the organic 
phase. The NANA constant, k, was 40,92 for N butanol and 32,92 for 
cyclohexanone,
It will be clear from Table 11 that in the 30 min T.B.A, 
assay neither the Koch-Light nor the Sigma neuraminidase preparations 
showed the level of enzyme activity as cited by the manufacturers^
oIaÎ a o Ï
T.B.A, assay|690 and 290 ImU respectively. The levels of neuramini­
dase activity in the semi-purified preparations from the culture 
fluid of V, cholerae grown in bovine colostrum:proteose peptone 
medium (Table 11) varied between 30-55 ImU (mg protein)”^.
122
0.4
w
0.2
0.02 0.040.01 0.03 0.05 0.06
ymoles ' nana
Figure 16 ; Standard curve for measurement of NANA in T.B.A. procedure.
Æ  = Standard NANA curve with cyclohexanone (distilled) as 
the organic phase
= Standard NANA curve with N-butanol as the organic phase.
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M.P.N. procedure for neuraminidase
A standard curve was obtained by plotting nanomoles (nmoi|.e8) 
of 3-methoxyphenol (M.P.) against ^  values (Figure 17). The
M.P, constant, k, was 105*26. The nmoles of 3-methoxyphenol released 
was a reflection of the level of neuraminidase activity. The level 
of neuraminidase activity could also be expressed as ng of NANA 
released by multiplying nm of 3-methoxyphenol by 0.4 (the conversion 
factor from the ratio of the molecular weight of 3-methoxyphenol 
124.14 : the molecular weight of NANA 309.3). An elution profile of 
neuraminidase active peaks eluted from a G 100 Sephadex column 
expressed as jj,g of NANA liberated was plotted (Figure 18).
The M.P.N. assay revealed that preparations N^-N^ had levels 
of specific activity ranging from 81-741 ImU (mg protein)"^ (Table 12).
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1.0
0.2
10060 804020
nmoles 3-methoxyphenol
Figure 17 : Standard curve for measurement of M.P. in M.P.N,
procedure.
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Figure 18 : Elution profile of neuraminidase active peak from
G 100 column (M.P.N, procedure).
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3, Proteinase activity
A standard curve was obtained by plotting jig of proteinase 
(as trypsin) against the ^  values (Figure 19). The proteinase
constant, k, obtained from the standard curve was 142*85, The 
enzyme content in each of the semi-purified preparations was expressed 
as jig of proteinase ((mg micro-biuret protein) ^),
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00<N
W
7
6
5
0.4
3
2
1
40 60 80 10020
Micrograms trypsin
Figure 19 : Stati’dard' fcürvte' 'for proteinase activity
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Sample Volume Total 
Protein 
(mg micro- 
b iuret)
ml
-1
Proteinase
(yg)
( as trypsin)
( mg micro-biuret
protein)"! )
Pooled 
G 100 
Fractions
N,
N,
N,
N,
8.0
31.8
14.0
20.0
2.6
3.35
0.46
2.72
16.71
4.00
1.86
0
51.42
37.01
56.51
Table 13 : Proteinase activity,
Legend ; yg proteinase ml
-1
A;
A X total volume
total protein
= yg proteinase 
(as trypsin)
(mg micro-biuret protein)
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4*. Phospholipase-C
A standard curve was obtained by plotting ngrams of phospho- 
lipase-C against the difference in ^  readings (A E  = E^-Eg,
where E^ = reading prior to the addition of glycerol kinase and E2  = 
reading subsequent to the addition of glycerol kinase (Figure 20).
The phospholipase-C constant, k, obtained from the standard curve was 
559* The levels of phospholipase-C activity are shown in Table 14*
132
w
I
w"
<N
0.4
. 2
.1
240 320 360200 280
Nano^rams phospholipase"C
Figure 20 : Standard curve for phospholipase-C activity.
Legend: - ^ 3 4 0  nm 9^^°^ glycerol kinase treatment.
^2 ” ^340 nm glycerol kinase treatment.
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5. Endoglycos i das e
A standard curve was obtained by plotting the number of pg 
of neutral sugar (glucose) against (Figure 21). The phenol-
HgSO^ constant, k, obtained from the curve was 121,95, The endo- 
glycosidase activity of the preparations was obtained by
measuring the release of neutral sugar (glucose) from an ovalbumin 
substrate, and comparing it against the level of neutral sugar 
(glucose) released from ovalbumin substrate by commercial endoglycosidase 
of known activity (Table 15),
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Figure 21 : ‘ Standard curve,for neutral sugar (as glucose).
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6. Aldolase
A standard curve was obtained by plotting |ig of aldolase
against the mean values of x 10  ^min  ^ (Figure 22),
There were no changes in the E... values at 1 min intervals
° 340 nm
during the 5 min test period for the preparations. Therefore
it was concluded that the N^-N^ preparations did not possess aldolase 
activity. The aldolase standard, however, gave variations in the 
^340 nm during the same 5 min period.
^ • Summary of enzyme activities in preparations
The various enzyme activities associated with the Sephadex 
I G 100 preparations (N^^-N^) are shown in Table 16,
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Figure 22 : Standard curve for aldolase concentration.
Legend: In this procedure che reaction is read at E
340 nm at
1 minute intervals (for a period of 5 minutes) and 
A E  extinction was calculated at each 1 minute interval 
From mean values of AE,
A e ,
min  ^ (obtained from the340 nm
values), the concentration of aldolase (pg)340 nm
could be read from the curve on the x-axis.
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PREPARATION OF IgG IMMUNOGLOBULIN (BY DEAE)
Ion exchange chromatography on D.E.A.E.-cellulose gave an
elution profile with two E„q^ peaks. The first peak eluted
ZoV nm
with 0.01 M PO^ buffer pH 7.5 contained the IgG, Figure 23,
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IST PURIFIED CHOLERA ENTEROTOXIN
Previous work in the Microbiology Department showed that 
cholera enterotoxin could be purified from crude culture filtrate 
by Sephadex G ICO filtration. The purified toxin was eluted from 
the column immediately after the void volume with borate gelatin 
buffer as the eluate, Figure 24, The peak fractions were concen­
trated to 5,0 ml and neuraminidase activité was measured by the 
T,B,A, and M,P,N. assays. No detectable neuraminidase activity 
was found in the toxin preparation.
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Figure 24 : Elution profile of V. cholerae enterotoxin on
Sephadex GlOO,
Column dimensions: 2.6 x 81 cm, flow rate 0.8 ml min ^.
Sample: crude N.I.A.I.D. V. cholerae enterotoxin 3 g 
(5.0 ml)  ^borate gelatin buffer.
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3Z: EFFECTS OF NEURAMINIDASE AND OTHER CHEMICAL TREATMENTS ON GOBLET 
CELL HISTOCHEMISTRY
Treatment with neuraminidase changed the number of cells
stained by either Alcian Blue or PAS (Plates 2 and 4). The counts
have been displayed in a bar graph (Figure 25), Differences in cell 
counts were analysed statistically by use of the t-test in its double
tailed form (pp 232-233, Appendix VIII),
It will be noticed from Figure 25 that the number of goblet 
cells stained by Alcian Blue for the presence of NANA (sialic acid, 
N-acetylneuraminic acid) was reduced from 978 (17,68 mm ) to 499 
after treatment with 136 ImU of neuraminidase for 24 h at 37°G, At 
the same time the number of goblet cells in the neuraminidase treated 
rat ileal sections stained by PAS increased to 342 (17,68 mm^)  ^
compared to the control value 211,
Statistical analysis indicated that the counts in the 
neuraminidase treated ileal sections stained by Alcian Blue or PAS
I
were significantly different, at the p < 0*0002 and p < 0,001 levels 
respectively. There was no significant difference in the Alcian Blue 
stained sections between untreated sections and those treated with 
distilled water or 0,05 M NaAc buffer, pH 5,5,
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A Rat ileum, cross section, vapour fixed,
stained with Alcian blue/PAS pH 2,5 (X 164)
As above, except stained with Alcian blue/PAS 
at pH 2,5 and higher magnification (X 656).
As B above
Plate 2 : Histological sections of rat ileum.
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A Rat ileum, cross section, vapour fixed,
untreated, and stained with Haemotoxylin and 
Eosin (X 164).
B Rat ileum, longitudinal section, vapour fixed, 
untreated, and stained with Alcian blue/PAS 
(X 656).
As B above, except treated with Cl.perfringens 
neuraminidase (136 ImU Worthington) for 24 h 
at 37 0 before staining.
Place 3 : Histological sections bf rat ileum.
%
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Rat ileum, longitudinal section, vapour fixed, 
treated with Cl. perfringens neuraminidase 
(136 ImU Worthington) for 24 h at 37°C, and 
stained with Alcian blue/PAS at pH 2,5 (X 164),
As above, except cross section and at higher 
magnification (X 656),
As A above, except buffer control (no enzyme) 
and higher magnification (X 656),
Plate 4 : Histological sections of rat ileum.
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Figure 25 : Effect of commercial neuraminidase
(Worthington Cl. perfringens)
Legend:
*Note: No, ImU cited is total enzymic activity
in preparation.
H ,  Goblet cells stained by Alcian Blue to
show the presence of neuraminic acid, and
Q ,  Goblet cells stained by PAS to show 
mucopolysaccharide.
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I. Effects of commercial neuraminidase
In view of these results it was decided to compare the neura­
minidase activity of a number of commercial enzyme preparations 
against the V, cholerae Sephadex G 100 preparation (see Plates 2-4; 
Figure 26), The most active commercial preparation with respect to 
loss of Alcian Blue staining in tissue sections when compared with 
untreated sections was the Sigma Cl. perfringens neuraminidase (Plate 
2), In addition, the Cl. perfringens neuraminidase treated sections 
showed the highest PAS count (17,68 mm^)  ^when compared to untreated 
sections. It will be noticed with both preparations of Cl. perfrin­
gens neuraminidase that there was a change from Alcian Blue to PAS 
staining. However, with the V. cholerae preparations not only was 
there a change in the content of NANA-containing sialomucin but, in 
addition, many of the goblet cells seemed to lose PAS stainable 
mucosubs tance.
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Figure 26 : Effect of several neuraminidase preparations.
Legend: Comparison of the total number of goblet cells (17.68 ram**)
H ,  Alcian Blue staining goblet cells,
Q ,  PAS staining goblet cells.
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Effect of cholera enterotoxin
The counts of sections treated with Sephadex G 100 purified 
enterotoxin showed no significant difference from those of the 
controls treated with borate gelatin buffer pH 7.5. However, 
some difference was noted between the comparative PAS counts 
(p< 0,0002 Figure 27).
On the other hand, sections treated with neuraminidase 
showed that the staining in the goblet cells switched from a neura­
minic acid to a positive mucopolysaccharide reaction*
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Figure 27 : Effect of cholera enterotoxin.
Legend; Comparison of the total number of Goblet Cells
(8.84 mm^) ^ .
0 ,  Alcian Blue staining Goblet Cells, Q , PAS 
staining Goblet Cells, The lower part of the 
figure shows the average number of goblet cells 
(0,442 mm^)”^, and the range of counts.
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3. Effect of trypsin inhibitor and trypsin inhibitor + neuraminidase
The trypsin inhibitor and trypsin inhibitor plus neuraminidase 
was tested to see if the small amount of proteinase present in the 
N 2  semi-purified preparation could perhaps have been due to the 
proteinase trypsin. Pretreatment of tissue sections alone with 
trypsin inhibitor did not significantly alter the count (8,84 sq ram)  ^
with respect to the level of Alcian blue stain when compared to 
untreated sections. By contrast, the presence of trypsin inhibitor 
significantly Increased (p< 0,02) the level of PAS staining vhen 
compared to untreated sections. When trypsin inhibitor was added 
with semi-purified V, cholerae neuraminidase, it caused the PAS 
count to be significantly increased with respect to untreated sections, 
but the level was not significantly different with respect to the 
Alcian blue staining (pp 236-237, Appendix VIII),
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Effect of specific anti-neuraminidase serum (PST R77)
The counts of Alcian Blue and PAS reactions in goblet cells 
of untreated sections were compared with those of NaAc buffer 
neuraminidase (N^) and neuraminidase:anti‘-neuraminidase antiserum 
treated ileal sections (Figures 28, 29), Treatment of the ileal 
sections with NaAc buffer did not cause a significant alteration in 
the Alcian Blue or PAS counts when compared with those of untreated 
sections. Because the N 2  preparation of V, cholerae neuraminidase, 
and anti-neuraminidase antiserum (DST-R77) were both suspended in 
NaAc buffer, the counts of the other treatments were compared with 
those of the NaAc treatment.
When sections were treated with diluted neuraminidase the 
Alcian Blue count was significantly lower (p < 0,0002 than that of 
the sections which were treated with NaAc buffer, while the PAS count 
was significantly higher (p < 0 ,0 0 0 %) than that of the buffer treated 
sections (pp 238-242, Appendix VIII), Sections which were treated 
with antineuraminidase serum (0,1 ml, DST-R77) plus N 2  V, cholerae 
neuraminidase (0,2 ml) showed that the alteration from Alcian Blue 
to PAS reaction of the goblet cells could be prevented, in part, by 
the addition of specific antiserum (Figure 28), When the volume 
of the anti-neuraminidase serum to the N2  preparation was increased 
it was apparent that the initial neutralisation was overtaken by a 
decrease in the Alcian Blue count (Figure 29), Statistically, the 
difference in the counts for neuraminidase plus 0 , 1  ml antiserum and 
0,4 ml antiserum was significant at the p < 0,0002 level. It will 
be noticed that the Alcian Blue count in the antiserum control was 
significantly lower than the count for untreated sections (p < 0 ,0 0 0 2 ) 
and the PAS reaction was significantly higher (p < 0,0002),
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'5'. Effect of anti-neuramlnidase serum (DST R78) on non-cholera 
neuraminidase
It will be noticed from Figure 30 that the Cl. perfringens 
neuraminidase effected a similar alteration in the staining reaction 
of fixed rat ileal sections to that previously reported in Figure 28, 
There was a significant difference in the number of goblet cells 
stained with Alcian Blue (p < 0,0002) or PAS (p < 0,0002) in untreated 
rat ileal sections or those treated with Cl, perfringens neuraminidase 
(pp 243-248, Appendix VIII).
However, the addition of increasing volumes of anti-V, cholerae 
neuraminidase serum (DST R78) neutralised the alteration in change of 
staining from Alcian Blue to PAS, ■ In the presence of 0,3 ml anti- 
V, cholerae neuraminidase serum the Alcian Blue counts were similar 
to those sections left untreated (p < 0,10) as shown in Figures 31 
and 30.
The rabbit anti-neuraminidase serum DST R77, produced against 
■ the G75 preparation, did not appear to neutralise V, cholerae neura­
minidase and DST R78, produced against Koch-Light V, cholerae neura­
minidase, appeared to neutralise Cl, perfringens neuraminidase. 
Consequently, it was decided to examine the effect of DST-R78 whole 
antiserum or the IgG fraction on the action of V, cholerae neuramini­
dase, As shown in Figure 32 the whole antiserum Increased the 
activity of the N 2  V, cholerae neuraminidase preparation. The change 
of staining from Alcian Blue to PAS was significantly greater with 
either enzyme plus 0,25 ml DST-R78 (p< 0,0002), or with 0,25 ml
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Figure 32: Effect of specific anti-neuraminidase serum
(DST R78) and the IgG fraction (of DST R78).
Legend : B >  Alcian Blue staining goblet cells; O ,  PAS
staining goblet cells.
1. Untreated
2. Sodium acetate buffer pH 5.0.
3. V. cholerae neuraminidase (1.57 ImU in assay)
4. (1.57 ImU in assay) + DST R78 anti­
neuraminidase, 0.05 ml.
5. (1.57 ImU in assay) + DST R78 anti­
neuraminidase, 0.25 ml.
6 . Serum control DST R78 0.25 ml
7. N (1,57 ImU in assay) + IgG anti­
neuraminidase (DST R78), 0,05 ml.
8 . N- (1.57 ImU in assay) + IgG anti­
neuraminidase (DST R78), 0.25 ml.
9. Serum control IgG anti-neuraminidase
(DST R78), 0.25 ml.
Average number of goblet cells  
(0.442 mm^)’^
Number of goblet cells  
(8.84 mm^) ^
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DST-R78 alone (p< 0,001) when compared with untreated rat ileal 
sections (pp 249-256, Appendix VIII).
However, when the rat ileal sections were treated with 0,25 ml 
of the IgG fraction of DST-R78 and ^ 2  there was complete neutral­
isation of the Ng neuraminidase activity (pp 249-256, Appendix VIII), 
In addition, there was no effect produced by 0,25 ml of the IgG 
fraction of DST-R78 alone. There was an absence of PAS staining 
with sections treated with 0,1 ml neuraminidase and 0,05 ml IgG 
fraction. In an earlier experiment it was found that the combin­
ation of NaAc and PO^ buffers caused a reduction in PAS staining.
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Effect of non-immune serum
The Alcian Blue and PAS counts (8,84 mm ) of untreated 
sections were compared with those of either neuraminidase treated or 
neuraminidase plus increasing volumes of non-immune whole rabbit 
serum (Figure 33), There was no significant difference between the 
number of goblet cells stained with Alcian Blue in rat ileal sections 
treated with the N 2  preparation alone or in combination with 0 , 1  ml 
normal rabbit serum (pp 257-263 Appendix VIII), However, if the 
amount of normal rabbit serum was increased to 0,4 ml there was a 
significant difference (p < 0,0002), There was also a significant 
difference in the goblet cells stained by PAS after the addition of 
normal rabbit serum to the reaction mixture (p< 0 ,0 0 0 2 ),
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V r  EFFECT OF SPECIFIC ANTISERUM ON NEURAMINIDASE ACTIVITY
a) Effect on T.B.A. assay
The absorption of neuraminidase preparations with the rabbit 
anti-V. cholerae neuraminidase serum (DST R77) for 1 h at 37^C 
effectively reduced the amount of NANA released from mucin (p 264, 
Appendix IX), However, in the course of the experiment it was found 
that 0,5 ml of serum released 0,5 pg NANA from mucin as measured by 
the T,B,A, assay. In addition the neuraminidase preparations 
released T,B.A, reactive material, possibly NANA, from the serum 
itself; 1,25 pg by N 2 , 0.5 pg by Ng, 1,85 pg by N^ preparations 
and 3,5 pg by the Sigma Cl, perfringens neuraminidase,
b) Effect on M.P.N, assay
Since it was apparent that the addition of excess amounts of 
the rabbit anti-neuraminidase serum caused an increase in the amount 
of T.B.A* reactive material released from a standard quantity of 
: mucin, it was decided to repeat the experiment with the specific
substrate 2-(3*-Mèthoxyphenyl-N-acetyl-a-neuraminic acid for 
neuraminidase activity. When increasing volumes of anti-neuramini- 
dase serum were added to a constant amount of either N 2  or semi­
purified Vo cholerae neuraminidase, a corresponding increase in the 
levels of methoxyphenol liberated occurred (Figure 34).
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Figure 34 : Absorption of neuraminidase activity
(M.P.N. procedure)
Legend;
Ækf N^ neuraminidase fraction (1.57 ImU 
in assay); N^ neuraminidase fraction
(1.43 ImU in assay).
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c) Effect of specific IgG fractions and sera (T,B,A. assay)
When the IgG fraction of DST-R78 anti-neuraminidase and the 
whole serum were compared, it was found that the former absorbed 
neuraminidase activity* The addition of whole anti-neuraminidase 
serum appeared to increase the enzymic activity as increasing volumes 
of it were added to a fixed volume of enzyme (Figure 35A)#
When the IgG fraction of non-immune rabbit serum was compared 
with non-immune whole rabbit serum, it was found that the former 
possessed no neutralising activity (Figure 35B), As in the case 
of whole anti-neuraminidase anti-serum the whole non-immune serum 
appeared to increase enzymic activity as increasing volumes of it 
were added to a fixed volume of enzyme (Figures 35A, 35B),
d) Effect of specific IgG fractions and sera (MaP,N@ assay)
When the IgG fraction of the rabbit anti-neuraminidase serum 
(DST R78) was compared with the whole anti-neuraminidase serum, the 
former absorbed the neuraminidase activity as the volume was increased 
(Figure 36A). In the case of the whole anti-neuraminidase serum an 
increase in the volume of anti-serum caused an increase rather than a 
decrease in neuraminidase activity (Figure 36A)*
When the IgG fraction of non-immune whole rabbit serum was 
compared with non-immune whole rabbit serum, no absorption of neura­
minidase activity occurred (Figure 36B)*
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Figure 35 : Absorption of neuraminidase activity
(T.B.A, procedure).
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A« Rabbit anti-neuraminidase serum 
DST-R78
B, Normal rabbit non-immune 
serum
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Figure 36; Effect of IgG fraction and serum ^  neur^minidas e . 
activity (M.P.N.)
Legends: ■  JD, IgG fraction; #,o, whole serum; C, Enzyme control.
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V U  DILUENT RELATED SIALOMÜCIN LOSS AND NEURAMINIDASE INDUCED NANA 
LIBERATION
Initially, experiments were done with unfixed rat ileal 
segments but it was apparent that treatment of these with aqueous 
solutions (i.e. P.B.S. or C.A.Y.E, medium) removed the mucin layer 
completely* For this reason it was necessary to do the experiments 
with fixed tissue segments.
The loss of sialomucin or NANA in the washings from 3 pairs 
of tissue segments was determined by the T.B.A. assay. The greatest 
loss of sialomucin occurred Wien the tissue was exposed to C.A.Y.E. 
broth after a wash in NaAc buffer (Figure 37). It was noticed that 
even with fixed tissue segments there was some loss of sialomucin 
with sodium acetate buffer or C.A.Y.E. medium. This imposed limitations 
on the quantitative determination of the release of NANA from tissue 
segments by V. cholerae neuraminidase. It was necessary to differ­
entiate between the mucin lost by aqueous solubility or by enzymic 
activity. Consequently, the values for sialomucin and NANA were 
relative to each other.
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Figure 37 : Diluent related sialomucin loss and neura­
minidase induced NANA release.
Legend: ( H  ) Sialomucin released non-enzymatica1ly;
( O )  NANA (N-acetylneuraminic acid).
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EFFECT OF NEURAMINIDASE ON ADHESION OF V. CHOLERAE TO RAT ILEUM
The adhesion of V, cholerae to fixed rat ileal tissue segments 
after pretreatment with either NaAc buffer or V. cholerae neuraminidase, 
was compared to determine whether there was an increase in adherent 
organisms after exposure to neuraminidase. In three experiments, B,
F and H there was a slight increase in the number of adherent organisms. 
In experiments A, D, E and G there was a decrease in the number of
I
adherent organisms (Table 17). However, when the results were ' 
examined statistically it was apparent that there was no significant 
difference between the number of organisms adhering to neuraminidase- 
treated and untreated ileal tissue (t = 0.745 with 7 degrees of freedom), 
The solutions exposed to the tissue segments were also tested by the 
T.B.A. assay to determine; (a) loss of sialomucin (non-enzymatically 
released substances) and (b) N-acetylneuraminic acid moieties released 
by V. cholerae neuraminidase.
These data were analysed as shown in Table 18. The recovery 
of V. cholerae was expressed as the ratio of V. cholerae adhering to 
neuraminidase-treated ; untreated tissue and tabulated in the rank 
order of increase in binding. When this order was compared with the 
rank order of sialomucin release by buffer or neuraminic acid release 
by neuraminidase/neuraminidase +  V. cholerae organisms/V. cholerae 
organisms alone no particular relationship between the rank orders and 
binding was apparent.
172
Table 17 : Effect of neuraminidase pretreatment on the binding
of V. cholerae organisms tp/rat ileal tissue
V . cholerae organisms were suspended in 
phosphate buffered saline.
Neuraminidase utilised in these experiments 
was Galbiochem V. cholerae neuraminidase
1.0 X.U. ml"l.
Legend: *reaction to non-enzymatically released
substances in NaAc buffer wash.
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Œ :  e f f e c t o f  NEURAMINIDASE ON ADSORPTION OF CHOLERA ENTEROTOXIN TO 
RAT ILEUM
The stock solution of N.I.AoIoD» cholera enterotoxin (3.0 mg 
(ml BOB pH 7*5) ^) contained 600 skin blueing doses. The enterotoxin 
solution after exposure to the tissue segments, was diluted to give 
solutions containing theoretically, 60, 30 and 15 BD. Rabbits were 
injected i*d. with 0*1 ml of each of these dilutions. The presence
of active toxin was revealed 24 h later by the injection of Pontamine
Sky Blue dye* '
The effect of V. cholerae neuraminidase on the adsorption of 
cholera enterotoxin to ileal tissue is shown in Table 19* It was
i ::
apparent that the treatment of rat ileal segments significantly 
increased the capacity of the tissue to adsorb V. cholerae enterotoxin. 
Whereas in untreated tissue there was only slight, if any, binding of 
the enterotoxin after treatment with neuraminidase for 1 h, more than 
400 blueing doses of enterotoxin were adsorbed to the tissue.
In a further experiment the effect of adding the cholera 
enterotoxin at the same time as the neuraminidase solution was 
compared. Although there was evidence that neuraminidase combination 
with cholera enterotoxin stimulated adsorption to the rat ileal tissue, 
this effect was greater if the enzyme treatment preceded the addition 
of enterotoxin by one hour (Table 20),
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X  ISOLATION AND PURIFICATION
Growth of V. cholerae in proteose peptone bovine colostrum
medium stimulated the production of good yields of neuraminidase of
X •
the order of 12.42 lU litre in the crude preparation. After 
Sephadex G 100 semi-purification the yield increased to 43,6 lU litre 
The yield compared favourably to that obtained by Ada, French and Lind 
(1961) who utilised a more complicated procedure for purification (see 
page 32 ). The ^  peak and the Lowry protein peak did not
coincide with the main peak of neuraminidase activity \dien individual 
column fractions were analysed which might indicate closeness of peaks 
of impurity. The latter peak was detected both by the T.B.A. and by
the M.P.N. assays. Consequently, a direct comparison of activity in 
terms of lU (mg protein)  ^between these results and those of Ada, 
French and Lind (1961) was not meaningful.
It was noticeable with DEAE-cellulose chromatography that at 
least five protein peaks which were separated from the methanolic precipitate 
possessed no enzymic activity. Two peaks eluted from the column with
1.0 M NaCl were associated with enzymic activity. Thèse peaks were 
incompletely separated so the effect noted with possible peaks of 
protein impurity with Sephadex G 100 was not observed. In some of the 
chromatographic procedures it was not possible to separate the enzyme 
from the brown pigment present in the culture fluid. This pigment
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interfered with the ^  readings. For these reasons the neuramini­
dase preparations were semi-purified by Sephadex G 100 filtration and 
detection of enzyme peaks was achieved with the T.B.A. or M.P.N. assays 
(Figure 10). However, none of these methods allowed the separation 
of a highly purified neuraminidase preparation. Significant levels of 
proteinase and endoglycosidase activity were found together with slight 
phospholipase-G activity.
The assay for N-acetylneuraminic acid aldolase was included
because the earlier investigation of Ada, French and Lind (1961) revealed
that N-acetylneuraminic acid aldolasejif present, would interfere with
any assay in which neuraminidase activity was measured by the liberation
of N-acetylneuraminic acid moieties (e.g. thiobarbituric acid assay;
Warren, 1959) since the aldolase would degrade NANA into N-acetyl-
mannosamine. Although one did not expect aldolase activity, this was
checked because Schick and Zilg (1978) had also included the determination
in their study; no activity was found in any preparations obtained in
the present work. The V. cholerae neuraminidase preparation of these
workers purified by chromatography twice on a DEAE column did not possess
any endoglycosidase, proteinase, phospholipase-G or aldolase activity.
Although they achieved a 424-fold increase in the purification of enzyme
this was accomplished by an 85% loss in yield. Similarly Ada, French
and Lind (1961) used a complicated scheme of purification but a
(Ada, French and Lind, 1961) 
79.0% loss in yield. The crystalline preparation^lacked proteinase and
aldolase activity. Though M y  Sephadex G 100 V. cholerae neuraminidase
preparation did not achieve the degree of purity of either Ada, French
and Lind (1961) or Schick and Zilg (1978), it was a much simplified rapid
procedure, and produced a semi-purified preparation that could be utilised
in parallel experiments with a more highly purified commercial preparations
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of V. cholerae neuraminidase* Gel filtration allowed a 3*88 fold 
concentration in specific enzyme activity*
The T.B.A. assay was not the most specific method to determine 
neuraminidase activity levels. Non-enzymatically released substances
from mucin as well as enzymatically released N-acetylneuraminic acid 
moieties reacted in the assay. This weakness, however, was put to a 
practical use to measure the loss of sialomucin, in supernates of, 
unfixed, washed and unwashed rat ileal segments (see page 170).
The M.P.N, assay which measured neuraminidase activity by the 
liberation of 3-methoxyphenol moieties from an artificial substrate 
(2-3* methoxyphenol-N-acetyl-D-neuraminic acid), proved to be highly 
specific. In general it was noticed that the quantity of neuraminidase 
was greater when measured by this method.
The semi-purified neuraminidase preparations N^-N^ contained 
up to 0.5% (w/w) proteinase. Although the amount of proteinase was 
small it was not discounted that it might interact with the neuraminidase
in the other biological experiments. In this respect it is interesting
1
that Chien et al^  (1975) found that commercial preparations of neuramini­
dase were contaminated with endo-(3-N-acetylglucosaminidase and protein­
ase. The latter hydrolysed Azocoll, haemoglobin, casein, ovalbumin, 
human serum albumin and a^-acid glycoprotein. In this study an endo-p- 
N-acetylhexosaminidase was present in considerable quantities in the 
neuraminidase preparation. This enzyme might attack the p-glycosidic 
ester link in the bovine submaxillary mucin (see Figure 4a), between 
N-acetylglucosamiiiè linked to the p-carboxyl group of aspartic or the 
y-carboxyl group of glutamic acid. Ovine and bovine mucin contain 
N-acetylneuraminic acid and N-acetylgalactosamine and the latter was 
used in these investigations. However, it should be remembered that
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human mucin contains N-acetylneuraminic acid, N-acetylgalactosamine plus 
fucose and galactose. The oligosaccharide groups of the mucin are 
linked to either serine or threonine in the polypeptide chain (White 
et al, 1978), It is also possible to propose that the crude N-acetyl- 
hexosaminidase might attack the a-glycosidic link between N-acetylgalacto- 
samine and D-galactose in the monosialoganglioside (the enterotoxin 
receptor on the cell membrane).
It was apparent that the purification procedures used in the 
present study did not allow the separation of these enzymes by gel 
filtration nor by ion-exchange chromatography.
3: NEURAMINIDASE ACTIVITY AND NEUTRALISATION
Gad (1969) found that pretreatment of human alimentary tract 
histological sections with V. cholerae neuraminidase caused a loss in 
Alcian blue staining. This was attributed to the loss of sialic acid 
(N-acetylneuraminic acid) moieties, a fact which was exploited in this 
study where it was observed that there was a characteristic whorl of 
goblet cells in cross-sections of villi. In addition, loss of Alcian 
blue staining was accompanied by a positive PAS staining reaction. 
Therefore, to quantitate the neuraminidase activity histochemically 
random counts were made in tissue sections and the number of Alcian 
blue : PAS stained cells was determined - the new goblet cell assay.
When sections treated with NaAc buffer were compared with 
sections treated with Worthington Cl. perfringens neuraminidase a 
significantly lower number of goblet cells stained Alcian blue was 
observed after enzyme treatment (Plates 2-4). This assay proved to be 
quite useful as a histochemical reflection of the removal of N-acetyl-
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neuraminic acid moieties by V. cholerae enzyme. The assay, however, 
could not be used to measure secretion of sialomucin caused by cholera 
enterotoxin (Forstner et al, 1981) as a function of loss in Alcian blue 
staining of fixed rat ileum sections. Treatment of fixed rat ileum 
sections with cholera enterotoxin did not significantly alter the level 
of Alcian blue staining when compared with control sections.
It was observed in some instances that V, cholerae neuraminidase 
N 2  and the Calbiochem commercial sample actually reduced the total 
number of stained goblet cells. This was noted to be due in one 
experiment to the complete évagination of the goblet cells. This 
effect was not so readily noticeable with the Sigma or Worthington 
Cl. perfringens enzyme preparations. The goblet cell assay was also 
used to determine the effect of a specific V. cholerae anti-neuraminidase 
serum. Initially, problems were encountered because the whole rabbit 
antisera (DST R77 and DST R78) activated the change from Alcian Blue to 
PAS. This was attributed to the presence of a serum sialidase.
However, after a double purification of the serum IgG fraction on DEAE 
this activity was removed. In addition the IgG fraction of the anti- 
neuraminidase serum absorbed the enzyme and neutralised activity prior 
to treatment of the rat ileal tissue section (Figure 32), It was also 
noticed that occasionally this neutralisation tended to affect the 
intensity of the PAS stain. The buffer used with the IgG might be 
responsible for this effect.
These results were confirmed biochemically by the T.B.A, and 
M.P.N, assays. In the T,B,A, assay both the neuraminidase and endo­
glycosidase activities would provide a positive reaction but the M.P.N, 
assay only measures the specific activity of neuraminidase. In both 
assays there was an increase in the measurable levels of free neuraminic
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acid in the presence of increasing quantities of rabbit anti-neuramini- 
dase (Figures 35A and 36A). With normal rabbit serum a similar effect 
was observed (Figures 35B and 36B) and this confirmed that a serum 
sialidase was present.
On the other hand, the twice purified IgG fraction of rabbit 
anti-neuraminidase serum caused a significant decrease in the enzyme 
activity with increasing amounts of IgG when assayed by the M.P.N, assay. 
This effect was not found with the IgG of normal rabbit serum.
These neutralisation experiments contradict the statement by 
Palese, Bucher and Kilbourne (1973) that neuraminidase is not neutral­
ised by specific antiserum when M.P.N. is used as substrate. They 
postulated that antibody molecules failed to block the active site of 
the enzyme by steric hindrance due in part to the small molecular size 
of methoxyphenol-neuraminic acid (423 dal,)* However, it is more 
likely that their results were confused by the presence of the sialidase 
in the antiserum.
H r  MEASUREMENT OF THE LOSS OF N-ACETYLNEURAMINIC ACID AND SIALOMUCIN IN 
FIXED RAT ILEAL SEGMENTS TREATED WITH NEURAMINIDASE
1 .
Freter et al (1981) stated that the vast majority of the vibrios 
associated with the mucus gel rather than the mucosal epithelium when 
rabbit ileal slices were exposed to V, cholerae organisms. If the 
neuraminidase is involved in the adhesion of V* cholerae to the gut 
surface by exposing receptor sites this would presuppose that a 
continuous mucus layer must be available over the ileal surfaces.
However, as shown in Plate 1 this may not be the usual case in
1
experimental animals of all ages. Rozee et al (1982) noted that in
18)
mice a continuous mucin layer was observed after 24 days. In 
experiments described in this thesis an attempt was made to retain the 
mucin layer in a state which would not preclude enzymic attack# In 
addition, aqueous solutions were shown to release mucin and this would 
affect the neuraminidase study. This difficulty had been encountered 
by Pearse (1968c) and Schmitz-Moormann (1969), The problem was 
controlled by a fixation procedure cited by Culling (1974), It must 
be stated that some non-enzymatic loss of mucin did occur after 
fixation but this was considerably less than that found with fresh 
tissue. Recently, this point has been re-emphasised, Ramphal and 
Pyle (1983a) advocated the retention of the mucin layer in assessing 
the adhesion of bacteria to tissue. They urged investigators to 
utilise an immobilisation procedure to prevent the unavoidable loss of 
mucin during the obligatory rinsing, steps which are necessary in adhesion 
experiments,
EZ*EFFECT OF NEURAMINIDASE ON THE ADHESION OF V, CHOLERAE TO RAT ILEUM
The investigation differed from the earlier investigations of 
Freter (1969), Bhattacharjee and Srivastava (1978) and Bhattacharjee 
and Srivastava (1979) who used extirpated animal ileal segments to 
measure V, cholerae adsorption, in that: (a) rat ileal tissue was
used rather than rabbit ileal tissue, (b) rat ileal segments were 
fixed in an attempt to preserve the sialomucin layer and (c) loss of 
sialomucin and N-acetylneuraminic acid as well as adhesion of V, cholerae 
to the extirpated tissue segment were measured.
In 8 experiments in which one group of tissue segments was 
pretreated with V, cholerae neuraminidase, and another group was
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pretreated with NaAc buffer before exposure to V, cholerae organisms, 
a significant increase in the number of adherent organisms did not occur 
after enzyme pretreatment (Tables 17 and 18), In an earlier investi­
gation using Kanagawa-positive Vibrio parahaemolyticus and foetal 
intestinal cell monolayer which had been pretreated with Cl, perfringens 
neuraminidase, Carruthers (1977) did not find any significant difference 
in the number of adherent organisms when compared with the controls, 
Arbuthnott and Smyth (1979) pointed out that numerous limitations exist 
in a single ija vitro adsorption system, and advised the use of extreme 
caution when drawing conclusions for an iu vivo situation.
Perhaps the greatest limitation in the use of the tissue 
segment in an vitro assay is the inability, as mentioned above, to 
prevent non-enzymatic loss of mucin. Therefore, without the preser­
vation and maintenance of such a layer, firm conclusions about the
effects of various agents on V, cholerae adsorption vivo cannot be
1
drawn. It would be profitable to compare this i^ vitro system with an 
in vivo system where the effects of neuraminidase on the adsorption of 
Vo cholerae to the sialomucin layer could be monitored, for example, by 
scanning electron microscopy. Consequently, it must not be ruled out 
that these initial adsorption studies signify that the neuraminidase is 
not involved in adherence dm vivo although a positive effect was 
observed with the binding of enterotoxin to the ileal surface.
In addition, it is interesting that Attridge and Rowley (1983) 
found that V. cholerae organisms bound equally to both mucosal and 
serosal surfaces of mouse intestinal tissue and that even when the 
tissue was boiled, the V, cholerae organisms still showed undiminished 
binding. Consequently, although the V, cholerae organisms bound to the 
paraformaldehyde fixed rat ileal segments it should be remembered that
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the numbers of adhérent organisms represent the combined effect of 
binding to both mucosal and serosal surfaces. Since the neuraminidase 
preparation did not cause an increase in binding the results of Attridge 
and Rowley (1983) were not thought to alter the conclusions drawn in 
this study.
3T EFFECT OF VIBRIO CHOLERAE NEURAMINIDASE ON ADSORPTION OF, CHOLERA 
ENTEROTOXIN TO RAT ILEUM
Treatment of rat ileal segments with V. cholerae neuraminidase 
did affect the binding of the cholera enterotoxin to the rat ileal 
segments. There was a significant difference in the amount of enterotoxin 
remaining in the test fluid between the neuraminidase-treated and 
untreated tests. It was necessary to measure the toxin adsorption by 
a reverse assay, namely, measurement of the free enterotoxin left in
I
solution because the homogenate of tissue with bound enterotoxin failed 
to produce the typical skin blueing reaction, A direct assay could be 
done with a radio-labelled sample of enterotoxin.
These results strengthen the claims of Gascoyne and van 
Heyningen (1979) and Ackerman, Wolken and Celder (1980) published during 
the period of experimental work.
When rabbit intestinal homogenates were incubated in the 
presence of V, cholerae neuraminidase, Gascoyne and van Heyningen (1979) 
found that their capacity to bind cholera enterotoxin was increased four 
to five-fold. This increase in binding was thought to be due to the 
conversion of neuraminidase-labile to neuraminidase-stable gangliosides. 
The neuraminidase-labile gangliosides were converted to the stable 
cholera enterotoxin-binding G^ ganglioside. Essentially, similar
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results were obtained by Ackerman, Wolken and Gelder (1980) who found an 
increase in the binding of cholera enterotoxin to the cell surface of 
human neutrophils after treatment with V, cholerae neuraminidase. This 
investigation, however, contradicted the finding of Holmgren (1981) who 
stated that V, cholerae neuraminidase treatment of rabbit intestinal 
epithelium failed to create new receptors for the binding of cholera 
enterotoxin, Holmgren (1981), however, did not state whether the 
sialomucin layer, a region rich in glycoprotein, a possible source of 
gangliosides for cholera enterotoxin binding, and an important component 
of the intestinal mucosa was preserved. If treatment with exogeneous 
neuraminidase does create and unmask receptors in the sialomucin layer, 
perhaps this could account for the discrepancy between these two sets 
of observations. In epithelial tissue devoid of a sialomucin layer, 
there would be a fixed number of receptors of cholera enterotoxin, and 
neuraminidase treatment would not increase this number,
r !
The observation that neuraminidase activity increases the 
binding of the enterotoxin to the mucin layer deserves further investi­
gation, If such a mechanism occurred in the course of a cholera 
infection it would seem that enterotoxin molecules bound to the mucin 
layer might be sloughed off and would be unable to exert their effect 
on the epithelial cells lining the small intestine.
It should also be considered that Schneider and Parker (1982) 
proposed that the neuraminidase activated the enterotoxin molecule. 
Therefore, one must not ignore the possibility that the results described 
in this thesis might also be due to the action of the neuraminidase on 
the toxin molecule itself and not on the exposure of additional receptor 
sites.
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3Zr GENERAL DISCUSSION
The procedures used in this investigation for the production 
and purification of V. cholerae neuraminidase were chosen to provide 
sufficient quantities of active enzyme for experimental work. In 
unison with other research groups who have become interested in the 
exoenzymes of V. cholerae since this investigation began (Schick and 
Zilg, 1978; Schneider and Parker, 1978, 1982), it was apparent that a 
high degree of purification had to be sacrificed in order to maintain 
high yields and levels of enzymic activity. The enzyme preparation 
contained neuraminidase, endo-N-acetylhexosaminidase and proteinase.
The specific activity of the neuraminidase was measured by the action 
on the specific substrate methoxypheno1 : neuraminic acid. However, 
it was realised that in the thiobarbituric acid assay the moles of 
neuraminic acid released could be due to the concerted action of both 
the neuraminidase and the endoglycosidase. The small level of
) I
proteinase would not be expected to interfere with these assays,
Ramphal and Pyle (1983b) recently found that i) the particular 
origin of the neuraminidase utilised in mucin experiments and ii) the 
chemical nature of the host mucin does make a difference. Both 
Cl, perfringens and V, cholerae neuraminidases cleaved NANA from a 
bovine submaxillary mucin but only V. cholerae neuraminidase released 
NANA and reduced adhesion of Pseudomonas aeruginosa organisms to mouse 
tracheal tissue. From this finding it would appear that neuraminidase 
from a particular organism is specific for certain sialic-acid glyco­
proteins, Whether these limitations upon the use of a neuraminidase 
derived from a specific organism are due to differences in the steric 
configuration of the intended target sialic-acid glycoprotein or to enzyme
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specificities of the neuraminidase has still to be determined.
However, in the context of this study it would seem possible to suggest 
that additional enzyme activities associated with the "semi-purified" 
neuraminidase may play a part in this phenomenon. It seems relevant 
to retain the use of the term "mucinase complex" until such time as we 
have highly purified, individual enzymes.
It is interesting that other workers (Burnet and Stone, 1947a; 
Kusama and Craig, 1970; Schneider and Parker, 1978, 1982) have also 
observed that V, cholerae produce an array of exo-enzymes that may 
attack the mucin layer. Because of the reported difficulties in
separating these enzymes there has been a tendency to group the activity 
under the broad terra of "mucinase" (Burnet and Stone, 1947a; Burnet,
1948, 1949; Jensen, 1953; Singh and Ahuja, 1953; Freter, 1955;
Kusama and Craig, 1970; Schneider and Parker, 1982), In the natural 
environment it seems reasonable to propose that the numerous exo-enzymes 
do interact in the breakdown of mucus leading to the adhesion of 
V, cholerae organisms to the mucus itself ^Schrank and Verwey, 1976;
Reed and Williams, 1970; Freter, O'Brien and Halstead, 1978; Freter 
et al, 1981) and finally to the epithelial surface. It is important 
to examine the biological activities of the individual exo-enzymes in 
order to elucidate the precise mechanism of these interactions. At 
present it would still seem to be relevant to retain the term "mucinases", 
Recently, Schneider and Parker (1982) discussed V. cholerae 
exo-cellular enzymes and stated that there are several possible 
mechanisms which are not mutually exclusive by which the mucinase could 
affect the process of V, cholerae pathogenesis, namely, mucinase (1) may 
suppress the normal flora, thus permitting the V, cholerae organisms to 
initiate infection, (2) could proteolytically activate cholera entero-
189
toxin, enhancing uptake by intestinal cells, (3) could bring about the 
degradation of the intestinal mucin thus facilitating penetration of 
the mucus barrier to allow adherence to the intestinal epithelium, and 
(4) could degrade the mucus to provide nutrition for the vibrios. In 
this respect the results produced in this thesis provide additional 
support for the ideas set out in (2) and (3) above.
There seems to be little doubt that the neuraminidase action 
is part of a complicated process whereby V, cholerae is able to colonise 
the gut. Although as has been shown in the introduction V. cholerae 
neuraminidase has been characterised (Gottschalk, 1957; Pye and 
Curtain, 1961; Neurath, Hartzell and Rubin, 1970), assayed for its 
activity (Warren, 1959; Palese, Bucher and Kilbourne, 1973), purified 
(Ada, French and Line, 1961; Cuatrecasas and Illiano, 1971; Schick 
and Zilg, 1978), utilised for removing influenza virus receptors from 
erythrocytes (Burnet and Stone, 1947b), utilised for a variety of 
histological studies (Quintarelli £t al, 1961; Kent, 1963; Mowry,
1961; Gad, 1969; Yamada and Shimazu, 1979), utilised to increase the 
binding of cholera enterotoxin to a variety of mammalian tissues 
(Gascoyne and van Heyningen, 1979; Ackerman, Wolken and Gelder, 1980) 
and utilised for a variety of other biological and biochemical 
applications (Finne, 1978a,b; Corfield, Beau and Schauer, 1978; Knight, 
Nahrwald and Rosenberg, 1978), a clear idea of its true role in 
V, cholerae pathology is still unclear.
The work in this thesis has extended the knowledge about 
"mucinase" and it would be interesting to continue the study examining 
further interactions with other exo-enzymes and also to determine 
whether antibodies against these enzymes would provide protection for 
the mammalian host against V, cholerae.
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BUFFERS AND DILUENTS
Ammonium sulphate for protein precipitation
a) 100% saturated ammonium sulphate solution:
Ammonium sulphate (BoD.H,) 69.7 g
Distilled water 100 ml
b) 50% saturated ammonium sulphate solution;
Ammonium sulphate 29.7 g ■
Distilled water 100 ml
Borate gelatin buffer (Dr. Stewart-Tull, personal communication) 
Boric acid 3,1 g
NaCl 4.0 g
NaOH 80 mg
Gelatine 6% (w/v) 5.0 ml
" r
Adjust the volume to 1 litre with distilled water. The pH of the 
buffer is 7.5.
Phosphate buffered saline (P.B.S.)
a) Solution A
Na2HPO^LH20 3.58 g
Adjust the volume to 1 litre with distilled water,
b) Solution
NaH2P0^.2H20 1.56 g
Adjust the volume to 1 litre with distilled water.
c) Buffer;
Solution A 720 ml
Solution B 280 ml
NaCl 17.53 g
Distilled water 1.0 litre
The pH of the buffer is adjusted to 7.2.
Sodium acetate buffer
a) Solution A (0.3M acetic acid) *
Glacial acetic acid 18,0 ml
Adjust the volume to 1 litre with distilled water.
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b) Solution B (0.3M sodium acetate):
sodium acetate 24,6 g
Adjust the volume to 1 litre with distilled water,
c) Buffer:
Solution G (0.05M acetic acid) 48 ml
Solution D (Oo05M sodium acetate) 452 ml
Distilled water 500 ml
Adjust the pH of the buffer to 5.0,
f) Buffer for use with V. cholerae neuraminidase;
Solution G 48 ml
Solution D 452 ml
Distilled water 500 ml
CaCl2 1,0 g
NaCl 10,0 g
I
Adjust the pH of the buffer to 5.5.
Sodium Phosphate Buffer
a) Solution A (0.3M sodium phosphate dibasic);
Na2HPO^<H20 42,58 g
Adjust the volume to 1 litre with distilled water,
b) Solution B (0,3M sodium phosphate monobasic);
NaH2PO^i2H20 44.77 g
Adjust the volume tp 1 litre with distilled water.
c) Buffer;
Solution A 160 ml
Solution B 840 ml
Adjust the pH to 7.5.
d) Buffer for use in M.P.N. assay for neuraminidase activity;
Solution C (O.IM sodium phosphate monobasic) 877 ml
Solution D (O.lM sodium phosphate dibasic) 123 ml
CaCl2  222 mg
The volume was brought up to 1 litre with distilled water. The pH 
was adjusted to 5,9,
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Triethanolamine Buffer (Boehringer Mannheim, 1983)
Triethanolamine hydrochloride (O.IM) 1.86 g
The volume was brought up to 100 ml with distilled water. The pH was 
adjusted to 7.6 with l.ON NaOH.
Triethanolamine Buffer +  Calcium Chloride (Boehringer Mannheim, 1983) 
Triethanolamine hydrochloride (O.lM) 1.86g
CaCl^.ZH^O 22 mg
The volume was brought up to 100 ml with distilled water. The pH was 
adjusted to 7.6 with l.ON NaOH,
Triethanolamine Buffer + Magnesium Sulphate (Boehringer Mannheim, 1983) 
Triethanolamine hydrochloride (0.3M) 6.0 g
MgS0^.7H2P 100 mg
The volume was brolught up to 100 ml with distilled water. The pH was 
adjusted to 7.6 with l.ON NaOH. i
Tris (hydroxymethyl) aminomethane Buffer
a) Solution A. (0.2M Tris);
Tris * 24.2 g
The volume was adjusted to 1 litre with distilled water.
b) Solutions (0.2M HCl);
Concentrated HCl 1.0 ml
The volume was adjusted to 60 ml with distilled water,
c) Buffer;
Solution C (0.05M Tris) 250 ml
Solution D (0.05M HCl) 25 ml
The volume was brought to 1 litre with distilled water. The pH was 
adjusted to 9,0.
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Casamino acid-yeast extract broth (C.A.Y.E.) (Dr. J.P, Craig,
personal communication) 
Casamino acid (vitramin free - Difco, U.S.A.) 30.0 g
Yeast extract (Difco) 3.0 g
K^HPO^ 500 mg
Bring to volume of 1 litre with distilled water. The pH was adjusted 
to 7.0 with l.ON NaOH. The broth was dispensed into 16 x 125 mm tubes 
in 10 ml amounts. The media was autoclaved for 15 min at 120°C.
Gel diffusion media (for Ouchterlony plates)
Ion agar No, 2 (Oxoid) 15.0 g
NaCl 16.0 g
Methyl orange (Kodak Ltd) 120 mg
10% Phenol (w/v) saline solution 50 ml
Bring to volume of 1 litre and steam for 45 min. After steaming the 
methyl orange and phenol saline solution were added and the gel media 
was filtered through Whatman Grade 11 filter paper. It was stored as 
25 ml amounts,
( »
2% (w/v) proteose peptone broth
Meat peptone (Gibco-Europe, Uxbridge, U.K.) 20.0 g
The volume was adjusted to 1 litre with distilled water and autoclaved 
for 15 min at 120°C.
Proteose peptone-Colostrum for neuraminidase production
(Ada, French and Lind, 1961)
Meat peptone (Gibco) 150.0 g
Colostrum dialysate (Univ. of Glasgow,
Cochno Farm) 7.0 litres
' Glycerol (B.D.H.) , 112.5 ml
Distilled water 8,0 litres
a) Proteose peptone component;
Meat peptone 150,0 g
The volume was adjusted to 7.0 litres with distilled water. The peptone
broth was poured into a 15 litre fermenter vessel and autoclaved for 60
min at 120^0.
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b) Colostrum component:
Bovine Colostrum 1,5 litres
Distilled water 7,0 litres
The colostrum was placed into dialysis tubing (Visking, 7.0 cm diam) 
and placed in a tank which contained distilled water saturated with 
chloroform (antibacterial agent), for 8-14 days. The dialysate in the 
tank was aerated for 2 h with air filtered through a 0,45 pm filter 
membrane (Oxoid) to expel any trace of chloroform which remained. The
colostrum was transferred to a 20 litre millipore pressure vessel
(Millipore Co., Bedford, Mass. U.S.A.), and filtered through a 0,45 pm 
membrane filter which was held in a 142 mm millipore filter holder 
under nitrogen pressure into the 15 litre fermenter vessel. It was 
necessary to replace the 0,45 pm filter membrane several times with 
presterilised filter membranes. These filter membrane changes were 
carried out under sterile technique.
I
c) Glycerol component;
Glycerol (B.D.H.) 112.0 ml
The glycerol was poured into an erlenmeyer flask and autoclaved for 
30 min at 120°C. *fhe glycerol was aseptically added to the fermenter 
vessel,
] (
Thiosulphate-citrat-e bile salt sucrose agar (T.C.B.S.)
T.C.BoS. powdered agar (BBL-Cockeysville, Maryland, U.S.A.)
86 g
The powdered agar was suspended in 1 litre of distilled water, heated 
with frequent agitation (to dissolve the powder) and boiled for 1 min.
The T.C.B.S* agar was cooled to 45-50^C and dispensed into petri-dishes,
T^N^ broth (Dr. J.P. Craig, personal communication)
Bacto-tryptone (Difco) 8.0 g
NaCl 8.0 g
The volume was brought to 1.0 litre with distilled water and the pH was 
adjusted to 7,2 with l.ON NaOH. The broth, was dispensed into 16 x 125 mm 
tubes in 5 ml amounts. The broth was autoclaved for 15 rain at 120^C,
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Aldolase assay
a) (3-Nicotinamide-adenine dinucleotide, reduced:
P“NADH-Na2 «2 H 2 0  (Grade I, disodium salt, 99%,
Boehringer Mannheim) 10 mg
O.lM Triethanolamine buffer, pH 7.6 1.0 ml
b) Fructose-1.6-diphosphate:
^6^10^12^2^^3*(^6^14^4)*^^^2^ (crystallised tetracyclohexyl- 
ammonium salt, Boehringer Mannheim)
30 mg '
OglM Trie|ûhanolamine buffer, pH 7,6 1.0 ml
c) Glycerol-3-phosphate dehydrogenase/Triosephosphate isomerase:
GDH/TIM (crystalline suspension in ammonium sulphate
suspension, Boehringer Mannheim)
d) Aldolase:
Aldolase (ex rabbit muscle; crystalline suspension in
' — 1 
I ammonium sulphate solution, 1 0  mg ml ,
Boehringer Mannheim)
The working solution was obtained by diluting the manufacturer's
solution 100-fold in O.lM triethanolamine buffer pH 7.6.
Endoglycosidase assay - phenol sulphuric acid assay for carbohydrates
a) Ovalbumin:
Ovalbumin (Grade V, Sigma) 2,0 mg
0,05 M Sodium acetate buffer,
0,5% SDS (w/v) pH 5.5 0,2 ml
b) Trichloroacetic acid;
12,5% (w/v) Trichloroacetic acid 12.5 g
Adjust the volume to 100 ml with distilled water
c) Phenol :
80% (w/v) Phenol (Reaeen^* Grade. B.D.H.^ 8 .A e
Ad lust the volume to 10 ml with distilled water
d) Glucose (stock solution);
Glucose (Analar) 100 ug
Bring the volume to 1,0 ml with distilled water.
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e) Endoglycosidase;
Endoglycosidase H (ex Streptomyces griseus.
Miles Labs U.K., 0*1 unit vial) 0*1 unit 
Distilled water 100 p,l
The working solution was obtained by diluting 2 of enzyme solution 
in 100 of a O.lM NaCl, 0.1% (w/v) bovine serum albumin solution*
Lowry assay
a) Folin A reagent;
2 % (w/v) Na^CO^ 2 . 0  g
Bring to a volume of 100 ml with 0*IN NaOH,
b) Folin B reagent;
Freshly prepare in equal proportions 1% (w/v) CuSO,*5H„0
I Ï H  z
and 2 % (w/v) sodium tartrate* "
c) Folin C reagent:
Add 50 ml of Folin A reagent to 1*0 ml of Folin B reagent*
d) Folin D reagent;
I
Folin-Clocalteau's reagent (Sigma, 2N)*
Folin-Ciocalteau reagent is diluted 2-fold with distilled water to 
obtain the l.ON Folin D reagent*
e) Protein standard:
Bovine serum albumin (Grade V, Sigma) 1,2 mg
Distilled water 1*0 ml
Micro-biuret assay
a) Copper sulphate;
2*5% (w/v) CuSO^.5 H 2 0  2*5 g
Bring to a volume of 100 ml with distilled water*
b) Sodium hydroxide (3*ON);
NaOH 120 g
Bring to a volume of 1 litre with distilled water*
c) Protein standard;
Ovalbumin (Grade V, Sigma) 1,5 mg
Distilled water 1*0 ml
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M,PoN, assay ,!
a) Diazonium salt of 4 amino-2,5 di methoxy-4® nitroazobenzene;
DS-ASNB (Koch-Light) 6*0 mg
0*4M Sodium phosphate buffer, pH 7.0 1*0 ml
This solution must be prepared on the day used and filtered through 
Whatman filter paper*
b) Di-sodium E*D*T*A* (0*IM);
Di-sodium E*D*T*A* , 4.12 g
0*1 M Sodium phosphate buffer, pH 7*0 10.0 ml
c) Methoxyphenol;
Methoxyphenol (1*14 g ml B.D.H.) 1,0 ml
0*1 M Sodium phosphate buffer, 2 mM CaCl2 , 9,18 ml
pH 5 *“9
The solution of iiiiethoxyphenol is diluted 1000 fold in 0.1 M  Sodium 
phosphate buffer, 2 rrM CaCl2  pH 5*9 to give a final concentration of 
1 0 0  nmoles (0 * 1  m,l) ^*
d) Sodium hydroxide (0*5 N):
NaOH 20 g
The volume is adjusted to 1 litre with distilled water,
e) 2-(3* mqthoxyphenyl)-N-acetyl-oc-neuraminic acid (10 nW);
M*P*N* (Research Resources Branch of the National 
Institute of Allergy and Infectious 
Diseases, Bethesda, Maryland, U.S.A.) 50,0 g
0*1 M  Sodium phosphate buffer pH 5.9 11,82 ml
Phospholipase-G assay
a) Lipase:
Lipase (ex Rhizopus arrhizus; suspension in
• ammonium sulphate solution, 1 0  mg ml ^
Boehringer Mannheim)
b) Trichloroacetic acid (1,5 M)
CaClgCOOH 24,5 g
Distilled water 100 ml
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c) ATP/NADH/PEP solution;
ATP-NagHg.SHgO (crystallised disodium 40mg
salt, Boehringer, Mannheim)
NADH-N& 2  (disodium salt grade II 10 mg
Boehringer Mannheim)
PEP-Na (crystallised mono-sodium salt, 20 mg
Boehringer Mannheim)
NaHCOg 1 0 0  mg
0.3M Triethanolamine buffer, pH 7,6 2,0 ml
d) Lactate dehydrogenase;
LDH (ex rabbit muscle, crystalline
suspension in ammonium sulphate 
solution, Boehringer Mannheim)
e) Pyruvate kinase:
PK (ex rabbit muscle, crystalline
suspension in ammonium sulphate 
solution, Boehringer Mannheim)
f) Glycerolkinase:
Glycerolkinase (ex Candida mycoderma,
suspension in ammonium sulphate, ^
Boehringer Mannheim)
g) Phospholipase-C;
Phospholipase-C (ex Bacillus cereus, grade II, 
suspension in ammonium sulphate,
Boehringer Mannheim) ,
h) Lecithin;
Lecithin (ex egg yolk, prepared according to 200 mg 
method of Pangborn, 1951)
Redistilled water 10*0 ml
The lecithin suspension is exposed to ultrasonic treatment for 5 min,
The ultrasonic treated lecithin serves as the substrate for the
phospholipase-C assay* ■
Proteinase
a) Trichloroacetic acid: ■
CCI 3 COOH I 5*0 g
Distilled water 100 ml
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b) Trypsin;
Trypsin (Sigma) 20 mg.
0.05M Tris buffer, pH 9,0 10 ml
c) Casein;
Casein (Hammarsten grade, BoD*H.) 1.0 g 
Ool M  Sodium phosphate buffer, 100 ml
pH 7.6
Thiobarbituric acid assay
a) N-acetylneuraminic acid:
NANA (Sigma) 6.18 mg
0.05 M Sodium acetate buffer, 10 ml
pH 5.5
b) Phosphotiingstic acid:
Phosphotungstic acid (B.D.H.) 5.0 g
2.5 N HCl 100 ml
c) Periodate solution:
NalO^ '(Sigma) 4.27 g
Distillled water 38,3 ml
Concentrated Phosphoric acid 61,7 ml
(Analar)
d) Arsenite solution:
NagSO^ 17.75 g
Distilled water 250 00 ml
5.0 N H^SO^ 5,00 ml
Sodium arsenite (B.D.H,) 25,00 g
e) Thiobarbituric acid;
Thiobarbituric acid (B.D.H,,
2X recrystallised) 4,5 g
0.5 M Na^SO^ 750,00 ml
f) N“butanol
g) Cyclohexanone;
Gyclohexanone (re-distilled)
h) Bovine submaxillary mucin:
Bovine submaxillary mucin (Sigma) 20 mg 
0,05 M Sodium acetate buffer, 5,0 ml
(1.0 g) CaCl^ (10 g)
NaCl, pH 5.5,
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Commercial neuraminidase preparations:
1) Vo choleras neuraminidase (Koch-Light; 200 ImlJ ml" ):
The working solution of this enzyme is obtained by making 
a 5-fold dilution of the enzyme in 0*05 M Sodium acetate 
buffer, CaClg (1*0 g) NaCl (10 g), pH 5*5, The activity 
of the working solution is 1 * 0  ImU in the assay.
2) Vo cholerae neuraminidase (Calbiochem; 1000 ImU ml  ^or
100 ImU in assay).
3) d o  perfringens neuraminidase (Sigma; 170 ImU mg ^):
Clo perfringens neuraminidase 1.0 mg
0o05 M Sodium acetate buffer, pH 5.0 5.0 ml
The activity of the working solution is 3.4 ImU in the assay.
4) Clo perfringens neuraminidase (Worthington; 1360 ImU ml  ^
or 136 ImU in assay).
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BATCH CULTURE FERMENTER 
A (L.H. ENGINEERING, LTD., STOKE POGES, BUCKS, ENGLAND)
Legend;
A = Sampling port !
B = Filling port *
C = Water in 
D « Air in 
E = Air out 
F * Anti-Foam Probe 
G = pH Probe 
H = Water out
I - Water flow connection carrying heater water to "water in"
1 £
connection
J = Water flow connection carrying water from main "Flow out" 
opening 
K = Thermometer opening 
L = Condenser
M = Temperature control gauge 
N - Water flow from fermenter vessel 
0 = Water flow into fermenter vessel 
P = Air flow gauge
Q = Air flow opening connected to air filter 
R = Irapellar
S = connection between impellar rotor blade and driving motor 
T ~ Anti-foam mixture (1% Silcolapse)
U = Speed control for impellar
V = Anti-foam pump
X = Air control dial
Y = Anti=foam dose control 
Z = Sampling bottle
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Inoculum
flask
/ tump
C
Anti-fc  
dosing 
contreJ 
knobSampling' device *
BATCH CULTURE FERMENTER
B (Anti-foam system, sampling system and addition of 
inoculum via f i l l in g  pore.)
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BATCH CULTURE FERMENTER
C (Temperature control gauge, water heating system)
I:
i
Legend: The arrow indicates the direction of flow of the cooling water
H = Water out opening
IsM = Temperature control gauge of fermenter vessel 
N = Water flow from fermenter vessel 
0 = Water flow\ into fermenter vessel
BATCH CULTURE FERMENTER 
B (Air flow system)
Legend: D Air in connection
E W Air out connection 
L =! Condenser 
P = Air flow gauge
Q ” Air flow opening connected to air filter 
X = Air control dial
Air CO
disinfectant
tray
water in
water
out
k P 0
J L n
Air
filter
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Alcian Blue/PAS, pH 2,5 (Mowry, 1963)
a) Alcian blue:
Alcian blue (Raymond Lamb, London) 100 g 
Concentrated acetic acid 300 ml
The volume is adjusted to 1 litre with distilled water»
b) Schiff reagent:
Pararosaniline Chloride (Kodak Ltd») 2*0 g { ,
, ■ I
The volume is adjusted to 200 ml with distilled water» The para- | 
rosaniline chloride is decolourised by bubbling sulphur dioxide 
through the solution until it took on a straw yellow appearance,
c) Periodate solution:
1 % (v/v) HIO^ = 1 » 0  ml '
Distilled water 99»0 ml
d) Sodium meta-bisulphite:
NagSaOg (B»D»Ho) 9»5 g
The volume is adjusted to 100 ml with distilled water.
1
Haematoxylin and Eosin (Humason, 1967)
a) Harris Haematoxylin - without acetic acid (Mallory, 1944):
Haematoxylin 1.0 g
Absolute alcohol 10.0 ml
Ammonium alum 20.0 g
Distilled water 200.00 ml
Note; The Harris Haematoxylin was obtained ready prepared from the 
supplier, Raymond Lamb, London.
b) Eosin yellow:
Eosin yellow (Kodak Ltd.) 2.0 g
The volume is adjusted to 200 ml with distilled water.
c) Scott's solution (Humason, 1967)
Sodium bicarbonate 2,0 g
MgSO^ 2 0 . 0  g
The volume is adjusted to 1 litre with distilled water.
APPENDIX VI
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STAINING PROCEDURES
Alcian Blue/PAS, pH 2.5 (Mowry, 1963)
a) Stain in Alcian blue for 30 min.
b) Wash in running water»
c) Oxidise for 10 min in 1% (v/v) aqueous HIO^.
d) Wash in running water»
e) Treat with Schiff*s reagent
f) Rinse 3 times in sodium metabisulphite for a period of i
2  min at each time interval.
g) Rinse in running water»
h) Dehydrate, clear, and mount in D.P.X»
Haematoxylin and Eosin (Progressive method, Humason, 1967)
a) Stain in Harris Haematoxylin for 2-5 min.
b) Rinse in running water 3-5 min»
c) Immerse in Scott's solution for 3 min,
d) Rinse in running water 3-5 min,
e) Immerse in eosin yellow counterstain 1-3 min.
f) Rinse in running water»
g) Dehydrate, clear, and mount in D.P.X.
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Millilitres added
Tube No, 1  2 3 4 5 6 7
V, cholerae neuraminidase (N^, 55 ImU ml'^)0,2 0.2 0 . 2 0 , 2 0 . 2 • .
DST R77 rabbit anti-neuraminidase serum 0 , 1  0 , 2 0,3 0,4 . 0.5 .
0,05 M NaAc buffer pH 5,5 0,4 0,3 0 , 2 0 , 1 0.5 0 . 2 0,7
Tube No,
Millilitres added 
1 2 3 4 5 6
Cl* perfringens neuraminidase 
(680 ImU ml”^) 0 , 2  0 , 2 0 , 2 0 . 2 0 , 2
DST R78 rabbit anti-neuraminidase s erum 0 , 1  0 , 2 0,3 0.5 . .
0,05 M NaAc buffer pH 5,0 0,4 0,3 0 , 2 • 0,5 0,7
I
1
Tube No,
(
(
Millilitres added 
1 2  3 4 5 6 7 8
V, cholerae neuraminidase _ 
(N^, 55 ImU ml ) 0 , 1  0 , 1 0 . 1 0 , 1 0 . 1
DST R78 rabbit anti-neuraminidase serum, , 0,05 0.25 0.25 . . .
IgG (R78) fraction of rabbit 
anti-neuraminidase èerum 0,05 0.25 0,25
0.05 M NaAc buffer pH 5,5 0,35 0,25 0 , 2 0 • 0 . 1 0 , 2 0 • 0 , 1 0
1
Tube No,
1
Millilitres added 
; 1 2 3 4 5
V, cholerae neuraminidase (N^, 55 ImU ml  ^ , 0 , 2 0 , 2 0 , 2
Normal rabbit serum 0.5\ , 0 . 1 0,4
0.05 M NaAc buffer pH 5,5 0,7 0,2 0,5 0,4 0 . 1
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Millilitres added
Tube No. 1 2 3 4 5 6  7 8 9  10 II 12
V.cholerae neura­
minidase (Ng, . 0 . 1  0 . 1  0 . 1  0 . 1  0 . 1  0 . 1  0 . 1  0 . 1  0 . 1  0 . 1  0 . 1
55 ImU ml“^)
DST R78 rabbit anti­
neuraminidase serum . • « . , . 0.05 0.1 0.15 0 . 2 0  0.25
IgG (DST R78
fraction of rabbit  ^ , 0.05 0 . 1 0  0.15 0 . 2 0  0.25 ......................
anti-neuraminidase
serum
0,05 M NaAc buffer
pH 5,5 0,35 0,25 0,20 0,15 0.10 0,05 , 0,20 0.15 0,10 0,05 ,
Serum Control Millilitres added
Tube No. 1 2 3 4 5 6 . 7  8  9 10
DST R78 rabbit anti-
neuraminidase serum . . . , , 0,05 0,10 0.15 0,20 0,25
IgG (DST R78) fraction
of rabbit anti-neura- 0,05 0,10 0,15 0,20 0,25 . , , , .
minidase serum
0,05 M NaAc buffer
pH 5.5* 0,30 0,25 0,20 0,15 0,10 0,30 0,25 0,20 0,15 0.10
**The above experiment was repeated with normal rabbit sera and the IgG 
fraction of normal rabbit serum
Millilitres Added Test  ^ Controls
Tube No, ' 1 2  3 ' 4 5 6  7 8  Ç
V, chûlêtae neuraminidase
*(N^-N^) 0.2 0.2 0,2 0,2 ....................
DST R77 rabbit anti-
neuraminidase serum , . 0,3 0,4 0,5 0,5 . 0,3 0.4 0.5
Sigma Cl.perfringens
neuraminidase ' , , , , 0 ,2 ,
(30 ImU ml"*^)
0,05 .M.NaAc buffer pH 5.5 0.5 0,2 0.1 , 0.7 0.4 0.3 0.2
*N^ = 0.05 I.U, ml'^, N^ = 0.01 I.U.ml"^, *N^ = 0.03 I.U.ml’^,
**The neuraminidase was diluted 1:5 in 0.05 M NaAc buffer pH 5,5 for 
M.P.N. and T,B,A, assays,
***Tubes 4-6 were also assayed without the addition of bovine submaxillary 
by the T.B.A, assay in order to check for the possible addition of sialic 
acid from serum.
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The effect of commercial neuraminidase (Worthington Cl. perfringens)
Treatment and Prep.
No, Individual counts field
-1 Total
count
Mean
Arith,*Geom
Alcian Blue 1
Uncreated (x.s.) 18 18 23 2 1 17 2 0 2 0 14 19 19
17 27 2 1 28 26 16 27 27 23 2 0 421 2 1 20,7
PAS 6 5 4 1 1 0 0 3 2 0
16 9 8 8 7 4 3 6 5 6 94 4.7 0
Alcian Blue 2
Water (x.s,) 9 8 1 0 9 13 16 17 19 18 28
1 1 14 14 17 16 14 1 1 1 2 2 2 18 .• 296 14,8 14,1
PAS 5 6 3 3 1 3 5 6 0 7
1 2 9 8 7 5 6 7 5 2 1 1 1 1 1 5.6 0
Alcian Blue (x.s,) 3
0,05M NaAc buffer pH 5.0 14 23 25 30 13 2 1 24 2 0 18 15
15 1 2 2 0 16 27 16 18 19 2 1 2 1 388 19,4 18,8
PAS 5 4 3 3 0 0 0 0 0 0
1 0 1 1 7 8 0 0 0 2 7 8 6 8  ' 3,4 0
Alcian Blue (x.s,) 4
Neuraminidase (136 ImU) 3 7 1 4 5 7 3 3 2 5
13 16 19 2 1 2 2 13 15 1 2 18 15 204 1 0 , 2 7,5
PAS. 8 6 4 2 6 16 6 2 3 0
2 0 17 14 14 1 0 1 1 1 2 9 16 8 184 9,2 0
Alcian Blue 5
Untreated (l.s.) 43 17 39 27 27 31 15 41 31 17
2 2 23 30 45 38 28 24 24 24 1 1 557 27,9 26,2
PAS 7 8 9 4 7 3 4 5 8 3
3 5 8 4 9 8 3 9 7 3 117 5.9 5.4
Alcian Blue
Water (l.s,)
1 1 13 13 1 2 1 0 1 0 15 19 17 9
63 57 48 56 48 53 62 53 59 50 678 33,9 26,2
PAS 6 5 5 3 3 5 3 6 4 3
13 15 2 0 15 15 15 13 18 13 13 193 9.7 7.8
Alcian Blue (l.s.) 7
6,05M NaAc buffer pH 5,0 23 18 16 18 16 24 2 1 2 0 16 14
45 56 61 50 45 44 45 56 44 50 682 34.1 30,1
PAS 0 0 0 1 2 0 0 1 0 2
5 2 3 5 3 4 2 3 5 6 44 2 , 2 0
Alcian Blue (l.s,) 8
Neuraminidase (136 ImU) 6 1 1 8 8 4 1 0 4 1 1 1 2 5
15 2 0 13 2 2 2 1 25 23 2 2 28 27 295 14,8 12,4
PAS 1 2 5 5 5 3 3 8 1 0 2 2
14 9 7 9 13 1 1 13 14 6 7 158 7,9 6,7
^Geometric mean = %
2 n
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The effect of commercial neuraminidase (Worthington Cl. perfringens)
Treatment and Staining
Prep, Total
No . count
Statistical 
t-value significance
(two-tailed test) 
p value 78 d.f,
Alcian Blue
Untreated 1+5 978
Neuraminidase (136 ImU) 4+8 499
PAS
Untreated 1+5 2 1 1
Neuraminidase (136 ImU) 4+8 342
Alcian Blue
Untreated 1+5 978
0.05M NaAc buffer pH 5.0 3+6 1070
PAS
Untreated 1+5 2 1 1
0.05M NaAc buffer pH 5.0 3+6 1 1 2
Alcian Blue
Untreated i+5 978
Water 2 + 6 974
PAS
Untreated 1+5 2 1 1
Water 2 + 6 304
6.78
-3.53
-0.892
3.52
0.0314
-2.46
<0.0002
< 0.001
<0.50
<0.001
>0.8
>0.02
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The effect of cholera enterotoxin
Treatment and 
Staining
Prep. 
No. Individual counts field
-1 Total Mean
count Arith. *Geom.
Alcian Blue 1
Untreated (x.s.)
PAS
Alcian Blue
0,05M NaAc buffer 2
pH 5.5
pis
Aj-cian Blue
Neuraminidase (100 ImU) 
Calbiochem V.cholerae
PM.
Alcian Blue
Borate Gelatin buffer ^
pH 7.3 (x.s.)
P M
Alcian Blue 5
Cholera enterotoxin 
G 100 purified (x.s.)
PAS
13 1 2 18 9 16 18 19 9 15 14
19 18 13 1 2 1 2 13 24 1 1 1 1 15 292 14.6 14.1
6 9 6 5 5 7 6 9 4 0
1 0 8 1 0 9 6 0 9 8 3 0 1 2 0 6 . 0 0
2 0 29 1 2 25 14 9 8 0 1 1 14 1
9 1 0 3 2 0 7 14 18 9 6 2 1 0 10.5 0
1 0 0 0 0 1 0 0 0 0 0 1 0
0 1 0 0 1 0 0 0 1 2 9 1 1 8 90 4.5 0
7 6 4 2 2 4 . 0 0 0 0
9 7 7 6 4 9 1 0 7 3 1 1 98 4.9 0
1 2 0 9 16 9 16 0 15 0 16
1 2 15 6 7 5 0 15 16 14 17 2 0 0 1 0 0
6 5 1 0 8 1 0 5 1 2 3 1 0 3
1 2 15 9 9 13 1 2 2 0 17 19 18 216 1 0 . 8 9
3 8 3 5 3 0 0 0 0 0
5 1 6 7 6 1 0 7 9 6 5 84 4.2 0
24 14 14 1 1 1 0 9 9 7 8 7
5 8 9 9 1 1 1 1 1 1 7 8 7 199 1 0 9
8 9 1 0 13 1 0 16 9 15 5 0
6 1 0 13 7 1 2 1 0 8 1 0 7 9 187 9.4 0
* Geometric mean X .. .X
n
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Appendix VIII
The effect df choleta entetdtdxin
Statistical
Prep. Total significance
Treatment and Staining No, count t-value (two-tailed test) 
p value 38 d.f.
Alcian Blue 1 292 3.32 < 0 . 0 1
Cholera enterotoxin 5 199
GlOO purified
PAS
Untreated
Cholera enterotoxin
1
5
1 2 0
187 -2.14 <0.05
GlOO purified '
Alcian Blue
Borate Gelatin buffer pH7.3 4 
Cholera enterotoxin 5
216
2 1 2
0 . 1 2 >0.80
GlOO purified
PAS
Borate Gelatin buffer pH7.3 4 
Cholera enterotoxin 5
84
187 -4.76 < 0 . 0 0 0 2
GlOO purified
Alcian Blue
Untreated i 1 
Borate Gelatin buffer pH7.3 4
292
216 2,42 <0.05
PAS
Untreated 1 1 2 0
1.18 <0.50Borate Gelatin buffer pH7 .3 4 84
Alcian Blue
Untreated
Neuraminidase (100 ImU)
1
3
292
98 7.47 < 0 . 0 0 0 2
Calbiochem V. cholerae
PAS
Untreated
Neuraminidase (100 ImU)
1
3
1 2 0
2 0 0
- 2 . 0 2 < 0 . 1 0
Calbiochem V. cholétae
Alcian Blue
0.05M NaAc buffer pH 5.5 2 2 1 0
3.34 < 0 . 0 1Neuraminidase (100 ImU) 3 98
Calbiochem V. cholerae
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase (100 ImU)
2
3
90
2 0 0
-2.96 < 0 . 0 1
Calbiochem V. cholerae
Alcian Blue
Untreated
0.05M NaAc buffer pH 5.5
1
2
292
2 1 0
2 . 2 2 < 0.05
PAS
Untreated
0.05M NaAc buffer pH 5.5
1
2
1 2 0
90 0.85 < 0.50
236
Appendix VIII
Effect of Trypsin Inhibitor and Trypsin Inhibitor + Neuraminidase
Treatment and 
Staining
Prep
No. Individual counts field
-1 Total Mean
count Arith, *Geom.
Alcian Blue
Uncreated (x.s.) 9 9 1 0 5 6 9 6 3 6 5
6 7 0 3 5 0 4 5 0 0 98 4.9 0
PAS 13 7 9 1 0 8 1 1 0 5 9 2
7 6 0 6 5 0 0 0 0 6 104 5.2 0
Alcian Blue 2
Water (x.s,) 13 9 7 0 0 3 13 9 6 6
5 5 2 9 4 0 0 0 0 0 91 4.6 0
PAS 1 2 13 9 13 7 9 8 0 5 14
5 8 4 6 9 6 0 0 0 0 128 6.4 0
Alcian Blue
0.O5M NaAc buffer 3 L
pH 5.5 (x.s.) 9 5 4 6 6 8 6 5 9 4
6 3 0 5 4 5 4 0 0 0 89 4.5 0
PAS 1 1 9 8 1 0 9 1 1 4 1 0 14 18
9 7 8 0 5 0 1 0 0 6 8 157 7.9 0
Alcian Blue 
Semi-purified 
V. cholerae 
neuraminidase
(5.5 ImU) (x.s.) 7 2 2 0 3 0 0 0 0 0
0 4 0 5 0 4 3 5 0 5 40 i 2 0
PAS 5 1 0 6 14 8 1 0 8 14 28 30
0 7 1 0 8 5 4 0 9 0 0 176 8 . 8 0
Alcian Blue (x.s.) 5
Trypsin Inhibitor 7 6 8 5 2 5 7 7 3 2
0 5 3 2 3 3 0 4 4 4 80 4 0
PAS 9 13 1 2 8 14 5 1 0 1 2 25 7
8 0 1 0 9 1 0 8 3 3 6 5 177 8.9 0
Alcian Blue (x.s.) 6
Serai-purified
V, cholerae
neuraminidase
(5.5 ImU) +
Trypsin Inhibitor 7 4 4 1 2 2 4 2 6 4 6
0 0 0 0 0 1 0 3 0 0 55 2 . 8 0
PAS 26 27 13 17 19 16 25 18 19 24
0 0 7 7 6 5 0 4 0 0 233 11.7 0
* Geometric mean = X X - I..X...X
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Appendix VIII
Effect of trypsin inhibitor and trypsin inhibitor + neuraminidase
Treatment and Staining Prep,
No.
Total
count
t-value Statistical significanc
(two-tailed test) 
______________________ p value 38 d.f.
Alcian Blue
Untreated 1
Trypsin Inhibitor 5
PAS
Untreated 1
Trypsin Inhibitor 5
Alcian Blue
Untreated ' 1
Semi-purified V.cholerae 6
neuraminidase (5.5ImU)
+ Trypsin Inhibitor 5
PAS
Untreated 1
Semi-purified V.cholerae 6
neuraminidase (5.5 ImU)
+ Trypsin Inhibitor
Alcian Blue
Untreated 1
Semi-purified V.cholerae 4
neuraminidase (5.5 ImU)
PAS
Untreated 1
Semi-purified V.cholerae 4
neuraminidase (5.5 ImU)~
Alcian Blue
Untreated 1
0.05M NaAc buffer pH 5.5 3
PAS
Untreated 1
0.05M NaAc buffer pH 5.5 3
Alcian Blue
Untreated 1
Water • 2
PAS
Untreated 1
Water 2
98
80
104
177
98
55
104
233
98
40
104
176
98
89
104
157
98
91
104
128
1.03
-2.44
2.13
-2.70
3.3
-1.76
0.478
-1.92
0.289
-0.853
<0.50
<0.02
<0.05
<0.02
<0.010
<0.1
<0,80
<0.10
<0.80
<0.50
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Appendix VIII
The effect of specific anti-neuraminidase serum (DST R77)
Treatment and 
Staining___
Prep.
No. Individual counts field
-1 Total Mean
count Arith. *Geom.
Alcian Blue 1
Uncreated Cx,s .)
PAS I-
Alcian Blue
0.05M NaAc buffer 2
pH 5.5 (x.s.)
PAS
Alcian Blue 3
Neuraminidase (VJCholerae) 
N^ (11 ImU) + NaAc buffer 
0.2 ml + 0.5 ml (x.s.)
PAS
Alcian Blue
Neuraminidase + Anti-ser. 
N 2  (11 ImU) + R77 4
0 . 2  ml + 0 . 1  ml (x.s.)
PAS
Alcian Blue
Neuraminidase + Anti-ser. 
N 2 (11 ImU) + R77 5
0 . 2  ml + 0 . 2  ml (x.s.)
PAS
Alcian Blue
Neuraminidase + Anti-ser. 
N 2  (11 ImU) + R77 6
0.2 ml + 0.3 ml (x.s.)
PAS
Alcian Blue
Neuraminidase + Anti-ser. 
Ng (11 ImU) + R77 7
0.2 ml + 0.4 ml (x.s.)
PAS
alcian Blue 8
Anti-ser. + 0.05M NaAc 
0.5 ml + 0 . 2  ml (x.s.)
PAS
27 20 30 25 32 25 30 33 27 31 
18 15 21 18 20 17 24 11 17 10 
7 7 2 0 0 0 0 6 4 7  
3 6 5 4 2 0 2 8 5 6
26 29 2 2  31 20 28 21 20 27 19 
15 13 11 10 16 12 11 18 12 13 
5 7 5 0 1 0 1 0 0 6  
8  10 6 9 7 3 7 4 3 4
5 9 6  1 2  4 5 12 9 11 6
6  5 10 9 11 15 16 13 1 2  10
27 22 33 19 18 16 21 23 17 24
17 19 11 21 13 10 11 15 10 18
]
13 17 16 16 13 15 10 14 13 11
1 1  12 13 15 17 12 15 19 17 14
6  5 4 1 2  15 10 1 2  21 6  12
16 14 11 2 1  12 16 11 23 9 8
21 11 2 12 13 15 7 5 9 12
18 9 10 14 19 21 16 15 13 16
1 1  13 16 8  5 10 3 2 0 1
17 12 15 19 12 18 13 11 10 8
8  2 3 1 5 8 2 8 6 3
10 5 11 9 13 15 15 19 18 13
31 32 25 23 23 30 33 28 34 25
18 16 17 15 26 14 20 22 2 1  11
5 3 0 3 0 0  11 2 4 0
12 13 10 7 12 6  17 13 12 7
19 17 20 23 27 17 14 17 15 16
32 29 26 28 21 26 25 26 25 22
10 14 11 7 12 6  8  10 7 11
13 11 15 12 11 11 15 12 8  10
9 13 13 1 1  7 8  14 11 10 8
6  8  9 10 14 12 9 16 9 6
451 22.6
74 3.7
376
86
18.8
4.3
283 14.2
244 12.2
21.4
0
17.7
0
186 9.3 8 . 6
365 18.3 17.3
14
11
258 12.9 11.6
204 10.2 0
174 8.7 6.7
464 23.2 22.2
137 6.9 0
445 22.3 21.7
214 10.7 10.4
203 10.2 9.8
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Appendix VIII
Thé effect of specific anti-neuraminidase serum (DST R77)
Treatment and Staining Prep,
No.
Total
count
t-value Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
Alcian Blue
Untreated 1
Anti-ser.+0.05M NaAc 8
0.5 ml + 0,2 ml
■ PAS
Untreated 1
Anti-ser.+ 0.05M NaAc 8
0.5 ml + 0.2 ml
Alcian Blue
Untreated 1
Neuraminidase+Anti-ser. 7
PAS
Untreated 1
Neuraminidase+Anti-ser. 7
Ü2 (11 linU) + R77 
0 . 2  ml + 0.4 ml 
Alcian Blue
Untreated 1
Neuraminidase+Anti-ser. 6
N 2  (11 ImU) + R77 
0.2 ml + 0,3 ml
PAS
Untreated 1
Neuraminidase + Anti-ser. 6
N 2  (11 ImU) + R77 
0.2 ml + O', ml
Alcian Blue
Untreated 1
, Neuraminidase + Anti-ser, 5
N 2  (11 ImU) + R77 
' 0 . 2  ml + 0 . 2  ml
PAS
Untreated 1
Neuraminidase + Anti-ser. 5
N 2  (11 ImU) + R77 
0 . 2  ml + 0 . 2  m
Alcian Blue
Untreated 1
Neuraminidase + Anti-ser. 4
N 2  (11 ImU) + R77 
0 . 2  ml + 0 . 1  ml 
PAS
Untreated 1
Neuraminidase + Anti-ser. 4
N 2  (11 ImU) + R77 
0 . 2  ml + 0 . 1  ml
451
214
74
203
451
157
74
445
451
174
74
464
451
258
74
204
451
283
74
244
7.21
-7.30
8.07
-14.05
7.05
-11.92
5.06
-4.06
5.15
-6.30
<0.0002
<0.0002
<0.0002
<0 .0002
<0.0002
<0.0002
<0.0002
<0.001
<0.0002
<0.0002
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Appendix yi l l  i
The effect of specific anti-neuraminidase serum (DST R77)
Treatment and 
Standing
Prep, 
No.
Total
count
Statistical 
t-value significance
(two-tailed test)
Alcian Blue
Untreated
Neuraminidase (V,cholerae)
1
3
451
186
7.66 < 0 . 0 0 0 2
N 2  ( 1 1  ImU) + NaAc buffer
6,2 ml + 0,5 ml
FAS
Untreated
Neuraminidase (V,cholerae)
1
3
74
365
-9.93 < 0 . 0 0 0 2
N 2  ( 1 1  ImU) + NaAc buffer
0 . 2  ml + 0.5 ml
Alcian Blue
Untreated
0.05M NaAc buffer pH 5.5
1
2
451
376 1.75
< 0 . 1 0
FAS
Untreated
0.05M NaAc buffer pH 5.5
1
2
74
8 6
-0.63 <0.80
Alcian Blue
0.05 M NaAc buffer pH 5.5 2 376
5.65 <0 . 0 0 0 2
N 2  ( 1 1  ImU) + NaAc buffer 3 186
d.2 ml + 0.5 ml
PAS '
0.05M NaAc buffer pH 5.5 
Ù 2  ( 1 1  ImU) + NaAc buffer
2
3
8 6
365
-9.25 < 0 . 0 0 0 2
0 . 2  ml + 0.5 ml ,
Alcian Blue
0.05M NaAc buffer pH 5.5 2 376
2.95 < 0 . 0 1
Neuraminidase + Anti-ser. 4 283
N 2  (11 ImU) + R77
0 . 2  ml + 0 . 1  ml
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase + Anti-ser.
2
4
8 6
244
-5,66 < 0 .0 0 0 2 .
N 2  (11 ImU) + R77
0 . 2  ml + 0 , 1  ml
Alcian Blue
0.05M NaAc buffer pH 5.5 2 376
3.16 < 0 . 0 1
Neuraminidase + Anti-ser. 5' 258
N 2  (11 ImU) + R77 V
0 . 2  ml + 0 . 2  ml
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase + Anti-ser,
2
5
8 6
204 -4.05 < 0 . 0 1
N 2  (11 ImU) + R77
0 , 2  ml + 0 . 2  ml
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Appendix VIII
The effect of specific anti-neuraminidase; serum (DST R77)
Treatment and Staining Prep. Total Statistical
No. count t-value significance 
(two-tailed test) 
p value 38 d.f.
Alcian Blue
0.05M NaAc buffer pH 5.5 2 376
5.26 <0.0002
Neuraminidase + Anti-ser, 6 174
N 2  (11 ImU) + R77
0.2 ml + 0.3 ml
PAS
0.5 M NaAc buffer pH 5.5 
Neuraminidase + Anti-ser.
2
6
86
464
-11.29 <0.0002
N 2  (11 ImU) + R77
0.2 ml + 0 ml
Alcian Blue
0.05M NaAc buffer pH 5.5 2 376
6.29 <0.0002Neuraminidase + Anti-ser. 7 137
N^ (11 ImU) + R77
0.2 ml + 0,4 ml
PAS
0.05M NaAc buffer pH 5.5. 
Neuraminidase + Anti-ser.
2
7
86
445
-13.13 <0.0002
N2 (11 ImU) + R77 '
0.2 ml + 0,4 ml
Alcian Blue
0.05M NaAc buffer pH 5.5 
Anti-ser, + 0.05M NaAc ;
2
8
376
214 4.85 <0.0002
0«5 ml + 0.2 ]ml
PÀS
0.05M NaAc buffer pH 5.5 
Aiiti-ser. + 0.05M NaAc
2
8
86
203 -6.14 <0.0002
0.5 ml + 0.2 ml
Alcian Blue
Neuraminidase (V.cholerae) 3 186
N 2  ( 1 1  ImU) + NaAc buffer
0.2 ml + 0.5 ml -5.09 <0,0002
Neuraminidase + Anti-ser, 4 283
0.2 ml + 0.1 ml
PAS
Neuraminidase (V.cholerae) 3 365
N 2  ( 1 1  ImU) + NaAc buffer 
0.2 ml + 0.5 ml 3.39 <0.01
Neuraminidase + Anti-ser. 4 244
0.2 ml + 0.1 ml '
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The effect of specific anti-neuraminidase serum (DST R77)
Treatment and Staining Prep
No,
Total
count
t-value Statistical
significance 
(two-tailed test) 
_______________p value 38 d.f.
Alcian Blue
Neuraminidase (V.cholerae) 
N^ (11 ImU) + NaAc buffer 
0.2 ml + 0.5 ml 
Neuraminidase + Anti-ser, 
0.2 ml + 0.2 ml 
PÀS
Neuraminidase (V.cholerae) 
N 2  (11 IraU) + NaAc buffer 
0,2 ml + 0.5 ml 
Neuraminidase + Anti-ser. 
0.2 ml + 0.2 ml
Alcian Blue
Neuraminidase (V.cholerae) 
N 2  (11 ImU) + NaAc buffer 
0.2 ml + 0.5 ml 
Neuraminidase + Anti-ser. 
0.2 ml + 0.3 ml 
PAS I
Neuraminidase (V.cholerae) 
N 2  ( 1 1  ImU) + NaAc buffer 
0.2 ml + 0.5 ml ■
Neuraminidase + Anti-ser.
0.2 ml + 0.3 ml
Alcian Blue ;
Neuraminidase (V.cholerae) 
N 2  (11 ImU) + NaAc buffer 
0.2 ml + 0.5 ml 
Neuraminidase + Anti-ser. 
0.2 ml + 0.4 ml 
PAS
Neuraminidase (V.cholerae) 
N 2  ( 1 1  ImU) + NaAc buffer 
0.2 ml + 0.2 ml 
Neuraminidase + Anti-ser. 
0.2 ml + 0.4 ml
186
258
365
204
186
174
365
464
186
137
365
445
-2.62
4.39
0,41
-2.46
1.72
-2.27
<0.02
<0.0002
<0,80
<0.02
<0.10
<0.05
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Appendix VIII
The effect of anti-neuraminidase serum (DST R78) against
non-cholera neuraminidase
Treatment and Prep. 
N o . Individual counts field
-1
Total Mean
count Arith. *Geom,
Alcian Blue 1
Untreated (x.s.) 20 22 23 18 16 19 24 23 18 20
19.818 16 19 25 20 23 22 15 21 17 299 20
PAS 6 13 6 4 0 0 4 2 1 7
.. 9 11 14 13 12 2 10 6 1 10 151 6,6 0
Alcian Blue
0.05M NaAc buffer 2 6 5 7 10 4 5 9 0 11 7
pH 5.0 (x.s.) 
PAb
11 18 23 13 12 13 17 21 17 12 221 11.1 0
23 33 14 19 13 14 13 14 15 24
21 39 27 24 15 19 16 25 29 19 416 20.8 19.7
Alcian Blue 3
Neuraminidase (Cl.perfr. ) 0 0 0 2 0 0 3 2 0 0
(136 ImU) (x.s.) ' 0 6 5 7 6 8 7 6 3 5 60 3 0
PAS 28 34 28 23 17 25 40 37 23 21
25 21 19 18 19 16 18 22 21 26 481 24.1 23.3
Alcian Blue
Neuraminidase + 0.05M , 4 8 5 9 9 5 6 8 3 3 0
NaAc (136 ImU)(x.s.) 14 16 11 15 14 16 13 16 17 10 198 9.9 0
9 8 8 10 10 8 >3 6 8 7
PAS 25 27 22 33 24 20 21 19 16 299 15 12.6
Alcian Blue 5
Neuraminidase + Anti-ser .
(136 ImU) + R78 7 3 0 10 5 3 5 6 5 3
0.2 ml + 0.1 ml (x.s.) 4 4 8 20 27 11 10 10 13 11 165 8.3 0
10 5 4 25 12 22 29 8 7 5 I
Alcian Blue (x.s.) 11 17 19 21 18 20 17 14 14 17 295 14.8 12.9
Neuraminidase + Anti-ser •
(136 ImU) + R78 6
Q .2 ml + 0.2 ml 4 5 6 3 8 3 5 1 3 5
13 21 14 12 16 12 11 10 8 13 173 8.7 6.9
ms. 19 23 26 15 12 20 14 13 13 10
27 26 32 17 18 15 12 21 33 16 382 19.1 18.0
Alcian Blue 7
Neuraminidase + Anti-ser .
(136 ImU) + R78 12 26 12 11 9 10 7 6 8 3
0.2 ml + 0.3 ml 19 32 33 29 22 23 18 19 16 11 326 16.3 13.8
17 22 16 33 19 22 32 16 18 8
t
Alcian Blue (x.s.)
30 33 32 33 27 34 23 27 28 17 487 24.4 23
8
Neuraminidase + Anti-ser
(136 ImU) + R78 7 5 4 0 0 0 0 0 0 0
0.2 ml + 0,5 ml 17 21 19 0 0 0 0 0 2 1 76 3.8 0
PAS. 32 35 30 32 30 45 30 34 29 14
29 40 25 25 29 34 20 26 22 30 591 29.6 28.7
*
Geometric mean =
X. ;x
n
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Appendix VIII
The effect of anti-neuraminidase serum (DST R78) against
non-cholera neuraminidase
Prep. Total Statistical
Treatment and Staining No. count t-value significance 
(two-tailed test) 
p value 38 d.f.
Alcian Blue
Untreated
Neuraminidase + Anti-ser,
1
8
399
76
9.70 <0.0002
(136 IraU) + R78
0.2 ml + 0.5 ml
PAS
Untreated
Neuraminidase + Anti-ser.
1
8
131
591
-12.45 <0.0002
(136 IraU) + R78
0,2 ml + 0.5 ml "
Alcian Blue
Untreated 1 399
1.75 <0.10Neuraminidase + Anti-ser. 7 326
(136 ImU) + R78
0.2 ml + 0.3 ml
PAS
Untreated
Neuraminidase + Anti-ser,
1
7
131
487 -8.92
<0.0002
(136 ImU) + R78
0.2 ml + 0.3 ml .
Alcian Blue
Untreated
Neuraminidase + Anti-ser.
1
6
399
173 8.43
<0.0002
(136 ImU) + R78
0.2 ml + 0.2 ml
PAS
Untreated
Neuraminidase + Anti-ser.
1
6
131
382 -6.81 <0.0002
(136 IraU) + R78
0.2 ml + 0.2 ml
Alcian Blue
Untreated
Neuraminidase + Anti-ser,
1
5
399
165
7.52 <0.0002
(136 ImU) + R78
0.2 ml + 0.1 ml
PAS
Untreated
Neuraminidase + Anti-ser,
1
5
131
295
-4.35 <0,0002
(136 ImU) + R78
0.2 ml + 0.1 ml
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Appendix VIII
The effect of anti-neuraminidase serum (DST R78) against
non-cholera neuraminidase
Treatment and Staining
Prep. 
N o .
Total
count t-value
Statistical 
significance 
(two-tailed test 
p value 38 d.f.
Alcian Blue 
Untreated
Neuraminidase + 0.05M NaAc 
(136 IraU)
0.2 ml + 0,5 ml
PAS
Untreated
Neuraminidase + 0.05M NaAc 
(136 ImU)
0.2 ml + 0,5 ml
Alcian Blue 
Untreated
Neuraminidase (Cl.perfrin,) 
(136 ImU)
PAS
Untreated
Neuraminidase (Cl.perfrin.) 
(136 ImU)
Alcian Blue ^
Untreated
0.05M NaAc buffer pH 5.0 
PAS
Untreated
0«05M NaAc buffer pH 5.0, 
Alcian Blue
0.05M NaAc buffer pH 5.0 
Neuraminidase (Cl,perfrin.) 
(136 ImU) 1
■PAS
0.05M NaAc buffer pH 5.0 
Neuraminidase (CI.perfrin.) 
(136 ImU)
Alcian Blue
0.05M NaAc buffer pH 5.0 
Neuraminidase + 0.05M NaAc 
(136 ImU)
0.2 ml + 0.5 ml 
PAS
0.05M NaAc buffer pH 5.0 
Neuraminidase + 0.05M NaAc 
(136 ImU)
0.2 ml + 0.5 ml
399
198
131
299
399
60
131
481
399
221
131
416
221
60
416
481
221
198
416
299
7.66
-3.89
18.39
-9.64
6.00
-7.40
5.40
-1.48
0.65
<0.0002
<0.001
<0.0002
<0.0002
<0.0002
<0.0002
<0.0002
<0.20
<0.80
2.36 <0.050
Appendix VIII
i
The effect of anti-neuratainldase serum (DST R78) against
non-cholera neuraminidase
Treatment and Staining
Prep. 
No.
Total
count t-value
Alcian Blue
0,05M NaAc buffer pH 5,0 
Neuraminidase + Anti-ser. 
(136 ImU) + R78 
0.2 ml + 0.1 ml 
PAS
0;05M NaAc buffer pH 5.0 
Neuraminidase + Anti-ser. 
(136 ImU) + R78 
0 i 2 ml + 0.1 ml
Aj-cian Blue
0ij05M NaAc buffer pH 5.0 
Neuraminidase + Anti-ser. 
(136 ImU) + R78 
0 ’2 ml + 0.2 ml 
PAS
0.05M NaAc buffer pH 5.0 
Neuraminidase + Anti-ser. 
(136 ImU) + R78 
0.2 ml + 0.2 ml
Alcian Blue
0.05M NaAc buffer pH 5.0 
Neuraminidase + Anti-ser. 
(136 IraU) + R78 
0.2 ml + 0.3 ml 
PAS
0.05M NaAc buffer pH 5.0 
Neuraminidase + Anti-ser, 
(136 ImU) + R78 
0.2 ml + 0,3 ml
Alcian Blue
0.05M NaAc buffer pH 5.0 
Neuraminidase + Anti-ser. 
(136 ImU) + R78 
0.2 ml + 0,5 ml 
PAS
0.5M NaAc buffer pH 5.0 
Neuraminidase + Anti-ser. 
(136 IraU) + R78 
0.2 ml + 0.5 ml
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
221
165
416
295
221
173
416
382
221
326
416
487
221
76
416
591
1.44
2.69
1.35
0.77
-2.19
-1.52
3.56
-3.95
<0.20
<0.02
<0.20
<0.50
<0.05
<0.20
<0.01
<0.001
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Appendix VIII
The effect of anti-neuraminidase serum (DST R78) against
non-cholera neuraminidase
Treatment and Staining
Prep. Total
No. count
Statistical 
t-value significance
(two-tailed test) 
_______________p value 38 d.f.
Alcian Blue
Neuraminidase + 0.05M NaAc 
(136 ImU)
0.2 ml + 0.5 ml 
Neuraminidase + Anti-ser. 
(136 ImU) + R78 
0.2 ml + 0.1 ml 
PAS
Neuraminidase + 0.05M NaAc 
(136 IraU)
0.2 ml + 0.5 ml 
Neuraminidase + Anti-ser. 
(136 ImU) + R78 
0.2 ml + 0.1 ml
Alcian Blue 
Neuraminidase + 
(136 ImU)
0.2 ml + 0.5 ml 
Neuraminidase + 
(136 ImU) + 
0.2 ml + 0.2 ml 
PAS
Neuraminidase + 
(136 ImU)
0,2 ml + 0.5 ml 
Neuraminidase + 
(136 ImU)
0.2 ml + 0.2 ml
Alcian Blue 
Neuraminidase + 
(136 IraU)
0.2 ml + 0.5 ml 
Neuraminidase + 
(136 ImU) ; +
0,2 ml + 0,3 ml 
PAS
Neuraminidase + 
(136 ImU)
0.2 ml + 0.5 ml
Neuraminidase +
(136 ImU) + 
0.2 ml + 0.3 ml
0.05M NaAc
Anti-ser.^
R78
0.05M NaAc
Anti-ser.
0.05M NaAc
Anti-ser. 
R78
0.05M NaAc
Anti-ser.'
R78
198
165
299
295
198
173
299
382
198
326
299
487
0.91
0.082
0.76
-1.72
-2.79
-3.71
<0.50
>0.80
<0.50
<0.10
<0.01
<0.001
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Appendix VIII
The effect of anti-neuraminidase serum (DST R78) against 
non-cholera neuraminidase
TjJreatment and Staining
Prep, 
N o .
Total
count
Statistical 
t-value significance
(two-tailed test) 
_____________ p value 38 d.f.
Alcian Blue 
Neuraminidase + 
(136 ImU)
0.2 ml + 0.5 ml 
Neuraminidase + 
(136 ImU) +
0.2 ml + 0.5 ml 
PAS
Neuraminidase + 
(136 ImU)
0.2 ml + 0.5 ml 
Neuraminidase + 
(136 ImU) +
0,2 ml + 0.5 ml
0.05M NaAc
Anti-ser,
R78
0.05M NaAc
Anti-ser.
R78
198
76
299
591
3.18
-6.04
<0.01
<0.0002
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The effect of specific anti-neuraminidase serum (DST R78) and
the IgG fraction (of D^T R78)
Treatment and Prep.
No. Individual counts field
-1
Total Mean
count Arith. *Geom,
Alcian Blue
Untreated (x.s.) i 25 20 23 16 25 18 44 11 32 26
22 16 17 10 13 13 12 14 18 19 394 19.7 18,4
PAS 7 13 4 3 2 11 5 10 0 0
9 15 0 6 7 9 7 12 3 5 128 6.4 0
Alcian Blue 2
Water (x.s.) 36 32 20 29 15 25 16 15 8 20
11 16 13 18 12 22 18 14 12 13 365 18.3 17.0
PAS 4 6 8 5 4 9 13 9 10 0
6 3 0 8 5 8 6 11 7 0 122 6.1 0
Alcian Blue
b.05M NaAc buffer 10 22 31 16 17 19 21 18 10 25
pH 5,5 (x.s.) 24 26 20 14 20 12 14 15 24 22 380 19 18.2
PAS 14 12 2 0 3 1 3 6 8 0
25 16 8 3 0 0 6 16 14 5 142 7.1 0
Alcian Blue (x.s,) .4
Neuraminidase ^ 18 13 19 7 9 11 5 7 11 9
(V,cholerae)(5.5 ImU) 11 5 18 10 16 21 8 13 4 17 232 11.6 10,5
PAS 22 17 21 18 23 16 25 18 12 21
10 11 9 8 13 12 11 9 8 15 299 15 14
Alcian Blue (x.s.) 5
Neuraminidase +
NaAc buffer N 2  (5.5 IraU) 20 18 6 11 23 12 13 18 11 22
0.1 ml + 0.25 ml 13 11 17 7 14 10 19 15 17 19 296 14.8 14
PAS 16 19 12 9 2 21 17 13 8 4
12 8 9 14 8 9 11 9 7 3 211 10.6 9.2
Alcian Blue (x.s.) 6
Neuraminidase + IgG fr^ct.
«2 (5.5 ImU) + IgG (R78> 16 20 19 14 23 25 24 23 26 20
0.1 ml + 0.05 ml 22 15 17 10 26 28 19 21 14 11 393 19.7 18.9
PAS 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
Alcian Blue;(x.3.) 7
Neuraminidase + IgG fract.
N2 (5.5 ImU) + IgG (R78r 18 16 15 10 19 12 18 17 10 25
0.1 ml + 0.25 ml 19 18 32 23 26 24 15 24 21 16 378 18,9 18.1
PAS 0 0 0 0 0 0 0 0 0 0
1 2 0 0 0 0 6 1 3 0 13 1 0
/ician Blue (x.s,) 8
IgG fract. f; 0.05M NaAc 41 24 29 30 18 40 12 15 18 12
0,25 ml + 0 , 1  ml 17 10 18 32 30 16 7 14 8 9 390 20 17.6
PAS 3 1 0 0 0 0 0 3 0 0
0 1 1 5 0 1 0 4 2 1 22 1.1 0
^Geometric mean ~ ^
X,.. X. ..X
1n
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The effect of specific anti-neuraminidaee serum (DST R78) and 
the IgG fraction (of DST R78)
Treatment and 
Staining_____
Prep,
No. Individual counts field
-1 Total Mean
count Arith. *Geom.
•Alcian Blue (x.s.) 
Neuraminidase + Anti-ser
N 2  (5.5 ImU) + R78 8 0 10 3 2 4 0 0 5 6
0.1 ml + 0.05 ml 10 9 7 9 18 11 2 3 11 4 122 6.1 0
PAS 46 47 41 30 38 26 25 24 47 20
11 19 17 10 14 18 13 16 13 10 485 24.3 21.3
Alcian Blue (x.s.) . 10 - ,
Neuraminidase + Anti-ser,
N2 (5.5 ImU) + R78 12 24 22 8 5 6 10 0 14 15
.0.1 ml + 0,2 ml 21 8 7 11 16 7 9 6 18 13 232 11.6 0
PAS 55 39 35 67 42 26 40 29 26 22
17 12 14 19 14 13 11 15 21 12 529 26.5 22.8
Alcian Blue (x.s.) 11
Neuraminidase + Anti-ser
N2 (5.5 ImU) + R78 6 8 9 0 0 0 5 7 0 4
0.1 ml + 0.25 ml 9 16 24 13 3 13 16 13 6 10 162 8.1 0
m s 40 63 28 41 14 24 36 37 30 24
13 21 15 21 10 12 9 10 12 15 475 23.8 20.4
Alcian Blue (x.s.) 12
Anti-ser. + 0.05M NaAc 33 7 0 4 0 10 0 6 0 3
0.25 ml + 0.1 ml 14 22 25 9 0 14 17 14 3 12 193 9.7 0
PAS 28 27 41 28 25 31 25 21 29 39
18 13 12 14 16 15 13 7 10 17 429 21.5 19.4
^Geometric mean = X X ...X...X
I n
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The effect of specific anti-neuraminidase serum (DST R78)
and the IgG fraction (of DST R78)
Treatment and Staining
Prep, Total 
No . count
Statistical 
s itnificance 
t-value (two-tailed test) 
p value 38 d,f.
Alcian Blue 
Untreated
Anti-ser, + 0,05M NaAc 
0.25 ml + 0.1 ml 
PAS
Untreated
Anti-ser. + 0.05M NaAc 
0.25 ml + 0.1 ml
Alcian Blue
Untreated ,
Neuraminidase + Anti-ser. 
N. (5.5 ImU) + R78 
0.1 ml + 0.25ml 
PAS
Untreated
Neuraminidase + Anti-ser. 
N 2  (5.5 ImU) + R78 
0.1 ml + 0.25 ml
Alcian Blue 
Untreated
Neuraminidase + Anti-ser. 
N^ (5.5 ImU) + R78 
0.1 ml + 0.20 ml
PAS
Untreated 
: Neuraminidase + Anti-ser. 
• N2 (5.5 ImU) + R78 '
0.1 ml + 0.20 ml
Alcian Blue 
Untreated
Neuraminidase + Anti-ser. 
N2 (5.5 ImU) + R78 
0.1 ml + 0.05 ml
PAS
Untreated
Neuraminidase + Anti-ser. 
N 2  (5.5 ImU) + R78 
0.1 ml + 0.05 ml
1
12
1
12
1
11
1
11
1
10
1
10
394
193
128
429
394
162
128
475
394
232
128
529
394
122
128
485
3.64
-6.43
5.02
-5.28
3.54
-5.55
6.50
-5.85
<0.001
<0.0002
■ < 0.0002
<0.0002
<0.01
<0.0002
<0.0002
<0.0002
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The effect of specific anti-neuraminidase serum (DST R78) and
the IgG fraction (of DST R78)
Treatment and Staining
Prep. Total 
No. count t-value
Alcian Blue 
Untreated
IgG fract. + 0.05 M NaAc 
0.25 ml + 0.1 ml '
PAS
Untreated
IgG fract. + 0.05 M NaAfc 
0.25 ml + 0.1 ml
Alcian Blue ;
Tjfntreated f
Neuraminidase + IgG fract. 
N2 (5.5 ImU) + IgG (R78) 
0.1 ml + 0.25 ml 
PAS
Untreated
Neuraminidase + IgG fract. 
È2 (5.5 IraU) + IgG (R78) 
0.1 ml + 0.25 ml '
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
Alcian Blue E
Untreated
Neuraminidase + IgG fract. 
N2 (5,5 ImU) + IgG (R78) 
0.1 ml + 0.05 ml 
PAS
Untreated
Neuraminidase + IgG fract. 
N 2  (5.5 ImU) + IgG (R78) 
0.1 ml + 0.05 ml
Alcian Blue 
Untreated
Neuraminidase + NaAc buffer 
N2 (5.5 ImU)
0.1 ml + 0.25 ml 
PAS
Untreated
Neuraminidase + NaAc buffer 
N2 (5.5 ImU)
0,1 ml + 0.25 ml
Alcian Blue 
Untreated
Neuraminidase (V. Cholerae) 
(5.5 ImU)
FAS
Untreated
Neuraminidase (V. Cholétàe) 
(5.5 ImU) ...................
394
390
128
22
394
378
128
13
394
393
128
0
394
296
128
211
394
232
128
299
0.068
5.06
0.364
5.50
0.023
6.46
2.33
-2.75
3,78
-5.47
>0.80
<0.0002
<0.80
<0.0002
>0.80
<0.0002
<0.05
<0.01
<0.001
<0.0002
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The effect of specific anti-neuraminidase serum (DST R78) and
the IgG fraction (of DST R78)
Treatment and Staining
Prep. Total 
N o . count
Statistical 
t-value significance
(two-tailed test) 
______ ______ p value 38 d.f.
Alcian Blue 
Untreated
0.05M NaAc buffer pH 5.5
PAS
Untreated
0.05M NaAc buffer pH 5.5
Alcian Blue 
Untreated 
Water 
PAS
Untreated
Water i
Alcian Blue
0.05M NaAc buffer pH 5.5 
Neuraminidase ( v .cholerae) 
(5.5 ImU)
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase (V.cholerae) 
(5.5 ImU)
Alcian Blue
0.05M NaAc buffer pH 5.5 
Neuraminidase + NaAc buffer 
N 2  (5.5 ImU)
0.1 ml + 0.25 ml 
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase + NaAc buffer 
N 2  (5.5 ImU)
0.1 ml + 0.25 ml
Alcian Blue
0.05M NaAc buffer pH 5.5 
Neuraminidase + Anti-ser.
N 2  (5.5 ImU) + R78 
0.1 ml + 0.05 ml 
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase + Anti-ser.
N 2  (5.5 ImU) + R78 
0,1 ml + 0.05 ml
394
380
128
142
394
365
128
122
380
232
142
299
380
296
142
211
380
122
142
485
0.318
-0.379
0.593
0.235
4.37
-3.98
2.56
-1.79
7.91
<0.80
<0.80
<0.80
<0.80
<0.0002
<0.001
<0.02
<0.10
<0.0002
-5.23 <0.0002
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li
The effect of specific anti-neuraminidase serum (DST R78) and
the IgG fraction (of DST R78)
Treatment and Staining.
Alcian Blue
0.05M NaAc buffer pH 5,5 
Neuraminidase + Anti-ser. 
N2 (5.5 ImU) + R78 
0.1 ml + 0.20 ml 
hPAS
D.05M NaAc buffer pH 5.5 
Neuraminidase + Anti-ser. 
'N2  (5.5 ImU) + R78 
0.1 ml + 0.20 ml
,Alcian Blue
0.05M NaAc buffer pH 5.5 
Neuraminidase + Anti-ser. 
N2 (5.5 ImU) + R78 
0.1 ml + 0.25 ml |
PAS
0.05M NaAc buffer pH 5,5 
Neuraminidase + Anti-ser. 
N 2  (5.5 ImU) + R78 
0.1 ml + 0.25 ml ^
Alcian Blue
0,05M NaAc buffer pH 5.5 
Anti-ser. + 0.05M NaAc 
0.25 ml + 0.1 ml 
PAS
0,05M NaAc buffer pH 5.5 
Anti-ser. + 0.05M NaAc 
0.25 ml + 0.1 ml
Alcian Blue
0.05M NaAc buffer pH 5.5 
Neuraminidase + IgG fract. 
N2 (5.5 ImU) + IgG (R78) 
0.1 ml + 0,05 ml
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase + IgG fract. 
N2 (5.5 ImU) + IgG (R78) 
0.1 ml + 0.05 ml
Prep.
No.
Total
count
Statistical 
significance 
t-value (two-tailed test) 
_____________ p value 38 d.f.
3
10
3
10
3
11
3
11
3
12
3
12
380
232
142
529
380
162
142
475
380
193
142
429
380
393
142
0
3.94
-5.08
5.73
-4.76
3.84
-5.45
-0.38
4.56
<0.001
<0.0002
<0.0002
<0.0002
<0.001
<0.0002
<0.80
<0.0002
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The effect of specific anti-neuraminidase serum (DST R78) and
the IgG fraction (of DST R78)
Prep
No,
Total
countTreatment and S t a i n i n g _________________
Alcian Blue
0.05M NaAc buffer pH 5.5 3 380
Neuraminidase + IgG fract. 7 378
N 2  (5.5 ImU) + IgG (R78)
0.1 ml + 0.25 ml 
PAS
0.05M NaAc buffer pH 5.5 3 142
Neuraminidase + IgG fratt. 7 13
N 2  (5.5 ImU) + IgG (R78)
0.1 ml + 0.25 ml
Alcian Blue
0,05M NaAc buffer pH 5.5 3 380
IgG fract, + 0.05M NaAc, 8 390
0.25 ml + 0.1 ml 
PAS
0.05M NaAc buffer pH 5.5 3 142
IgG fract. + 0.05M NaAc 8 22
0.25 ml + 0.1 ml f
Alcian Blue
Neuraminidase + NaAc buffer 5 296
N2 (5.5 ImU)
0.1 ml + 0.25 ml
Neuraminidase + Anti-ser. 9 122
N 2  (5,5 ImU) + R78 
0.1 ml + 0.05 ml 
PAS
Neuraminidase + NaAc buffer 5 211
N (5.5 ImU)
071 ml + 0.25 ml
Neuraminidase + Anti-ser. 9 485
N 2  (5.5 ImU) + R78 
0,1 ml + 0,05 ml
Alcian Blue
Neuraminidase + NaAc buffer 5 296
N2 (5.5 IraU)
0.1 ml + 0.25 ml
Neuraminidase + Anti-ser. 10 232
N2 (5.5 ImU) + R78 
0.1 ml + 0.20 ml 
PAS
Neuraminidase + NaAc buffer 5 211
N 2  (5.5 ImU)
0.1 ml + 0.25 ml
Neuraminidase + Anti-ser. 10 529
N2 (5.5 ImU) + R78 
0.1 ml + 0.20 ml
t-value
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
0.06
4.05
-0.19
3.76
5.83
-4.42
1.82
-4.35
>0.80
<0.001
>0.80
<0,001
<0.0002
<0.0002
<0.10
<0.0002
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The effect of specific ‘anti-neuraminidase serum (DST R78) and
the IgG fraction (of DST R78)
Treatment and 
Alcian Blue ^  
Neuraminidase 
N2 (5,5 ImU) 
0.1 ml + 0.25 
Neuraminidase 
N 2  (5.5 ImU) 
0.1 ml + 0.25 
PAS
Neuraminidase 
N2 (5.5 ImU) 
Q.l ml + 0.25 
Neuraminidase 
«2 (5.5 ImU) 
Q.l ml + 0.25
Staining
Prep,
No.
Total
count t-value
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
IIcian Blue euraminidase 
^ 2  (5.5 ImU) 
0.1 ml + 0.25 
Neuraminidas e 
N 2  (5.5 IraU) 
0.1 ml + 0.05 
PAS
Neuraminidase 
N 2  (5.5 ImU) 
0.1 ml + 0.25 
Neuraminidase 
N2 (5.5 ImU) 
0.1 ml + 0.05
Alcian Blue 
Neuraminidase 
N 2  (5,5 ImU) 
0.1 ml + 0,25 
Neuraminidas e 
N2 (5.5 IraU) 
0.1 ml + 0,25 
PAS
Neuraminidase 
N2 (5.5 ImU) 
0,1 ml + 0,25 
Neuraminidase 
N 2  (5.5 ImU) 
0.1 ml + 0.25
+ NaAc buffer 
ml
+ Anti-ser.
+ R78 
ml I
+ NaAc buffer
L
ml 1
+ Anti-ser.
+ R78 
ml £
+ NaAc buffer
ml ^
+ IgG fract.
+ IgG (R78) 
ml
+ NaAc buffer
ml '■
+ IgG fract.
+ IgG (R78) 
ml
+ NaAc buffer 
ml
+ IgG fract.
+ IgG (R78) 
ml
+ NaAc buffer 
ml
+ IgG fract.
+ IgG (R78) 
ml
11
5
11
296
162
211
475
296
393
211
3.75
-3.96
-3.09
9.30
296
378
211
13
-2.50
8.37
<0.001
<0.001
<0.01
<0,0002
<0.02
<0.0002
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The effect of non-inununè serum
Treatment and Prep.
No. Individual counts field-1
Total Mean
count Arith, *Geom.
Alcian Blue 1
Untreated (x.s.) 28 38 27 31 36 35 25 17 25 17
40 20 14 18 17 20 18 12 17 22 477 22.9 22.5
PAS 0 5 0 0 1 2 5 4 6 7
' 8 4 12 6 3 7 8 3 7 10 98 4.9 0
Alcian Blue 2'
Water (x.s.) 16 13 22 25 12 14 18 11 26 20
12 14 19 11 9 12 10 12 18 16 310 15.5 14.8
PAS 1 0 9 12 1 2 3 1 4 0
4 6 5 6 5 4 0 7 5 5 80 4 i 0
Alcian Blue 3
0 .05M NaAc buffer pH 5,5 17 16 7 8 14 8 19 23 14 7
23 21 22 15 12 13 15 11 13 14 292 14.6 13.7
ÉAS 5 3 11 0 2 2 ■ 0 0 0 1
9 10 12 13 7 14 • 5 7 15 10 126 6.3 0
Alcian Blue (x.s.) 4
Neuraminidase (V.cholerae) 11 17 9 10 9 13 , 9 15 13 11
(11 ImU) 16 18 22 18 19 17 13 12 16 12 280 14 13.5
PAS 3 0 3 1 0 4 ' 3 2 6 4
0 7 7 15 12 6 6 4 10 0 93 4.7 0
Alcian Blue (x.s.) 5
Nueraminidase+NaAc buffer
N 2  (11 ImU) 27 17 16 22 18 17 28 27 29 20
0,2 ml + 0.5 ml 23 26 25 27 24 21 20 18 15 10 430 21.5 20.8
PAS 1 0 0 2 3 1 ■ 4 3 0 4
0 0 3 5 1 6 3 2 3 8 49 2.5 0
Alcian Blue (x.s.) 6
Neuraminidase+Serum
N 2  (11 ImU) + Normal set. 27 25 34 17 30 24 17 12 21 16
,0.2 ml + 0.1 ml 19 12 18 5 14 11 19 14 6 12 353 17.7 16
PAS 12 15 10 9 7 15 20 6 8 13
13 18 14 10 12 13 11 10 9 7 232 11.6 11.1
Alcian Blue (x.s.) 7
Neuraminidase+Serum
N 2 (11 IraU) + Normal set. 24 26 29 12 29 14 30 19 18 15
0.2 ml + 0.2 ml 15 19 11 11 13 10 12 13 11 14 345 17.3 16,2
PAS 8 6 5 0 0 0 0 0 0 1
14 10 0 0 0 0 0 0 0 0 44 2.2 0
Alcian Blue (x.s.) 8 '
Neuraminidase+Norraal ser.
0.2 ml + 0.3 ml 28 14 10 12 13 25 10 13 12 21
10 9 8 9 7 11 16 8 9 7 252 12.6 11.6
2AS. 0 4 6 5 10 0 0 0 0 0
0 0 0 2 4 0 0 0 2 0 33 1.7 0
^Geometric mean = n
7 •Ï X ,x. Xn
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The effect of non-immune serum
Treatment and 
Staining
Prep,
No. Individual counts field
-1 Total Mean 
count Arith, *Geom.
Alcian Blue (x.s.) 
Neuraminidase+Serum
N2 (11 ImU)+Normal ser. 14 5 9 3 14 18 22 14 20 6
0.2 ml + 0.4 ml 12 7 5 8 13 12 10 17 10 11 230 11.5 10.3
PAS 17 21 19 17 9 6 9 8 12 10
11 9 12 10 7 19 14 18 9 7 244 12.2 11.4
Alcian Blue (x.s.) ^0
Normal ser. + 0.05M NaAc 
0.5 ml + 0.2 ml 
PAS
32 29 15 18 11 26 29 19 26 25
12 13 8 10 4 13 12 7 16 15 340 17 15
16 23 12 28 16 11 19 10 19 21
14 9 6 17 9 10 15 13 10 22 300 15 14
*Geometric mean X
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Treatment and Staining
Prep. 
No.
Total
count
Alcian Blue
Untreated 1 477
Neuraminidase + Serum 6 353
N 2  (11 ImU) + Normal ser.
0.2 ml + 0.1 ml
PAS
Untreated 1 98
Neuraminidase + Serum 6 232
N 2  (11 ImU) + Normal ser.
0.2 ml + 0.1 ml
Alcian Blue
Untreated 1 477
Neuraminidase + 0.05M NaAc 5 430
N 2  (11 ImU)
0.2 ml + 0.5 ml
PAS
Untreated 1 98
Neuraminidase + 0.05M NaAc 5 49
N 2  (11 ImU)
0,2 ml + 0.5 ml
Alcian Blue
Untreated 1 477
Nepraminidase (V.cholerae). 4 280
(11 ImU)
PAS
Untreated 1 98
Neuraminidase (V,cholerae) 4 93
(11 ImU)
Alcian Blue
Untreated 1 477
0.05M NaAc buffer pH 5.5 3 292
PAS
Untreated 1 98
0.05M NaAc buffer pH 5.5 3 126
Alcian Blue
Untreated 1 477
Water 2 310
PAS
Untreated 1 98
Water ......................... . , .2 . . , 80
t-value
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
2.46
- 6.02
lv07
2.72
4.79
0.210
4.21
-1.01
3.83
0.871
<0.02
<0.0002
<0.50
<0.01
<0.0002
>0.80
<0.0002
<0.50
<0.001
<0.50
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Treatment and Staining
Prep. 
No.
Total
count t-value
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
Alcian Blue 
Untreated
Normal ser. + 0.05M NaAc 
0.5 ml + 0.2 ml
PAS
Untreated
Normal ser. + 0.05M NaAc 
0.5 ml + 0.2 ml
Alcian Blue 
Untreated
Neuraminidase + Serum 
N 2  (11 ImU) + Normal ser. 
0.2 ml + 0.4 ml
PAS
Untreated
Neuraminidase + Serum 
N 2  (11 ImU) + Normal ser. 
0.2 ml + 0.4 ml
Alcian Blue 
Untreated
Neuraminidase + Serum 
N 2  (11 IraU) + Normal ser. 
0.2 ml + 0.3 ml
PAS
Untreated
Neuraminidase + Serum 
N 2  (11 ImU) + Normal ser. 
0.2 ml + 0.3 ml
Alcian Blue 
Untreated
Neuraminidase + Serum 
N2 (11 ImU) + Normal ser,
0,2 ml + 0.2 ml
FAS
Untreated
Neuraminidase + Serum 
N 2  (11 IraU) + Normal ser.
0.2 ml + 0.2 ml
1
10
1
10
477
340
98
300
477
230
98
244
477
252
98
33
477
345
98
44
2.61
-6.83
5.60
-5.67
4.92
3.33
2.74
2.26
<0.02
<0.0002
<0.0002
<0.0002
<0.0002
<0.01
<0.01
<0.05
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Treatment and Staining
Prep
No.
Total
count t-value
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
Alcian Blue
0.05M NaAc buffer pH 5.5 
Neuraminidase (V.cholerae) 
(11 ImU)
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase (V.cholerae) 
(11 IraU)
Alcian Blue
0.05M NaAc buffer pH 5.5» 
Neuraminidase + NaAc buffer 
N 2  (11 ImU)
0.2 ml + 0.5 ml
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase + NaAc buffer 
N 2  (11 ImU)
0.2 ml + 0.5 ml
Alcian Blue
0.05M NaAc buffer pH 5.5“ 
Neuraminidase + Serum 
N 2  (11 ImU) + Normal ser. 
0.2 ml + 0.1 ml ^
P^S
0,05M NaAc buffer pH 5.5 
Neuraminidase + Serum 
N 2  ( 1 1  ImU) + Normal ser. 
0.2 ml + 0.1 ml
;Alcian Blue
0.05M NaAc buffer pH 5.5 
Neuraminidase + Serum 
N 2  ( 1 1  ImU) + Normal ser. 
0.2 ml + 0 . 2  ml
PAS
0.05M NaAc buffer pH 5.5 
Neuraminidase + Serum 
N 2  ( 1 1  ImU) + Normal ser. 
0.2 ml + 0.2 ml
292
280
126
93
292
430
126
48
292
353
126
232
292
345
126
44
0.42
1.12
-4.26
3.09
-1.50
-3.74
-1.40
2.77
<0.80
<0.50
<0,0002
<0,01
<0.20
<0.001
<0.20
<0.010
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Treatment and Staining
Prep 
N o .
Total
count t-value
Statistical 
significance 
(two-tailed test) 
p value 38 d.f.
Alcian Blue
0.05M NaAc buffer pH 5.5 3
Neuraminidase + Serum 8
N2 (11 ImU) + Normal ser.
0.2 ml + 0.3 ml 
PAS
0.05M NaAc buffer pH 5.5 3
Neuraminidase + Serum 8
N2 (11 ImU) + Normal ser.
0.2 ml + 0.3 ml
Alcian Blue
0.05M NaAc buffer pH 5.5 3
Neuraminidase + Serum 9
N 2  (11 IraU) + Normal ser.
0.2 ml + 0.4 ml 
PAS
0.05M NaAc buffer pH 5.5. 3
Neuraminidase + Serum 9
N 2  ( 1 1  ImU) + Normal ser.
0.2 ml + 0.4 ml
(
Alcian Blue
0.05M NaAc buffer pH 5,5 3
Normal ser. + 0.05M NaAc 10
0*5 ml + 0.2 ml 
PAS
0.05M NaAc buffer pH 5.5 3
Normal ser, + 0.05M NaAc 10
0.5 ml + 0.2 ml
Alcian Blue 
Neuraminidase + 
N 2  (11 ImU)
0.2 ml + 0.5 ml 
Neuraminidase + 
N 2  (11 ImU) + 
0,2 ml + 0.1 ml 
PAS
Neuraminidase + 
N 2  (11 ImU)'
0.2 ml + 0.5 ml 
Neuraminidase + 
N 2  (11 ImU) + 
0.2 ml + 0.1 ml
NaAc buffer
Serum
Normal ser.
NaAc buffer
Serum
Normal ser.
292
252
126
33
292
230
126
244
292
340
126
300
430
353
49
232
1.16
3.54
1.91
-3.78
- 1.11
-5.06
1.88
-9.56
<0.50
<0.01
<0.10
<0.001
<0.50
<0.0002
<0.10
<0.0002
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Treatment and Staining
Prep,
No,
Total
count t-value
Statistical 
significance 
(two-tailed test) 
p value 38 d,f.
NaAc buffer
Serum
Normal ser.
NaAc buffer
Alcian Blue 
Neuraminidase +
N 2  (11 ImU)
0.2 ml + 0.5ml 
Neuraminidase +
N 2  (11 ImU) +
0.2 ml + 0.2 ml 
PAS
Neuraminidase +
N 2  (11 ImU)
0.2 ml + 0,5 ml 
Neuraminidase +Serum 
N 2  ( 1 1  ImU) + Normal ser. 
0.2 ml + 0.2 ml
Alcian Blue
Neuraminidase + NaAc buffer 
N2 (11 ImU)
0,2 ml + 0.5 ml 
Neuraminidase +
N 2  (11 ImU) +
0.2 ml + 0.3 ml 
PAS
Neuraminidase +
N 2  (11 ImU)
0.2 ml + 0.5 ml 
Neuraminidase +
N 2  (11 ImU) +
0.2 ml + 0.3 ml
Alcian Blue
Neuraminidase + NaAc buffer 
N 2  (11 ImU)
0.2 ml + 0.5 ml 
Neuraminidase + Serum 
N 2  ( 1 1  ImU) + Serum 
0.2 ml + 0.4 ml 
PAS
Neuraminidase + NaAc buffer 
N2 (11 ImU) ,
0.2 ml + 0.5 ml ,
Neuraminidase + Serum '
N 2  ( 1 1  ImU) + Normal ser. 
0.2 ml + 0 . 4  ml
S erum ^
Normal ser.
NaAc buffer
Serum
Normal ser.
430
345
49
44
430
252
49
33
430
230
49
244
2.24 <0.05
0.24 >0.80
5.12 <0.0002
1.01 <0.50
6.13 <0.0002
-8.43 <0.0002
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Appendix IX
Neuraminidase
preparation
Rabbit anti- 
neuraminidas e 
DST R77 (ml)
Corrected values of 
NANA released*
(yg)
«2 1.57 ImU 0.3 0
N2 1.57 ImU 0.4 1.50
«2
1.57 IraU 0.5 1.50
1,57 ImU 0 3.60
1.43 ImU 0.3 0
«3
1.43 ImU 0.4 0.25
«3 1.43 IraU
0.5 0.50
•^ 3
1.43 ImU 0 0.25
«4
1.0 ImU 0.3 1.25
1.0 ImU n 0.4 M 1.50
«4
1.0 ImU 0.5 2.50
«4
1.0 ImU 0 3.00
Sigma
3.4 ImU 0.5 1.00
Sigma
3.4 ImU 0 3.3
*Mucin (1.6 mg) was added to each test. All values were
corrected for the release of NANA i) from serum in the absence of mucin
and ii) from mucin by serum in the absence of enzyme.
NANA was measured by the T.B.A. assay.
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